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Summary 
Immuno-chemotherapeutic interactions in bovine onchocerciasis 
Germanus Soh Bah 
Onchocerciasis or river blindness is a debilitating skin disease caused by Onchocerca volvulus, 
with 15.5 million people afflicted in Africa. The adult stage of the causative agent, a filarial 
worm, resides in collagenous nodules and has a lifespan of 10 - 15 years. The control of 
onchocerciasis using annual mass drug administration with ivermectin targets the first-stage 
larvae (microfilariae, Mf). However, ivermectin fails to kill adult worms, and the treatment is 
contraindicated in individuals co-infected with another filarial nematode (Loa loa) due to the 
risk of severe adverse events. Whereas antibiotics of the tetracycline class can be adulticidal, 
treatment protocols are too long for widespread use. Tetracyclines target the obligate 
endobacterial symbiont of O. volvulus (Wolbachia), but the precise mechanism of worm 
killing is not fully defined. Previous data obtained from a bovine model of onchocerciasis 
(Onchocerca ochengi) indicate that worm death is associated with an immunological shift in 
the nodule from a neutrophil-dominated response to a local eosinophilia. We attempted to 
boost eosinophil responses against adult worms by vaccination preceding sub-lethal 
antibiotic therapy (SLT) in cattle. We assessed for the first time the effect of immunisation 
against an immunomodulatory antigen, onchocystatin, either alone or in combination with 
SLT, on skin Mf load, worm viability and intradermal nodule size at six time-points over one 
year. Systemic antibody and tissue eosinophil responses to vaccination were also evaluated. 
The effects of oxytetracycline on the female worm proteome and nodular transcriptome 
were analysed with reference to the O. ochengi, Wolbachia and bovine genomes. 
Immunochemotherapy was neither micro- nor macrofilaricidal, although significant levels of 
serum IgG and nodule eosinophilia were stimulated. “Gold standard” prolonged adulticidal 
therapy (ADT) induced a 60% reduction in adult worm viability after 52 weeks, while SLT was 
ineffective. Using label-free proteomics, 50% of 2,548 identified proteins were quantifiable 
between antibiotic-treated and control female worm samples. Wolbachia constituted <1% 
of these proteins, while the remainder were distributed between O. ochengi (30%) and 
bovine proteins on the worm surface (70%). The majority of the 203 differentially-regulated 
proteins of bovine origin were significantly enriched for cathelicidin, annexin, serpin, S-
100/ICaBP calcium binding, and Ras domains. Those associated with neutrophils were 
downregulated, whereas an eosinophil major basic protein homologue was upregulated, by 
the ADT regimen. Worm cuticle proteins were upregulated and all Wolbachia proteins were 
II 
 
downregulated by 36 weeks post-treatment. Applying RNA-seq to whole nodules, transcripts 
were assigned to each organism (68% worm, 28% bovine, 4% Wolbachia). In the ADT group, 
genes regulating apoptosis in bovine mitochondria (VDAC1) and worm neurons (CES-1 and 
CES-2) were highly expressed at early time-points. Filarial heat-shock proteins and innate 
immunity receptors were also upregulated, but there was reduced expression of the bovine 
NKG2D ligand 4 in the ADT group. Conversely, SLT upregulated the production of this ligand 
and other elements of the bovine immune response. Finally, Wolbachia initially upregulated 
stress-induced morphogen bolA and response regulator pleD alongside energy metabolism; 
but the latter was downregulated by the end of the experiment. In conclusion, prior 
immunisation failed to increase the efficacy of SLT in the O. ochengi model. Killing of adult 
worms following the ADT regimen was associated with decreases in neutrophil antimicrobial 
proteins, upregulation of an eosinophil granule protein and apoptotic events in both bovine 
cells and the worm. Disruption of Wolbachia energy metabolism and dysregulation of filarial 
innate immunity may also underlie the fatal effects of antibiotic treatment on O. ochengi. 
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Chapter 1 General Introduction 
 
1.1 Background 
Onchocerciasis is a vector-borne chronic skin and ocular disease of man caused by 
Onchocerca volvulus, a nematode filarial parasite that cannot replicate itself naturally 
in any other species, except gorillas (van den Berghe et al. 2009). It is a neglected 
tropical disease endemic in sub Saharan Africa, Latin America, and Yemen. The 
disease is believed to have originated from West African countries before spreading 
to the Americas during the slave trade era. Microfilariae (Mf) are responsible for the 
clinical manifestation of the disease. Reports of the disease have existed for more 
than two centuries and it was commonly referred to as “craw craw” (meaning itchy, 
scaly skin) and “river blindness”. Mf were first isolated from skin lesions and 
described by John O’Neill, a British surgeon on assignment in Sierra Leone (O'Neill 
1875). In 1890, the first adult worm was isolated from a nodule sample sent from 
Ghana and named Filarial volvulus by Leuckart, a German scientist. His finding was 
published by Patrick Manson in 1893, and he renamed the parasite O. volvulus 
(Blacklock 1927). Until 1917, the relationship between Mf and the adult intra-nodular 
worms was not yet established. Robles in 1917 from Guatamala, South America, 
provided evidence relating Mf from skin as a larval stage to adult worms located 
intranodularly, and described the clinical manifestations of the disease. Though he 
suspected that the black fly could be the vector responsible for the transmission of 
onchocerciasis, it was Blacklock (1927) who took the credit by proving with 
experimental evidence that Simulium damnosum Theobald, which breeds in fast-
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flowing rivers, was the vector transmitting O. volvulus (Blacklock 1927). Jean Hissette 
in 1932 and an American scientist, Strong, in 1938 observed that 20% of 
onchocerciasis patients on the Sankuru River in Congo were blind and half of the 
infected cases had visual impairment. Similar correlations between ocular pathology 
or eye disorders and onchocerciasis were reported in Ghana and Ivory Coast (Prost 
1986). Hence, the colloquial “river blindness” became synonymous with 
onchocerciasis. More eye disorders earlier associated with low skin or plasma vitamin 
A levels were reassessed and found to be caused by onchocerciasis (Macé et al. 
1997). Onchocerca patients in the early stages of the disease have a high risk of 
developing night blindness (Babalola 2012). 
Ivermectin (IVM) is the drug of choice used in global control programs to eradicate 
onchocerciasis. The manufacturer of Mectizan® (Merck) donated the drugs free of 
charge in 1989 for use in mass drug administration in infected areas by the World 
Health Organisation (WHO) for as long as it takes to eradicate the disease (WHO 
2018). The Onchocerciasis Control Programme (OCP), which was launched earlier in 
1974 to interrupt disease transmission by vector control in eleven West African 
countries, ended in 2002 after having freed 18 million children from the risk of 
blindness and reclaimed more than 250,000 km2 of fertile land for agriculture (WHO 
2018). IVM was introduced in 1987 during the OCP and became the mainstay of the 
African Programme for the Control of Onchocerciasis (APOC), which extended control 
to 19 countries outside the OCP. The original goal of APOC was to control 
onchocerciasis as a public health problem, but it changed its strategy to elimination 
in 2012 with a target of 80% eradication of onchocerciasis by 2025. The Technical 
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Consultative Committee of APOC recommended the intensification of current 
Community-Directed Treatment with Ivermectin (CDTI) and the use of a 
complementary strategy with alternative Community-Directed interventions CDI 
(Boussinesq et al. 2018), especially in areas with co-infection with Loa loa (Wanji et 
al. 2009). Although IVM is not macrofilaricidal, it renders the adult female worms 
temporarily infertile for at least six months. The WHO estimated with biannual mass 
drug distribution (MDA) of IVM over fifteen years, equivalent to the longest lifespan 
of O. volvulus, the disease will be eradicated. However, evidence of suboptimal 
response to IVM treatment has been reported from some foci in Ghana (Osei-
Atweneboana et al. 2011; Doyle et al. 2017) and Cameroon (Nana-Djeunga et al. 
2014). The main constraint in the control of the onchocerciasis is the lack of flexibility 
in the choice of drugs available for use. 
Antibiotics of the tetracycline family are macrofilaricidal when administered over a 
long period of time (Langworthy et al. 2000; Hoerauf et al. 2008b). Considerable 
efforts have been invested in the screening and identification of safe anthelminthics 
or antibiotics capable of macrofilaricidal activity with shorter treatment regimens, 
but to date, only doxycycline has been used in the field, being limited to restricted 
foci (Taylor et al. 2014). Significant insights has been made towards the identification 
of vaccine candidates (Boursou et al. 2018; Lustigman et al. 2018) with prophylactic 
and therapeutic potentials in the laboratory that need to be taken onto the clinical 
phase (Gregory and Maizels 2008). 
One way of diminishing the resistance of an organism is to discover its immune 
evasive strategy and counteract it. To evade immune attack, filarial parasites secrete 
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inhibitory molecules that prevent antigen-presenting cells from reporting their 
presence to T-cells. One major protein involved in worm protection is cysteine 
protease inhibitor (CPI), or cystatin (Lustigman et al. 1992), which interferes with 
antigen presentation (Manoury et al. 2001; Murray et al. 2005; Gregory and Maizels 
2008) thereby modulating adaptive immunity (Lustigman et al. 1991; Babayan et al. 
2012). CPI-2 from Onchocerca species is also known as onchocystatin or Ov7 
(Villadangos and Ploegh 2000; Manoury et al. 2001). Its presence on the cuticle of 
adult female worms and most other stages of O. volvulus, except mature Mf, makes 
it a potential vaccine target (Lustigman et al. 1991). Onchocystatin also plays an 
important role in parasite development by arresting the activity of cysteine proteases 
at the end of each moult (Lustigman et al. 1992). Acting as an immune evasion 
mechanism (Maizels et al. 2001), onchocystatin blocks the major histocompatibility 
complex (MHC) class II site on the antigen presenting cells (APC) and their ability to 
process antigen via papain-like proteases and asparaginyl endopeptidase (Manoury 
et al. 2001; Murray et al. 2005; Kopitar-Jerala 2006; Zavasnik-Bergant 2008; Maizels 
and McSorley 2016). 
Although the macrofilaricidal effect of tetracycline was first discovered some time 
ago using the cattle O. ochengi model (Langworthy et al. 2000) and doxycycline 
confirmed in other Wolbachia-harbouring filarial species (Hoerauf et al. 2008b), the 
exact mechanism of worm killing has yet to be clearly elucidated. Experimental 
evidence from both humans and cattle has shown that worm death is a sequela to 
depletion of the endosymbiont Wolbachia, depopulation of neutrophils and 
eosinophil degranulation on the worm surface. Eosinophils are effector immune cells 
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and release cytotoxic granules and mediatory cytokines onto helminths (Pearlman 
1997; Pearlman et al. 1999). Eosinophils play additional roles in the maintenance of 
cell integrity and wound healing, and serve as a linkage between the innate and 
adaptive immune responses (Klion and Nutman 2004; Berek 2016). The release of 
eosinophils into blood vessels is mediated by IL-5 and / or IL-4 (Horie et al. 1996) and 
they can be activated by a complement-dependent (the preferred site of attachment 
is on C3b-opsonised parasites) or antibody-dependent (IgG or IgE opsonised 
parasites) cell-mediated cytotoxicity, leading to a piecemeal degranulation response 
(Strote et al. 1990; Melo and Weller 2010). 
To elucidate the mechanism of worm killing by antibiotics, it is essential to 
understand the basis for mutualism between Wolbachia of Onchocerca spp and its 
filarial host. Because Wolbachia of Brugia (clade D) and that of Onchocerca (clade C) 
belong to different phylogenetic ”supergroups”, the mutual benefits with their hosts 
differ. While nutritional dependency on provision of haem and riboflavin by 
endosymbiont Wolbachia Brugia malayi (wBm) may exist (Rao et al. 2005), many 
filariae thrive without Wolbachia, including L. loa (Desjardins et al. 2013). 
Interestingly, uniquely among Wolbachia, Wolbachia Onchocerca ochengi (wOo) 
cannot synthesise riboflavin de novo; moreover, it cannot convert glucose to 
pyruvate in common with other Wolbachia strains (Darby et al. 2012). The worm’s 
glycolytic enzymes seem to interact with Wolbachia surface protein to enhance 
energy production to benefit both parties (S.L. O'Neill et al. 2013; Voronin et al. 
2016). Wolbachia may therefore serve as a source of energy for filarial nematodes. It 
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is most likely that targeting this energy source plays a vital role in worm death after 
antibiotic therapy. 
1.2 Rationale of Study 
1.2.1 Immunochemotherapy and Effects on Worm Viability 
Cytophilic antibodies (IgG3) generated by putative immune (PI) patients (Boyer et al. 
1991; Elson et al. 1995) target onchocystatin (CPI-2), retard larval development and 
affect worm viability, with a potential role in the long-term control and prevention of 
onchocerciasis (Arumugam et al. 2014a). Mutation of a key asparagine residue in CPI-
2 made the vaccine highly immunogenic  (Babayan et al. 2012; Arumugam et al. 
2014b) and using the Litomosoides sigmodontis laboratory mouse model, vaccination 
against mutated onchocystatin (LsCPI) and abundant larval transcript-1 (LsALT) 
induced significant prophylactic protection when co-administered with Th2 
enhancers. We are testing for the first time the combination of vaccination and 
antibiotic therapy for synergistic effects. 
1.2.2 Proteomics and Transcriptomic of Treated Parasites 
The proteome and transcriptome of antibiotic-treated Onchocerca worms have not 
been studied before. The concept of a “defence mutualism” between the filarial 
worm and its endosymbiont has been proposed as the most plausible mechanism 
underpinning the Wolbachia symbiosis with O. ochengi. This hypothesis was tested 
in a study illustrating eosinophil degranulation onto the worm surface before 
oxytetracycline-mediated death (Hansen et al. 2011). Other studies (Frederic 
Landmann et al. 2011) demonstrated that antibiotics cause apoptosis of germline 
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cells, embryos, and intrauterine Mf. It is essential to give an account of this symbiotic 
relationship at the transcriptional and protein levels. 
1.3 Objectives  
The aims of these studies are: 
1) To shorten the duration of anti-filarial antibiotic therapy by antibody 
opsonisation of the worm cuticle, prompting eosinophil degranulation. 
2) To identify molecular processes that can better explain the mechanism of 
worm killing using female worm proteomics and whole-nodule 
transcriptomics. 
3) To identify regulatory processes associated with worm death or survival 
after antibiotic therapy, paying attention to the worm-Wolbachia 
mutualism.  
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Chapter 2 Literature Review 
 
2.1 Characteristics of Filarial Nematodes  
2.1.1 Origin 
Filarial nematodes are parasitic roundworms (Figure 2.1) of vertebrates classified in 
the Onchocercidae with 80 genera as members (Anderson 1999). Only five of these 
genera (Brugia, Wuchereria, Onchocerca, Loa and Mansonella) commonly infect 
humans. The Onchocercidae probably originated from the Oswaldofilariinae of 
crocodiles that existed 150 million years ago (Chabaud and Bain 1994). 
2.1.2 Morphology 
A typical nematode has an anterior or cephalic blunt end, a cylindrical, slender and 
long body, and a tail that narrows to a pointed tip (Cross 1996; El-Massry and Derbala 
2000). Worm size varies with sex, age and species. John O’Neill was the first person 
to describe microfilaria (Mf), the first stage larva (L1) found in the skin of an O. 
volvulus infected person (O'Neill 1875; Neafie 1972). Mf is the motile stage that is 
released into the skin or blood for onward transmission by a blood-sucking vector. 
The first person to describe an adult O. volvulus was Leuckhart in an unpublished 
personal communication to Patrick Manson in 1886. A young male Onchocerca filaria 
will attain an adult size of 23 – 40 x 15 mm and female up to 500 – 700 mm long 
(Neafie 1972; Cross 1996; CAS 2012). A complete description of the anatomy of O. 
volvulus (Neafie 1972) highlighted key features which could be used to distinguish 
the different human filariae. This report also gave an apt description of the fine 
structures of the male and female worms, covering the cuticle, reproductive organs 
and digestive tracts. 
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Filarial nematodes are pseudocoelomates, with the reproductive and digestive tracts 
suspended within the pseudocoel. The body wall is composed of the hypodermis, 
epidermis and cuticle (the latter is outermost) (Franz 1982; Franz and Buttner 1983). 
The epidermis is a mass of membrane-less cells layered over a pair of longitudinal 
muscles which secrete the cuticle (Deas et al. 1974). The nervous system separates 
the epidermis from longitudinal muscles dorsally and ventrally. Unlike in the 
vertebrates, muscle cells branch towards the nerves. There are a series of nerve 
centres along the ventral nerves and close to the head, and a nerve ring connects the 
ventral to the dorsal nerves. Structural modifications exist on the cuticle of nodule-
forming worms, suggesting adaptation to permit limited active (energy-dependent) 
processes within the cuticle, allowing selective intake or excretion of substances 
across the cuticle (Deas et al. 1974). The cuticle of the male Onchocerca worm is 
thicker at the lateral regions and contains more layers than at the dorsal and ventral 
regions than those of the females (Franz 1982). The cuticle is about 90 μm thick, 
uniformly subdivided into three layers (Deas et al. 1974). The porous fibrous layer 
invaginates into the hypodermal plasmalemma or laminae. External to the fibrous 
layer is the matrix composed of amorphous material, which could only allow 
substances through via diffusion, and the cortex covered by an outward-folded 
trilaminate membrane covered with glycocalyx (Deas et al. 1974). The digestive tract 
of O. volvulus consists of a mouth, cuticle-lined oesophagus, and an intestine lined by 
a single layer of epithelium connected to the anus by a duct or cloaca in males, or 
cuticle-lined rectum in females (Neafie 1972). The anus terminates 65 or 210 μm from 
the posterior end of males or females, respectively. 
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Figure 2.1: Collagenase-digested O. ochengi nodule content (original magnification, x10) 
illustrating the female (♀) worm head (dark arrow) and male worms (♂). Host cells are bound 
to the coils of the female (green arrow). Image was taken using personal SAMSUNG GT-
S5830i phone. 
 
2.1.3 Habitat 
Adult filarial parasites dwell in body tissues of vertebrates, the most common sites 
being the dermis and the lymph vessels. The nodules containing female O. volvulus 
are in the subcutis, while those of its closest relative, O. ochengi in cattle are 
intradermal. Nodules are richly supplied with blood vessels and are the principal 
source of nutrients to the worm (George et al. 1985; Smith et al. 1988). There is 
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evidence for the presence of whole red blood cells in the gut of Litomosoides 
sigmodontis (Attout et al. 2005) implying that the worms from time to time consume 
a blood meal. Lymphatic filariae reside in lymph vessels and resist being carried away 
to the lymph nodes by adhering to the lymph vessel endothelium or “swimming” in 
an anti-current direction (Bain and Babayan 2003). 
2.1.4 Reproduction and Life Cycle 
Filarial worms are dioecious species. The males are mobile, migrating from nodule to 
nodule to inseminate mature females and are not always present in all nodules. 
Female worms are sedentary and confined within a nodule (Bwangamoi 1969). The 
first reports of the reproductive performance of male filariae described the process 
of spermatogenesis in both O. volvulus (Duke et al. 1990) and Wuchereria bancrofti 
(Miller 1966). A haploid chromosome number of five was identified in the spermatids 
of both species. The male reproductive system is a straight tube composed of the 
testis, vas deferens, and ejaculatory duct, which unites with the intestine to form the 
cloaca and a pair of spicules for copulation (Neafie 1972). Meanwhile, the female 
reproduction system consists of paired ovaries, oviducts, seminal receptacle and 
uteri that unite to form the vagina and ends at the vulva located about 940 μm from 
the anterior end (Neafie 1972). Sperm once deposited into the vagina becomes 
amoeboid and migrates into the uteri to fertilise the oocytes. Female worms attain 
maturity in nine to twelve months. Oogenesis and release of ova into the 
reproductive tract occur irrespective of the presence of male worms (Schulz-Key and 
Karam 1986; Schulz-Key and Soboslay 1994). Although there is a strong correlation 
between the presence of males and fertilisation, there are exceptions where the 
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males fertilise the female and then migrate out of the nodule, or unfertilised females 
being present in a nodule with a male (Duke et al. 1990). Approximately 1,000 Mf are 
released into the host’s body tissues every day (Schulz-Key 1990; Schulz-Key and 
Soboslay 1994). 
Filarial worms grow by periodically shedding their cuticles during moulting before 
elongation. During the six months to two-year lifespan of Mf, during which they are 
either ingested by a vector or eventually die, there is no longitudinal growth. The first 
two moults occur within the blood sucking arthropod as they penetrate the intestinal 
tissue and migrate to the salivary glands via the thorax to become the infective L3. 
During subsequent blood meals, the L3 are deposited into the vertebrate host to 
infect them. The third and the fourth moults occur within the definitive host. 
Organogenesis takes place during the development of the larval phase and ends with 
sexual differentiation during the 4th moult (Bain and Babayan 2003). The basic 
nutritional needs of the worms are not well known, but it is obvious that infection 
causes malnutrition in the host, while malnourished patients are much more 
susceptible to the disease (Storey 1993). 
2.1.5 Feeding and Locomotion 
The feeding habits of the larvae and worms have not yet been well documented. In 
L. sigmodontis, ingestion of blood occurs only after the fourth moult (Attout et al. 
2005). The nodules in onchocerciasis have been shown to be richly supplied with 
blood vessels (George et al. 1985), and capillaries are in close apposition with the 
worm’s cuticle (Smith et al. 1988). Parasite growth and embryogenesis are retarded 
when the host is malnourished (Storey 1993). Morphological adaptation and 
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histological evidence of the cuticle of O. volvulus showing mitochondria close to the 
hypodermal invaginations suggest that there may be trafficking substances across the 
cuticle (Deas et al. 1974). 
Filarial worms lack circular muscles and cannot creep. However, they have 
longitudinal muscles that drive lateral movements. On ingestion of Mf by the vector, 
they migrate and moult through a series of steps from the gut through the thorax to 
the mouth of the arthropod vector. In this process, the larvae develop features and 
behavioural patterns that will facilitate their rapid escape from the skin, when 
deposited during blood meals, to the safety of the nearest lymphatic vessel (Bain and 
Babayan 2003). The principal function of the locomotive system is to keep the worm 
from danger and carry the larvae to locations that are safe for the completion of the 
worm’s life cycle. Contractions of the longitudinal muscles enable adult worms of 
non-nodule forming species to actively maintain themselves in position within the 
lymph vessel against the slow flow of lymph current (Dreyer et al. 1999). In nodule-
forming filariae, the female worms are sedentary and have highly hypotrophied 
musculature. A greater portion of the female is restrained by fibrous tissues, while 
the anterior end is free and highly motile. This may be to permit feeding and 
copulation (Schulz-Key and Karam 1986). 
Though filarial worms have a poorly-developed locomotive system, they have 
developed certain adaptive behaviours to survive (Bain and Babayan 2003). The Mf 
are motile and can survive in the host tissues for many months, waiting to be 
consumed by an intermediate host. Some filarial nematodes when gravid, release Mf 
periodically at different times of the day and night (nocturnally sub-periodic or 
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periodic) or throughout the day (diurnally sub-periodic or periodic) (McFadzean and 
Hawking 1956; Duke 1957; Hawking et al. 1964; Hawking et al. 1965; Nanduri and 
Kazura 1989). The periodicity of the presence of Mf in the blood or skin of the host 
may coincide with a rest period such as during deep sleep at night, but is also linked 
to vector biting behaviour (Nanduri and Kazura 1989). 
In the rodent parasite Acanthocheilonema vitae, Mf use hooks situated at its anterior 
end to migrate to the point of release into saliva during blood meals (Bain and 
Babayan 2003). Sensory organs known as amphids located at the anterior end of the 
worm might detect changes in the partial pressures of carbon dioxide of surrounding 
fluid, which is thought to be essential in directing the Mf to detach or attach to nearby 
tissue (Hawking et al. 1965). These sensory and locomotive activities are important 
factors for the worm’s survival that Bain and Babayan (2003) have suggested could 
be exploited in the control of filarial diseases. 
2.1.6 Nodule Formation 
Only Onchocerca spp. from the five human filarial genera forms nodules. Lack of 
understanding of the mechanism of nodule production is the main limiting factor to 
the in vitro development of O. volvulus for research purposes. It is probable that 
nodule formation is provoked during the early period of growth of the young worm 
while provoking a haemorrhage to obtain blood meal. The worm expands to block 
the thin dermal or sub-dermal lymph vessels (Bain and Babayan 2003). The whole 
worm is submerged in a highly vascularized fibrin-lake (George et al. 1985; Attout et 
al. 2005) which probably contributes to immobilise the posterior part of the female 
as the condition becomes chronic. As the worm grows and the nodule develops, the 
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active anterior part of the body becomes avascularised (Figure 2.1), the fibrin lake 
becomes gel-like and the worms tend to control proliferation of blood vessels (Smith 
et al. 1988). Cell mediated immunity may also contribute to nodule formation as 
neutrophil extracellular traps (NET) induced by the endosymbiont bacteria 
Wolbachia are formed around the worm (Tamarozzi et al. 2016). 
 
2.2 Filarial Diseases 
2.2.1 Filarial Diseases of Domestic Animals 
Relatively little attention has been given to filarial diseases of domestic animals. The 
most widely studied disease of animals is dirofilariasis, especially canine heartworm 
disease caused by Dirofilaria immitis (Rani et al. 2010). This is the most important 
filarial disease of dogs transmitted by about 60 species of mosquitoes and can also 
cause respiratory symptoms in cats. Several other wild carnivores can act as 
reservoirs. Rarely, humans in exposed localities may also become infected but 
constitute a dead end for the lifecycle (Haddock 1987; Bowman and Atkins 2009; Lee 
et al. 2010; Ledesma and Harrington 2011).  The main horse filarial disease is equine 
parafilariosis, summer bleeding or bloody sweat (Maloufi 1995). In addition to 
humans, some strains of Brugia malayi infect domestic cats, dogs and monkeys (Rani 
et al. 2010; Ambily et al. 2011); while Cercopithifilaria sp. (Otranto et al. 2012a) and 
Onchocerca lupi (Otranto et al. 2012b) infect dogs, with the latter producing ocular 
disease (Sréter and Széll 2008; Otranto et al. 2012b). Given the close relationship that 
man has with these pet animals, these revelations not only show how filarial diseases 
of animals have been neglected, but also the danger posed to human health (Uni et 
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al. 2010) and the need to factor animal filariosis in future control programs of human 
filarioses (Rani et al. 2010). 
African zebu cattle are host to several Onchocerca spp.: O. ochengi, O. gutturosa, O. 
armillata and O. dukei (Wahl et al. 1994). The presence of nodules on cattle infected 
with O. ochengi is of little veterinary importance even though hide quality from 
infected cattle may be reduced (Bwangamoi 1969). Meat condemnations due to 
bovine onchocerciasis are rare and if done as in Finland, are purely for aesthetic 
reasons (Solismaa et al. 2008) as there is no risk of human infection from 
consumption of infected meat or hide. Cattle infected with O. ochengi are valued as 
a research model for human O. volvulus (Trees et al. 2000). Another filaria of cattle is 
Setaria spp., transmitted by Aedes mosquitoes. There are a number of species 
worldwide, some of which are also found in horses, sheep (Tschuor et al. 2006), goats 
and donkeys (Vos et al. 1985). The main clinical disorders caused by Setaria spp. are 
nervous symptoms and peritonitis, but generally they are of very little veterinary 
importance. However, an outbreak of Setaria peritonitis was reported in Finnish 
reindeer (Laaksonen et al. 2009).  
2.2.2 Filarial Diseases of Man 
There are three main types of human filariases: lymphatic filariasis, loiasis and 
onchocerciasis. 
 General Characteristics 
The first clinical manifestation of any active human filarial disease is persistent 
intensive skin irritation associated with vector bite and in onchocerciasis with the 
release of large numbers of Mf into the skin (Nanduri and Kazura 1989; Murdoch et 
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al. 1993). However, exposure to fly bites, which is often associated with deposition 
of infective larvae or immunogens, can cause transient pruritus. The first appearance 
of gross and chronic pathology which differentiates the filarial infections may take 
several months or years to appear (Storey 1993).  Chronic symptoms are associated 
with wasting, debilitation and disfigurement (Murdoch et al. 1993; Enk 2006; Udall 
2007) and such patients are stigmatised with severe life threatening consequences 
(Ovuga et al. 1995). Global disease control measures put in place over the past 30 
years has significantly reduced these symptoms (Remme et al. 2006; Prichard et al. 
2012).  
Human filariases are neglected tropical diseases because they are diseases of the 
poor (Murdoch et al. 1993) and at one time, more than 150 million people in Africa 
were at risk of infection (Knopp et al. 2012). Globally, 2.7 billion people were exposed 
to filariases (World Health 2006). Susceptible people with severe chronic disabilities 
generate significant health costs both on the infected persons or on their 
communities (Wasmuth et al. 2008). Consequently, the WHO has sponsored vector 
and parasite control for these diseases over several decades. 
 Lymphatic Filariasis 
Lymphatic filariasis (LF) is caused by Wuchereria bancrofti, Brugia timori or B. malayi. 
The main cause of LF in Africa, Latin America and the Caribbean is Wuchereria 
bancrofti, while Brugia spp. are common in Southeast Asia, Timor and surrounding 
islands of the Savu Sea (Udall 2007). The parasites reside in the lymphatic vessels and 
obstruct lymph flow. The main chronic clinical signs are swelling of the genitalia, legs, 
arms and breasts (WHO 2013). A review of the historical, epidemiological and control 
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features of LF suggested that the disease existed 1500 BC in Egypt, but the first report 
of the Mf was in 1863 from hydrocele fluid collected from a Cuban in Paris (Otsuji 
2011). The disease is transmitted by mosquitoes and is endemic in 73 Africa, South 
East Asian and Latin American countries including the Carribean Islands and across 
the Pacific. Unlike with onchocerciasis, 65% of LF infections are found in South East 
Asia (WHO 2013). Lymphatic filariasis, also known as elephantiasis, is the second 
leading cause of chronic disability worldwide (WHO 2012). According to the latest 
Global Burden of Disease study, about 38.5 million people are infected worldwide 
(Vos et al. 2016). A third of them develop elephantiasis (severe enlargement of the 
legs and feet), which is the most stigmatizing form of the disease (WHO 2012).  
Most patients of LF are usually infected when they were children, but clinical 
manifestations start appearing in adulthood. Acute forms of LF occur when the skin, 
lymph nodes and the lymphatics vessels are involved. About 20% of infected people 
have occult LF (amicrofilaraemia) and 40% of them have kidney damage or manifest 
urogenital swelling (WHO 2012). 
 Loiasis 
Loiasis is found only in Africa (Boussinesq 2006). It is caused by L. loa (African eye 
worm) and is transmitted by Chrysops flies (C. silica and C. dimidiata) belonging to 
the Tabanidae with 13 million people infected. The disease is prevalent among 
inhabitants of the equatorial rainforest of West and Central Africa including Sudan, 
Uganda, Zambia, Angola and six other countries and about 14.4 million people live in 
high-risk areas (Zouré et al. 2011). The prevalence of loiasis varies from one region to 
the other and could be as high as 54% (Boussinesq and Gardon 1997; Hassan et al. 
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2011). Adult L. loa reside in fatty subcutaneous tissues and migrate subcutaneously, 
causing local “Calabar” swellings. The parasite can be seen when the eye is affected, 
as it migrates across the eye subcutis (Eveland et al. 1975). Depending on 
geographical regions where infection occurs, the disease is known as subcutaneous 
filariasis, Calabar swelling, Fugitive swelling, Tropical swelling and African eye worm. 
The diagnosis of loiasis is difficult because most often the condition is asymptomatic 
and amicrofilaremic (Eveland et al. 1975). Acute symptoms of the disease such as 
lymphedema, episodic angioedema accompanied by localized skin eruptions and 
pruritus usually last only for 1-3 days  (Eveland et al. 1975; Boussinesq et al. 1998). 
During the chronic phase, there are cyst-like enlargements of the connective tissue 
around the sheaths of damaged muscle tendons. These swelling are very painful 
when touched. 
Loiasis is also a common infection of non-human primates. However, they are 
transmitted by Chrysops langi, which is different from the human vector, and there 
is no cross-infection between human and simian loiasis (Duke 1957). IVM causes 
rapid death of Mf and can evoke very severe adverse effects (SAEs) such as skin 
rashes, encephalopathy and finally death (Haselow et al. 2003). Because of these SAE, 
the use of IVM during control of onchocerciasis is not recommended in areas of co-
infection with loiasis (Boussinesq et al. 1998). Consequently, an epidemiological map 
of the distribution of loiasis in onchocerciasis infested zones was imperative, and a 
rapid assessment procedure “RAPLOA” was established to facilitate the mass 
distribution of ivermectin (Kelly-Hope et al. 2012). Ivermectin is not administered in 
areas of high onchocerciasis endemicity (Thomson et al. 2004; Baker et al. 2010; 
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Zouré et al. 2011) that also have a high risk of loiasis (Kelly-Hope et al. 2012; Wanji et 
al. 2012). 
 
 
Figure 2.2: Distribution of onchocerciasis control programmes worldwide (OCP, 
Onchocerciasis Control Programme; APOC, African Programme for Onchocerciasis Control; 
OEPA, Onchocerciasis Elimination Program for the Americas). The insert (A) marked in red 
has Yemen added to the OCP, APOC and OEPA countries. 
 
 Onchocerciasis 
Onchocerciasis is commonly known as river blindness. However, blindness is one of 
the irreversible clinical manifestations that begins with visual impairment and skin 
depigmentation or deformation caused by Mf that migrates out of gravid O. volvulus. 
The disease is prevalent in 31 African countries, part of Latin America and Yemen 
(Figure 2.2 A). 
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2.2.2.4.1 Epidemiology 
Onchocerciasis is a riverine disease affecting populations that carry out economic 
activities along unprotected streams, lakes, estuaries or rivers. It is endemic in 31 
tropical African countries (Figure 2.2). In Latin America, transmission has been 
stopped in all but one focus (WER 2012; Convit et al. 2013; Rodriguez-Perez et al. 
2013). However, western Yemen on the Arabian Peninsula remains endemic, with an 
estimated 350,000 – 400,000 people at risk (Al-Kubati et al. 2018). Onchocerciasis 
affects 15.5 million people (Vos et al. 2016), while 125 million people are exposed to 
the disease worldwide. Ninety-nine percent of the infected people are poverty-
stricken Sub-Sahelian Africans (Hall and Pearlman 1999; MD 2001; APOC/WHO 2011). 
To facilitate the implementation of control measures geared towards eradication of 
the disease by 2025, African countries endemic for onchocerciasis were mapped by 
using “Rapid Epidemiological Mapping of Onchocerciasis (REMO)” taking into 
consideration the presence of vector flies (Simulium spp.) and their breeding sites 
(Ngoumou et al. 1994; Macé et al. 1997). Formerly, only 10 West African countries 
were part of the Onchocerciasis Control Programme (OCP) for West Africa (Davies 
1994; Macé et al. 1997; Takougang et al. 2002). After REMO, 20 more countries in 
Africa were found to be endemic (Figure 2.3) and included in the African Programme 
for Onchocerciasis Control (APOC) countries. In Cameroon for example, half of the 
population are at risk (Macé et al. 1997), about 5 million suffered from onchocerciasis 
and there were 30,000 confirmed cases of blindness  (CAS 2012). The REMO of 
Cameroon (Figure 2.4) illustrates onchocerciasis-endemics areas in Cameroon 
targeted for community-directed treatment with ivermectin (CDTI). 
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Figure 2.3: “REMO” onchocerciasis endemicity in the additional 20 African countries placed 
under the African Programme for Onchocerciasis Control. Source of map: (Zoure et al. 2014) 
 
Unlike most infectious diseases, O. volvulus naturally infects and causes disease only 
in man. In chimpanzees, experimental infections lead to transient patency (Soboslay 
et al. 1992; Lüder et al. 1993; Eberhard et al. 1995). The closest biological relative of 
O. volvulus is O. ochengi  (Morales-Hojas et al. 2006), which has been very useful in 
the study of the biology, immunology and pharmacology of onchocerciasis (Graham 
et al. 2000; Trees et al. 2000). The female worms of both O. ochengi and O. volvulus 
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are immobilised within nodules (Figure 2.5). In most parts of Africa (95%), 
onchocerciasis is transmitted by Simulium damnosum sensu lato (sl), which also 
transmits O. ochengi. However, S. neavei is the principal vector in Ethiopia, Uganda, 
Tanzania and the Democratic Republic of the (Fischer et al. 1993) and S. metallicum 
sl, S. ochraceum, and S. exiguum in the Americas (Basáñez et al. 2002). 
 
Figure 2.4: Map of Cameroon showing Onchocerciasis endemic areas targeted for Community 
Directed Treatment with Ivermectin (CDTI). Source of map: WHO 
http://www.who.int/apoc/countries/cmr/en/. 
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Figure 2.5: Practical reasons for use of O. ochengi as an optimal research model for O. 
volvulus. 
 
 
 
Figure 2.6: Forms and clinical manifestation of onchocerciasis. Acute papular onchodermatitis 
(APOD) is characterised by reddening of the skin. The other manifestations, from chronic 
papular onchodermatitis (CPOD) and lichenified onchodermatitis (OD) to visual impairment, 
which often leads in complete blindness, are chronic forms. 
 
2.2.2.4.2 Clinical Manifestations 
The earliest signs of infection of O. volvulus in humans are fever, joint pains, pruritus, 
swollen glands and associated skin pathologies (Blacklock 1927) preceding visual 
impairment (Buttner et al. 1982; Albiez et al. 1988; Petit et al. 1992; Wanji et al. 2002; 
Brattig 2004). The pathognomonic sign of onchocerciasis (Figure 2.6) is the presence 
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of palpable subcutaneous nodules or worm “tumours” called onchocercomata. The 
subcutaneous nodules can be easily palpated as small, soft and smooth, loose 
subcutaneous tumours or large, hard irregular aggregates of nodules on the head, 
arm and ribs, or associated with the elbow and knee joints (Blacklock 1927). In cattle, 
the nodules of O. ochengi are intradermal and are identified as smooth, soft spherical 
dermal tumours situated mostly between the hind limbs, udder or scrotal sac and 
ventral abdomen (Wahl et al. 1994). However, nodules can be formed on any part of 
the body. 
Chronic symptoms of onchocerciasis are consequences of immunopathology over a 
long period of time (Nanduri and Kazura 1989; Udall 2007). Consequently, visual 
impairment and blindness are high amongst adults. Before the introduction of the 
onchocerciasis control programmes, one- third of patients infected with O. volvulus 
became blind (Prost 1986), and mortality was high due to social stigmatisation as 
much  as the morbidity of the disease (Kirkwood et al. 1983; Ovuga et al. 1995; Boatin 
and Richards Jr 2006). Retrospective studies conducted by Little et al. (2004) between 
1971 and 2001, showed that 5.2% of the world’s onchocerciasis-related mortalities 
were due to blindness. 
Although onchocerciasis is caused by a single infective agent, clinical manifestations 
vary from location to location and depend on the immunological response to 
infection. A chronic hyper-reactive form of onchodermatitis emanating from strong 
cellular and humoral immune responses generated against Mf (Buttner et al. 1982; 
Brattig et al. 1987), and characterised by very low Mf densities, few onchocercomata 
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and relatively lower serum triglycerides, is “sowda” (Mpagi et al. 2000). Sowda, also 
known as reactive onchodermatitis (Hoerauf et al. 2002; Magdi M. M. Ali et al. 2007), 
was first described in Yemen and Sudan, but the condition occurs in less than 1% of 
patients in other endemic regions. Pathologies are limited most often to a single 
lower extremity, though both limbs may be involved (Figure 2.6). Older patients in the 
hyper-endemic areas may present sowda (Stingl et al. 1984), characterised by 
pretibial depigmentation portraying a “leopard skin” appearance (Bradley and 
Unnasch 1996). 
Epilepsy is a neglected symptom of onchocerciasis that has only recently been 
recognised (Colebunders et al. 2017). Consequently, this clinical manifestation is not 
often included in the calculation of the disease burden. Studies have shown that for 
every 10% increase in onchocerciasis, there is a corresponding increase of 0.4% in 
cases of epilepsy across all the Onchocerca-endemic African countries (Pion et al. 
2009). Controlled experiments in Cameroon and Central Africa Republic showed that 
the Mf level of epileptic patients in oncho-endemic regions is higher but not 
statistically significantly different from those of the control population (Boussinesq 
et al. 2002). Though there is a high probability that epilepsy may be associated with 
high Mf levels in Onchocerca patients (Kaiser et al. 2011) more studies will need to 
be conducted with larger sample sizes to resolve the relationship between epilepsy 
and onchocerciasis. Such studies are becoming increasingly difficult to execute given 
the success recorded by the ongoing onchocerciasis control programmes in reducing 
skin Mf load. 
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2.2.2.4.3 Life Cycles of Onchocerca spp 
The life cycle of both O. volvulus and O. ochengi are like those of other filarial 
infections described earlier under reproduction (section 2.1.4) and summarised in 
Figure 2.7. Ingested Mf penetrate the gut walls of the vector fly into the hemocoel 
through the digestive cells and the basal lamina (Bain and Babayan 2003). In 3 to 5 
days, the L1 undergoes two obligatory moults while migrating to the head to become 
infective larvae or L3 (Blacklock 1927). In the process, the vector’s tissues are 
damaged and in very heavy infections, the vector dies within 10 days (Bain et al. 1976; 
Chabaud et al. 1986). The duration of blood feeding during which L3 are transmitted 
to humans or cattle is about 5 minutes (Nanduri and Kazura 1989). 
 
 
Figure 2.7: Life cycle of onchocerciasis 
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The vector fly, S. damnosum, usually flies at very low altitudes (about 50 cm from the 
ground or water surface). Therefore, areas such as the ankles, hands, and head (in 
children) in humans are most susceptible to bites and infection (Wahl et al. 1994). 
While standing in a stream to drink, the abdomen, udder or testicles of cattle are 
closer to the surface of the waters in which the fly breeds and are the most frequently 
bitten sites for transmission of infection. The chances of having an infective bite are 
usually higher in the evening than the early mornings, and the L3 present in the saliva 
is deposited to facilitate entry into the skin after every blood meal (Bain and Babayan 
2003). 
An infective L3 is 586-760 µm long and very motile. It will migrate into the 
subcutaneous tissues’ superficial lymph vessels where it grows and moults into fourth 
stage larvae (L4) within 3 months (Wahl et al. 1994; Achukwi et al. 2000). The L4 then 
moults into a young adult and matures within 18 – 34 months (Chabaud et al. 1986; 
Bain and Babayan 2003). A fertile female may live for 10 to 15 years while maintaining 
good fertility and producing between 1,300 to 1,900 L1 (0.3 mm long) per day 
(Burnham 1998). 
2.2.2.4.4 Diagnoses of Onchocerciasis  
The diagnosis of onchocerciasis is based on the history of the origin of patient 
(REMO), clinical manifestations, laboratory tests and the isolation and identification 
of worms or microfilariae.  
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2.2.2.4.4.1 Clinical and Epidemiological Diagnosis of Onchocerciasis 
The first rapid epidemiological diagnostic tool for onchocerciasis is REMO (Figure 2.3), 
a map that demarcates the risk zones in Africa. The first clinical symptom of early 
infection is acute papular onchodermatitis (APOD) and subsequently the chronic 
papular onchodermatitis (Figure 2.6). Before the appearance of clinical signs, 
subcutaneous Onchocerca nodules can be palpated. A clinical test kit has been 
developed to provoke a skin manifestation (the Mazzotti test) using 
diethylcarbamazine (DEC)-soaked gauze. The anthelminthic is applied on both the 
diseased and healthy areas of skin for 1 or 2 days (Stingl et al. 1984), and the 
appearance of more than 20 fresh papules on the infected skin alone is indicative of 
a positive Mazzotti reaction. This technique does not detect pre-patent infections, is 
time consuming and not patient-friendly (Stingl et al. 1984). 
2.2.2.4.4.2 Laboratory Diagnosis 
The most accurate laboratory technique used to diagnose onchocerciasis is the skin 
snip test for active disease or isolation of adult worms from nodules. Skin snips or 
biopsies are taken from specific sites, cultured in any physiological solution at 37oC 
and examined for the presence of Mf. This gold standard technique is less sensitive 
to low Mf load and is not recommended for the monitoring of the effectiveness of 
post-ivermectin therapy (Boatin and Richards Jr 2006). The Roswell Park Memorial 
Institute (RPMI) medium 1640 is the media of choice to monitor drug efficacy on 
parasites. Optimum results are obtained when antibiotics are added to prevent 
bacterial overgrowth and the skin is digested with collagenase for maximal release of 
Mf. 
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Immunoassays for anti-Onchocerca antibodies, especially targeting the Ov16 antigen, 
have been available for many years in both ELISA and rapid card formats (Weil et al. 
2000). This is becoming more widely used in post-control surveillance as the “SD 
BIOLINE Onchocerciasis IgG4 (Ov16) rapid test” following increased accessibility via 
the non-profit organisation PATH (Dieye et al. 2017). However, the Ov16 test is only 
appropriate for use in monitoring children (less than 11 years of age) as “sentinels” 
of transmission during post-elimination surveillance, as adults can remain 
seropositive for many years after transmission has stopped, due to either persisting 
infection or maintenance of antibodies after worm clearance (Golden et al. 2016). 
Sensitive diagnostic tools for active infection, including PCRs (Lloyd et al. 2015) and 
isothermal amplification methods (Lagatie et al. 2016) for use on skin snips, have 
been developed but are not yet widely used. Identification on non-invasive 
biomarkers of adult worm infections is a major research priority for onchocerciasis 
(Vlaminck et al. 2015). 
2.2.2.4.4.3 Pathogenesis of Onchocerciasis 
The path taken for any disease to establish is important in designing an effective 
disease control strategy. Immediately after deposition of L3 into the skin, the 
parasites quickly penetrate the lymph vessels to evade immune attack, establish and 
develop into adult worms by forming a nodule around the female. It is unclear how 
L3s migrate through tissues into the lymph vessels. The presence of cephalic hooks 
at the anterior end of the Mf suggest an important role in locomotion and invasion 
of tissues (Bain and Babayan 2003). The pathogenesis of nodule formation is also 
unclear and will remain so until time when in vitro studies can be performed on the 
31 
 
 
development of Onchocerca species. During the growth phase of the worm and 
establishment of the nodule, there seems to be limited pathology caused to the host 
as the parasite is sequestrated and immunity modulated to favour establishment. The 
clinical manifestations of infections from endemic and hypoendemic areas differ. In 
endemic areas, there is immune hyporesponsiveness, heavy nodule loads and skin 
Mf. There is widespread distribution of mild dermatitis and depigmentation 
(Soboslay et al. 1997), with limited involvement of the lymph nodes. At maturity, 
fertile females release hundreds of Mf into the vagina from where they migrate into 
nodule fluid and are carried along in the fine lymphatics vessels of the skin, from 
where they accidentally escape out into the subcutis to elicit allergic immune 
responses that cause pruritus, inflammation and reddening of the skin. Release of 
endobacteria Wolbachia from dead Mf further exacerbates the pathology  (Boatin 
and Richards Jr 2006). In hypoendemic regions,  hyperresponsiveness is observed, 
resulting in lower worm establishment and low or amicrofilaridermia  (Henson et al. 
1979; Brattig et al. 1994), but greater morbidity is caused by immunopathology  
(Kirkwood et al. 1983). 
Most of the circulating Mf die and are carried by lymph flow to the lymph nodes 
where they are phagocytized by immune cells. Daily, lymph nodes draining affected 
regions are over worked become hypertrophic and the lymphatic system fails. 
Hydrocele of the inguinal region ensues. With time, the failed lymph node atrophies 
and collapses to hang in the inguinal pouch created by the oedematous skin. 
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2.2.2.4.5 Treatment and Control of Onchocerciasis 
2.2.2.4.5.1 Treatment 
There is no recommended treatment against onchocerciasis that is macrofilaricidal. 
Antibiotics of the tetracycline family can kill adult worms, but their use is restricted 
to individual cases. Melarsomine dehydrochloride is an organoarsenical 
macrofilaricide used to treat heartworm in dogs (McTier et al. 1994; Bowman and 
Atkins 2009), but cannot be used in humans because of toxicity. It is used for research 
purposes in cattle as a positive control for macrofilaricidal activity, but the drug must 
be administered at a very high dose. Suramin a trypanoside used both on animals and 
humans (Nok 2003) had some pathological effects on embryos but was not 
macrofilaricidal (Renz et al. 1995). 
Ivermectin is the lone drug available for use in the mass control of human 
onchocerciasis. It is microfilaricidal and has limited effects on adult worm viability. 
Although nodules can be surgically removed  (Burnham 1998), circulating Mf with a 
lifespan of six months to two years would have to be treated with ivermectin. IVM 
was discovered in the 1970s as a veterinary parasiticide and its use in the human 
pharmacopeia was validated in the mid-1980s (Campbell W et al. 1984). 
The first anthelminthic used to control onchocerciasis in 1949 by Hawking and Laurie 
was diethylcarbamazine-citrate (DEC). It kills only Mf and not the adult worms 
(Adams and Woodruff 1953). Moreover, DEC was contraindicated in areas with high 
endemicity because of severe side effects, especially affecting the eye (Oomen 1969; 
Fuglsang and Anderson 1973; Fuglsang and Anderson 1974). DEC is less effective in 
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controlling disease in patients with low Mf load. Steroidal anti-inflammatory drugs 
could be administered to reduce the side effects of DEC (Awadzi and Gilles 1992).  
2.2.2.4.5.2 Onchocerciasis Control Programme for West Africa 
The WHO launched the Onchocerciasis Control Programme in West Africa (OCP) in 
December 1974 (Roberts et al. 1967; Waddy 1969) in collaboration with the United 
Nations Development Programme (UNDP), the International Monetary Fund (IMF) 
and the World Bank to interrupt disease transmission via vector control (Senghor and 
Samba 1988; WHO 2018). Weekly aerial applications of larvicides on Simulium 
breeding sites were conducted in 11 West African Countries (Figure 2.4). To eradicate 
onchocerciasis, the programme was to be applied for at least 14-16 years; equivalent 
to the lifespan of an adult female worm. All measures were taken to avoid the vector 
developing insecticide resistance (Hougard et al. 1997) and environmental 
degradation (Leveque et al. 1988; Calamari et al. 1998; Crosa et al. 1998). The main 
constraints to the programme were cost and accessibility. The program reclaimed 
1,200,000 km2 of land and protected 30 million people from 11 OCP countries 
(Hougard et al. 1997; WHO 2018), thereby greatly reducing onchocerciasis as a public 
health and socio-economic problem in these areas (Senghor and Samba 1988; De Sole 
and Remme 1991). About 25 million hectares of abandoned agricultural land were 
reclaimed, allowing 18 million births in areas freed of risk of getting blind from 
onchocerciasis (De Sole and Remme 1991; Molyneux 1995; Boatin et al. 1997). As 
more than 100 million people were still living in areas where transmission took place 
outside the OCP boundaries (Davies 1994; María-Gloria Basáñez et al. 2006), the 
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African Programme for Onchocerciasis Control (APOC) was created in 1995 (Taylor et 
al. 2009). 
2.2.2.4.5.3 The African Programme for Onchocerciasis Control  
Following the discovery of IVM (Campbell W et al. 1984) and confirmation of its 
superior clinical efficiency against O. volvulus compared to DEC in 1980 (Greene et al. 
1985; Lariviere et al. 1985; Diallo et al. 1986), the manufacturers of Mectizan® 
(Merck, Sharp and Dohme) in 1987 provided free drugs to be used in the control of 
onchocerciasis for as long as it would take to eradicate the disease (Colatrella 2008). 
This gave birth to APOC in 1995, and the OCP mandate extended to 2002. Twenty 
additional Onchocerca exposed countries in Africa (Figure 2.3) were added and mass 
drug administration of IVM tablets (Mectizan®) at a frequency of once per year was 
instituted (Delisle et al. 2005). In the Americas, the Onchocerciasis Eradication 
Programme for the Americas (OEPA) was initiated in 1992. Hyperendemic regions 
were earmarked for eradication of the disease. Thirteen regions had foci of 
onchocerciasis in six Latin American countries (Sauerbrey 2008). An annual or 
biannual Mectizan® distribution (the latter used predominantly by OEPA) and 
administration was adopted, aimed at eradicating onchocerciasis (in OEPA) or 
controlling it as a major public health and socio-economic developmental problem 
(in APOC). Given the success achieved such as apparent abrogation of transmission 
in certain regions of West Africa using IVM alone (Diawara et al. 2009; Traore et al. 
2012), WHO broadened the remit of APOC to include elimination of onchocerciasis in 
23 of 31 African countries by 2020 (Diawara et al. 2009; Traore et al. 2012). In 2015, 
APOC officially closed and onchocerciasis control is now devolved to the governments 
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of endemic countries under the umbrella of “ESPEN” (Expanded Special Project for 
Elimination of Neglected Tropical Diseases), potentially diluting efforts to break 
transmission across the continent (Hopkins 2016). 
However, the use of macrofilaricidal drugs would have a higher potential for the 
elimination of onchocerciasis (Wanji et al. 2009). The use of doxycycline in a 6-week 
course of community-directed intervention (CDI) has been cost effective (Turner et 
al. 2010) and is now being implemented in loiasis-endemic areas of Cameroon. 
Doxycycline has been recommended as an individual treatment for some years 
(Taylor et al. 2010), and is now known to be as effective after a 4-week course 
compared with the original 6-week course (Walker et al. 2015). 
2.2.2.4.6 Mechanism of Action of Drugs Used 
2.2.2.4.6.1 Ivermectin  
IVM is administered at a dosage of 150 µg/kg. A single dose is effective against the 
Mf for 3 – 6 months (Newland et al. 1988; Alexander et al. 1993) and affects the 
fertility of adult worms, sometimes stopping disease transmission following an 
annual treatment regimen in areas with seasonal transmission when administered 
for >15 years (Plaisier et al. 1995; Diawara et al. 2009). IVM selectively binds to 
parasite glutamate-gated chloride channels and has high affinity to nerve or muscle 
cells of invertebrates, causing either hyperpolarization (Bennett et al. 1988) or 
depolarization  (Pemberton et al. 2001). Membrane permeability to chloride ions is 
increased, and paralysis may cause direct death of the parasitic worms, starvation 
that indirectly leads to death, or cause the parasite to be carried by lymph to lymph 
nodes for destruction. Glutamate-gated chloride channels are absent in some 
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mammals, and avermectins have low affinity for mammalian ligand-gated chloride 
channels. Also, avermectins do not readily cross the blood-brain barrier and their 
antiparasitic activity targets nerves supplied by the general circulation. IVM 
penetrates onchocercomata and maintains a high concentration for 5 to 7 days (Cross 
et al. 1997). Adult female worm death reported in Cameroon after a three-monthly 
regimen of IVM (Duke 2005) might have been due to natural death. IVM also 
interferes with fertility, causing fatal pleomorphic ovarian neoplasms (Duke et al. 
2002; Duke 2005). 
Evidence of resistance to IVM in humans (Taylor et al. 2009; Osei-Atweneboana et al. 
2011) as well as in animals (Prichard and Prichard 2007) was originally thought to be 
linked to ATP-binding cassette (ABC) transporters (e.g., P-glycoproteins) and β-
tubulin (Bourguinat et al. 2007; Prichard 2007). New research using genome-wide 
sequencing of genetic polymorphisms between “good responder” and “suboptimal 
responder” worms has revealed that reduced susceptibility to IVM is a complex 
polygenic trait (Doyle et al. 2017). However, another macrocyclic lactone used in 
veterinary medicine, moxidectin, which is a 16-member pentacyclic lactone 
belonging to the milbemycin class of endectocides, might be used in humans in future 
(Cotreau et al. 2003; Opoku et al. 2018). The major limitation in using IVM in mass 
drug distributions are in areas coinfected with L. loa, but antibiotic therapy with 
doxycycline could be used in these locations (Wanji et al. 2009; Turner et al. 2010). 
2.2.2.4.6.2 Antibiotics   
Antibiotics of the tetracycline family (e.g., oxytetracycline, doxycycline and 
minocycline) when administered over a long period of time are effective against 
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filarial worms that harbour the endosymbiotic alpha-proteobacterium, Wolbachia 
(Genchi et al. 1998; Bandi et al. 1999; Hoerauf et al. 1999; A. Hoerauf et al. 2000b; 
Langworthy et al. 2000; Rao et al. 2002). The effect is indirect. When administered 
over several weeks (continuous) or months (intermittent), a long-acting formulation 
of oxytetracycline (at a dose rate of 20 mg/kg body weight once monthly for 6 
months) in cattle  (Langworthy et al. 2000; Gilbert et al. 2005), and doxycycline (at 
100 or 200 mg per day over a 4-6 week period) in humans (A. Hoerauf et al. 2000a; 
Taylor and Hoerauf 2001; Hoerauf et al. 2008b; Hoerauf et al. 2009; Walker et al. 
2015) can be macrofilaricidal and causes the disappearance of Onchocerca nodules 
over a period of 1 to 3 years. Community mass treatment with doxycycline is feasible 
and has been strongly recommended in loiasis-onchocerciasis coinfected areas 
(Wanji et al. 2009; Turner et al. 2010), as filarial nematodes of the Loa genus do not 
harbour Wolbachia and are not killed by antibiotics. The macrofilaricidal effect of 
antibiotics is slow and depends on the sustained depletion of Wolbachia on which 
the filarial nematodes rely for survival in both in vivo and in vitro studies   (Simoncini 
et al. 2001; Taylor and Hoerauf 2001; M. Casiraghia et al. 2002; Volkmann et al. 2003; 
Dangi et al. 2009; Hoerauf et al. 2009). An ineffective antibiotic therapy does have a 
transient effect on Wolbachia depletion, which usually repopulates within 24 weeks 
post treatment (Gilbert et al. 2005). 
Efforts to shorten the duration of an effective treatment by testing other antibiotics 
such as rifampicin or its combination with tetracyclines or other antibiotics yielded 
limited successes (Townson et al. 2000; Volkmann et al. 2003; F.O. Richards, Jr. et al. 
2007; Specht et al. 2008; Bah et al. 2014). The immediate post-antibiotic therapeutic 
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effect is the permanent sterilization of the adult filarial female worms (Hoerauf et al. 
1999; Hoerauf et al. 2001; Taylor and Hoerauf 2001; Hoerauf et al. 2003). This is an 
attractive therapeutic outcome, as no microfilariae are released into the skin (Rao 
and Well 2002) and hence the interruption of parasite transmission via blood-feeding 
insect vectors (Albers et al. 2012). Evidence confirming Wolbachia depletion are 
derived from polymerase chain reaction (PCR) assay showing clearance of Wolbachia 
DNA (Kramer et al. 2003; Volkmann et al. 2003; Gilbert et al. 2005) and reduction or 
clearance of bacterial specific hsp60 and Wolbachia surface protein (WSP) using an 
immunohistochemical staining technique (A. Hoerauf et al. 2000a; Kramer et al. 
2003). Penicillin, gentamycin, the macrolides (erythromycin and azithromycin), 
ciprofloxacin and chloramphenicol were shown to be ineffective against Wolbachia 
in rodent models and in vitro, and consequently did not display antifilarial activity 
(Achim Hoerauf et al. 2000; Townson et al. 2006). 
Tetracycline antibiotics generally inhibit protein synthesis in bacteria by preventing 
the binding of aminoacyl-tRNA to the ribosomal A site, inhibiting translation and cell 
growth (Tritton 1977; Chopra 1994; Chopra and Roberts 2001; Griffin et al. 2010). It 
is important to note that for the antibiotic to be effective it must penetrate the cells 
of the host. In Gram negative bacteria, the tetracycline-magnesium complex is 
absorbed through the outer membrane. The magnesium then dissociates and the 
released lipophilic tetracycline diffuses through the lipid inner layers of the cells (Dax 
1997). Once inside the cells, it complexes again with magnesium until it comes into 
contact with a ribosome. With onchocerciasis, the antibiotic will need not only to be 
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in the nodules in therapeutic quantities but also to be absorbed into the worms to 
have contact with the Wolbachia. 
Tetracyclines can also have direct effects on filarial moulting. This was demonstrated 
in vitro on Brugia larvae using chemically-modified tetracycline analogues that lack 
antibacterial activity (Hoerauf et al. 1999; Rajan 2004). 
 Endosymbiotic Wolbachia, its Deletion and Effects 
on Worm death 
2.2.2.5.1.1 Endosymbiotic Wolbachia 
Wolbachia are -proteobacterial, intracellular, Rickettsia-like microorganisms 
(Huigens et al. 2004; Casiraghi et al. 2005; Serbus et al. 2008). They appear as 
elongated or spherical, double-membraned bodies richly associated with glycogen in 
the cytoplasm of cells of the reproductive and other infected organs. The size of 
Wolbachia is similar to that of a mitochondrion when observed with an electron 
microscope, but may vary (Yen and Barr 1971). Wolbachia was first discovered in the 
Culex pipiens mosquitoes and named Wolbachia pipientis  (Hertig and Wolbach 
1924). There are currently 17 phylogenetic super-groups (A-Q) of Wolbachia found in 
>50% of terrestrial arthropods (Weinert et al. 2015), a few genera of the 
Onchocercidae (Fenn et al. 2006; Ferri et al. 2011) and two genera of plant-parasitic 
nematodes, Radopholus (Haegeman et al. 2009) and Pratylenchus (Brown et al. 
2016). Most of the Wolbachia found in arthropods belong to super-groups A, B and 
E, while those of nematodes to super-groups C and D (Bandi et al. 1998; Casiraghi et 
al. 2005; Comandatore et al. 2013; Gerth et al. 2014). Wolbachia of the super-group 
F are found in both nematodes and arthropods. They are transmitted vertically by the 
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female host through the germline. The mature spermatozoa contain minimal 
cytoplasm and infected males accounts for less than 2% of vertical transmission 
(Casiraghi et al. 2005). In many arthropod species, uninfected females mated with 
infected males do not produce viable offspring or have reduced fertility; a 
phenomenon called “cytoplasmic incompatibility” (Yen and Barr 1971; Huigens et al. 
2004; Serbus et al. 2008). This can also occur as bidirectional incompatibility if the 
Wolbachia strains in infected male and female arthropods differ in genomic copy 
number and mutations in two prophage-associated genes (Bonneau et al. 2018). The 
females are favoured by the Wolbachia, and parthenogenesis, male killing or 
feminisation of embryos are other reproductive effects observed in infected 
arthropods. In addition, the ability of Wolbachia to inflict phenotypic changes in its 
host is beginning to be exploited to reduce the transmission of some important 
arthropod-borne (Glaser and Meola 2010; Mousson et al. 2010) and protozoan 
(Moreira et al. 2009; Gomes et al. 2017) diseases.  
Unlike in some arthropods where Wolbachia also affect the fertility of its host (Yen 
and Barr 1971) and could modulate the arthropod’s ability to transmit diseases, in 
nematodes, they have been considered nutritional or energy-generating mutualists 
(Foster et al. 2005). They develop within the somatic and germline cells of adult 
worms as an endosymbiont (Landmann et al. 2012). This mutualistic association 
between Wolbachia and filarial nematodes became important when antibiotics of 
the tetracycline family were shown to retard the development of embryos and larvae 
(Bandi et al. 1999) and eliminate onchocerciasis in cattle (Langworthy et al. 2000). 
The basis for this mutualistic relationship may vary from one Wolbachia group to 
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another and may be immunologic and/or metabolic (Foster et al. 2005; Nfon et al. 
2006; Hansen et al. 2011; Darby et al. 2012). Efforts to trace the origin of the 
mutualistic relationship of Wolbachia and its host from genomic studies are on-going. 
Major limitations are serious long-branch attraction artefacts (considering distantly 
related bacteria as close relatives) in the molecular phylogenetic studies (Bordenstein 
et al. 2009).  
2.2.2.5.1.2 Role of Wolbachia in Filarial Nematode 
The depletion of Wolbachia populations following antibiotic therapy causes an 
immunological switch around parasitic nematodes from neutrophilia to eosinophilia 
and worm killing (Nfon et al. 2006; Hansen et al. 2011). The immediate post-
Wolbachia depletion did not affect the motility and viability of Mf; however, the adult 
females were sterilized (Hoerauf et al. 2003). The viable Mf, L4 and adult germline or 
embryos showed extensive non-autonomous apoptosis following tetracycline 
treatment of B. malayi (Frederic Landmann et al. 2011). Interestingly, apoptosis was 
absent in the hypodermal cords  (Frederic Landmann et al. 2011), although some 
disruptions to the hypodermal cytoskeleton were observed. The effects of antibiotics 
were more prominent in gravid females than other adults or stages of filarial worms. 
In the long term, the development of larval and embryonic worm stages are arrested, 
while sterilised female worms finally die within 1–2 years (Walker et al. 2015). In the 
cattle model of onchocerciasis, eosinophil degranulation on the surface of the worm 
following Wolbachia depletion contributed towards worm killing (Nfon et al. 2006; 
Hansen et al. 2011). Wolbachia may also have a mitochondria-like function in the 
42 
 
 
worms (Darby et al. 2012), which together with its metabolic and immunologic role, 
are vital for worm survival. 
Wolbachia released into the tissues during the natural death of Mf or drug-mediated 
killing may initiate a hyper-immune reaction responsible for the pathogenesis of 
filarial nematode diseases, particularly, the ocular form (André et al. 2002; Keiser et 
al. 2002). Wolbachia possesses highly immunogenic proteins and produces chemo-
attractants for neutrophils (Bazzocchi et al. 2007; Tamarozzi et al. 2016). In bovine 
onchocerciasis, the stimulated neutrophils escape from the blood via capillaries and 
migrate towards the infected worm cuticle to form a type of micro-physical barrier 
(Makepeace and Tanya 2016). Neutrophils appear to be harmless to intact worms 
and are prevented by the worm cuticle from phagocytising the endobacteria. In turn, 
the neutrophils’ dominant coat around the worm prevents eosinophils from 
attaching to the worm surface. Eosinophils are activated to release toxic granules 
only when attached to the worm’s surface after Wolbachia depletion (Hansen et al. 
2011). However, the exact immunological mechanism of worm killing by eosinophils 
is not known. Wolbachia express surface protein (WSP) (Bazzocchi et al. 2007) and 
lipoprotein (wBmPAL) (Power et al. 2004) that can inhibit neutrophil apoptosis 
(Tamarozzi et al. 2016). These lipoproteins have also been implicated in disease 
pathogenesis (Turner et al. 2009).  
In lymphatic filarial worms, Wolbachia synthesises haem and riboflavin (Foster et al. 
2005) and provide a tremendous iron-buffering potential to their hosts (Brownlie et 
al. 2009; Gill et al. 2014). However, the Wolbachia of O. ochengi (wOo) lacks the 
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ability to synthesise riboflavin (Darby et al. 2012), but may serve as a power house 
for the worm by provisioning ATP. 
2.3 Immunology of Onchocerciasis 
Onchocerciasis is an immune-mediated disease caused by an exaggerated response 
to the presence of Mf and/or Wolbachia in the skin after establishment of infection. 
The rational for the review of the immunology of onchocerciasis is to evaluate the 
possibility of preventing infection, arresting the establishment of infection and finally 
treating infected animals and prevent reinfection. 
2.3.1 Prophylaxis 
In areas endemic for onchocerciasis, less than 5% of persons (Kruppa and Burchard 
1999; Hoerauf and Brattig 2002) and cattle (Tchakouté et al. 2006) are referred to as 
putative immune (PI) or endemic normal because they are immune to new infection 
despite exposure to high levels of disease transmission. Zooprophylaxis amongst 
Fulani nomads living in areas endemic for cattle O. ochengi North of Cameroon, and 
exposed to natural transmission of O. ochengi L3 via S. damnosum is characterised by 
protection from O. volvulus infection (Wahl et al. 1994). Although it is possible that 
the presence of cattle with larger respiratory volume than man, hence emitting more 
CO2, which attract more flies to them than humans (Sutcliffe et al. 1994), it was not 
the main explanation of zooprophylaxis as experimental evidence on calves 
experimentally vaccinated with irradiated L3 from O. volvulus and challenged with O. 
ochengi L3 showed high levels of protection (Achukwi M et al. 2006; Tchakouté et al. 
2006). 
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 Immunology of Putatively Immune Individuals 
Attempts have been made to characterize the sera or immune cells from PI 
individuals for specific antibodies or cytokine profiles that could be responsible for PI 
status. In vitro studies confirmed that sera from the infected as well as PI individuals 
could kill L3 and limit the moulting of L3 to L4 during new infection (Berger 2000). 
Initially, the immunity in PI individuals were thought to be driven by an antigen-
specific Th 1-type response (Elson et al. 1995), with interferon gamma being the main 
cytokine produced (Amambua et al. 2006). However, it appears that PI individuals 
express a mixed Th1/Th2 response characterized by a weaker Th1 than Th2 response 
(Hoerauf and Brattig 2002). The dominant antigen on an infective larvae OvL3.C1, is 
a histidine-rich and helix-rich protein with a single transmembrane region (Vincent 
P.K. Titanji et al. 2002; Amambua et al. 2006). It elicits strong IgG3 and IgG4 
responses, which killed the L3 of parasites and blocked pathology respectively  
(Meyer et al. 1994). The PI individuals produce distinct larval and male worm-specific 
cytokine responses associated with proliferative reactions to O. volvulus antigens 
(Achukwi M et al. 2006; Tchakouté et al. 2006; Ziewer et al. 2012), similar to those of 
the hyperactive forms of onchocerciasis (Gregory et al. 1997; Murray et al. 2005; Cho-
Ngwa et al. 2010; Sam et al. 2011; Babayan et al. 2012). 
Absence of nodules and skin Mf in persons or animals in endemic areas is not 
diagnostic of PI. Additional tests are needed to differentiate PI from pre-patent or 
post-patent infections and Sowda. Certain genetic factors (HLA-D allele: haplotype 
DQA1*0501 and DQB1*0301) tended to lead to the development of PI status in 
humans (Meyer et al. 1994; Turaga et al. 2000). There is strong evidence of negative 
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correlations between Mf load and the immune response, with persons having low Mf 
load tending to develop the severest form of the disease (Duke and Moore 1968; 
Brattig et al. 1994). It is obvious that irradiated L3s induce strong protective immunity 
in animal models (Goff et al. 2000; Abraham et al. 2004), but L3 vaccines for humans 
will be difficult to licence for ethical reasons. 
 Immunogenic Onchocerca Molecules (Vaccine 
candidates) 
The best immunogenic proteins for use in vaccine production are those that will 
target the invader at the point of entry to the point of establishment of infection, 
such as attenuated L3s. As generating L3s for large-scale vaccination schemes is 
challenging and would raise safety concerns for human use, subunit antigens present 
in all of the stages of the worms have been evaluated for potential as vaccine 
candidates (Gregory et al. 1997; Joseph et al. 1998; Gregory et al. 2000; Sam et al. 
2011). To prevent establishment of worm, antigens present in secretory or excretory 
products of worms and not having host homologs such as the Abundant Larval 
Transcript (ALT) only expressed in L2 and L3 and the Cysteine Protease Inhibitors (CPI) 
are potential good vaccine candidates (Babayan et al. 2012). Identified recombinant 
proteins for experimental vaccine production can have their acidic domain mutated 
before the immunoregulatory genes (ALT and CPI) are genetically engineered (Joseph 
et al. 1998; Babayan et al. 2012). Both ALT and CPI are acidic proteins that contribute 
to parasite invasion and establishment by modulation of host immune attack 
(Kalyanasundaram and Balumuri 2011; Babayan et al. 2012). 
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Two forms of the secretory/excretory products ALT-1 and ALT-2 are released by the 
adult and infective larvae respectively of Brugia malayi (Bianco et al. 1990; Bianco et 
al. 1995; Wu et al. 2004), O. volvulus (Wu et al. 2004) and Acanthocheilonema 
(Pogonka et al. 1999). They are produced in the oesophageal glands and secreted 
only when the parasites are in the mammalian host (Sam et al. 2011). ALT-1 and ALT-
2 are secreted larval acidic proteins (SLAPs) belonging to the ALT family (Wu et al. 
2004; Sam et al. 2011). The immunogenic property of ALT-2 is highly linked to its 21 
amino acid terminal signal sequence. ALT-2 based vaccines induced both humoral 
and cell mediated immunity characterised by IgG1 and IgG2a, as well as IL4 and 
interferon gamma production, with or without adjuvant (Murray et al. 2005; Sam et 
al. 2011). Adjuvants are usually added to maintain Th1-Th2 balance essential for 
protection, so having a vaccine that will not need an adjuvant is of interest given that 
adjuvants may be toxic or provoke production granulomas (Hernández et al. 2008). 
Cystatins are protein inhibitors of the cysteine proteases found in all metazoan and 
plant taxa (Watts 2001) and are close relatives of stefins and kininogens in a 
superfamily of cysteine protease inhibitors (Villadangos and Ploegh 2000). Cystatins 
play an important role in blocking the activities of cysteine proteases essential in the 
breakdown of pathogen proteins during antigen presentation (Gregory et al. 1997; 
Manoury et al. 2001; Murray et al. 2005; Gregory and Maizels 2008; Cho-Ngwa et al. 
2010). Cysteine proteases are essential for use by APC, which need to generate 
intracellular peptides bound to products of the major histocompatibility complex 
(MHC) class II  (Gregory and Maizels 2008). CPI-1 and CPI-2 both constitute another 
subset of nematode cystatins. The structure and variability of cystatins has been 
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widely reviewed (Bode et al. 1988; Murray et al. 2005). Of importance to filarial 
vaccine research is CPI-2, which has acquired an additional function of inhibiting 
asparaginyl endopeptidase (AEP) and making nematode cystatins unique (Murray et 
al. 2005). Unlike CPI-2 which is present in all the stages of filarial nematodes except 
Mf, CPI-1 and -3 are expressed in the vector during the late stages of the infective 
larvae (Gregory et al. 1997). They lack the conserved glycine residue in the N-terminal 
region (Gregory et al. 1997) and have only 25% amino acid similarity with CPI-2 in 
Brugia malayi (Anand et al. 2011; Sam et al. 2011). The CPI-1 cDNA has a 22-nt 
nematode spliced leader sequence (SL-1) at the 5’ end immediately before the start 
codon, a 19 amino-acid predicted signal sequence, and is abundantly expressed in all 
L3 EST datasets (Vincent P. K. Titanji et al. 2002; Cho-Ngwa et al. 2010). The limitation 
of this subset of cystatins to the infective larvae also makes it a potential candidate 
for filarial vaccine production. 
Another important vaccine candidate identified in secretory products from L3s of 
most filariae is Vespid Allergen Homologue-like protein (VAH) (Anand et al. 2007; 
Gregory and Maizels 2008; Kalyanasundaram and Balumuri 2011). In B. malayi, 
recombinant proteins or a DNA vaccine encoding BmALT-2 and BmVAH elicit 
substantial Th2 (IgG1/IgG3) and Th1 (IgG2a) immune responses respectively in jirds 
and mice (Anand et al. 2011). 
 Vaccination Trials on Onchocerciasis 
The initial approach to filarial vaccine research was to compare sera between the 
infected and uninfected and monitor sera from L3-vaccinated animals for 
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identification of antigens (Sam et al. 2011; Babayan et al. 2012). Then subunit 
vaccines produced from identified immunogens did not stimulate sufficient 
protective immunity (Brattig et al. 1994). Another set of targets being researched for 
potential vaccine candidates are immunomodulators present in secretory and 
excretory products of the parasites. To survive, the parasites have evolved to produce 
secretions that facilitate invasion of the host and negatively modulate hosts immune 
attack. These secretary/excretory products have given hope of a possible vaccine 
against filarial diseases (Magdi M. M. Ali et al. 2007). 
Melarsomine-treated and irradiated L3-vaccinated cattle were compared in terms of 
susceptibility to infection, and after 2 years of continuous exposure to intense natural 
challenge from infected Simulium, significantly lower worm burdens were observed 
in vaccinated animals compared to controls (Tchakouté et al. 2006). In the same 
study, previously cured cattle were susceptible to reinfection. Similar reports of 
reinfection after treatment were from suramin treated (Renz et al. 1995), ivermectin 
treated (Njongmeta et al., 2004) and antibiotics treated (Nfon et al., 2007) cattle. 
Based on cross-reactivity and cross-protection between human O. volvulus and cattle 
O. ochengi (Wahl et al. 1998; Achukwi M et al. 2006; Graham et al. 2009), a major 
cattle experiment was conducted on naïve calves to evaluate eight O. ochengi 
recombinant antigens (onchocystatin inclusive) as a combined vaccine in Cameroon 
(Makepeace et al. 2009). Each antigen was administered separately with either 
Freund’s adjuvant or alum. After 22 months post-exposure only 58% of vaccinated 
cattle were infected compared to 100% in the controls. However, trials using 
irradiated L3s induced immune protection in other filarial systems are believed to be 
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eosinophil-dependent (Brattig NW et al. 1991; Goff et al. 2000; Klion and Nutman 
2004). 
 Innate Immunity 
This study seeks to elucidate the immunochemotherapeutic interaction in 
onchocerciasis. An in-depth review of the essential helminth immunology and its 
relationship to acquired immunity is essential. The innate immune system is the first 
line of defence operated by a combination of physical barriers, phagocytic cells, 
cytokines and antibacterial peptides (Delves et al. 2011). The skin acts as the primary 
physical barrier to overcome. In filariasis, the vector fly breaks the skin to inject L3 
into the subcutis. After invasion, key immune cells align to coordinate reduction of 
the danger posed by the invader are tissue macrophages, fibroblast, dendritic, 
endothelial or epithelial cells. These cells, in addition to neutrophils, eosinophils, 
lymphocytes, monocytes and other specialised immune proteins located in the 
cardiovascular system have receptors that cause them to respond to the presence of 
a foreign body to eject or contain it (Chaplin 2010). 
2.3.1.4.1 Innate Immune Receptors 
Innate immune cells use sensory molecular complexes (receptors) located either on 
the surface of a cell membrane or within the cytoplasm to communicate between 
themselves, with other cells and the external environment. These sensory protein 
complexes are pathogen recognition receptors (PRRs) (Kawai and Akira 2010). PPRs 
were first discovered in 1989 as cited by L.A.J. O'Neill et al. (2013) and are specialised 
at detecting damage (or pathogen) associated molecular patterns (D(P)AMP) in 
pathogens, aged cells, cell mediators or signals (Hoving et al. 2014). Each receptor 
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has specialised sub-units that detect different types of DAMPs or PAMPs. The 
receptors serve as a link between the innate and adaptive immunity. 
In innate immunity, PRRs on sentinel cells are germline-encoded receptors with 
heterogenous functions. They cause the cell to produce substances that activate 
innate immune mechanisms. Four subgroups of PRRs have been identified based on 
the type of molecular moieties they interact with (Delves et al. 2011). Toll-like 
receptors (TLRs) are located on the cytoplasmic membrane or in endo-lysosomes. 
They are the most abundant type (Delves et al. 2011), while C-type lectin receptors 
(CLR) with carbohydrate recognition are crucial in the control of fungal infection 
domains (Schroder and Tschopp 2010; Hardison and Brown 2012; Rathinam and 
Fitzgerald 2016). The third group of PRRs are retinoic acid-inducible gene 1 (RIG-1)-
like receptors (RLRs) essential for nuclear reprograming of somatic cells to induce 
pluripotent stem cells (Sayed et al. 2017). The fourth and most important source of 
pro-inflammation PRRs are called inflammasomes (Schroder and Tschopp 2010). 
They are intra-cytoplasmic nucleotide binding domain (NBD) or the nucleotide 
binding and oligomerization domain (NOD), leucine rich-repeat containing protein 
receptors (NLR) (Muñoz-Wolf and Lavelle 2016)  
2.3.1.4.1.1 NLR Receptors (Inflammasomes) 
NLRs form multiple cytoplasmic protein complexes called inflammasomes (Schroder 
and Tschopp 2010; Rathinam and Fitzgerald 2016) that activate proteolytic enzymes 
of the caspase 1 cascade while under stress or on exposure to intra-cytoplasmic 
PAMPs (Lamkanfi and Dixit 2014). Before activation to form inflammasones, NLRs are 
soluble proteins of a diverse family of receptors that reside within the cytoplasm in 
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an auto-inhibited state (Delves et al. 2011). The N-terminal protein-to-protein 
interaction motifs recruit proteases or kinases upon activation (Kufer and Sansonetti 
2011; Lamkanfi and Dixit 2014; Muñoz-Wolf and Lavelle 2016; Rathinam and 
Fitzgerald 2016). There is also a central oligomerization domain and C-terminal 
leucine rich repeats (LRRs) that act as a sensor for pathogen products and through 
which the NLRs are activated into an inflammasome capable of recruiting either an 
NFkB-activating kinase, protease of the caspase family, and IL-1β precursors (Muñoz-
Wolf and Lavelle 2016). In addition to playing important roles in the regulation of 
adaptive immunity, tissue homeostasis and apoptosis, NLR inflammasome complexes 
may also have roles beyond immune regulation (Kufer and Sansonetti 2011).  
2.3.1.4.1.2 Toll-like Receptors 
All 10 human TLRs (except TLR-3) are expressed by human neutrophils but fewer TLRs 
(TLR-1, 3, 4, 7, 9 and 10) are expressed in human eosinophils (Hayashi et al. 2003). 
Eosinophils express a greater quantity of TLR-7, which regulates the expression of 
adhesion molecules CD11b and L-selectin, than do neutrophils (Nagase et al. 2003). 
Together with TLR-8, TLR7 prolongs the generation of superoxide in eosinophils. TLRs 
are conserved proteins expressed in animals from invertebrates (Anderson 2000) 
through to dendritic cells (Kadowaki et al. 2001) and macrophages (Menzies and 
Ingham 2006) in mammals. In addition to mediating proinflammatory reactions and 
an adaptive immune response, TLRs regulate CD4+ CD25+ T cells (Treg) to supress host 
immunity (Liu and Zhao 2007). Bovine homologues of human TLRs 1 – 10 have 80 to 
95 percent similarity (Menzies and Ingham 2006), the most abundant being TLR-4 and 
TLR-7 (Brattig et al. 2004; Bazzocchi et al. 2007). Many authors have reviewed the 
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complex roles of TLRs in disease control, autoimmune diseases (Nagase et al. 2003; 
Zheng et al. 2005; Kubinak and Round 2012; L.A.J. O'Neill et al. 2013), tissue repair 
and maintenance of haemostasis. However, in filarial infection, WSP is recognised by 
TLR-2/4 (Gillette-Ferguson et al. 2007) and the Wolbachia-derived diacylated 
lipoprotein (Diacyl WoLP; a synthetic fragment of wBmPAL) is recognised by TLR 2/6 
(Turner et al. 2009). Diacyl WoLP induces neutrophil-mediated corneal inflammation 
via TLR-2/6 pathways in the murine keratitis model, while TLR-2 mediates CXC 
chemokine production by corneal bone-marrow derived cells (Gillette-Ferguson et al. 
2007). 
2.3.1.4.1.3 C-type Lectin Receptors 
The CLRs are transmembrane PRRs of macrophages and neutrophils that specifically 
bind to β-glucan and mannan ligands of fungal cells to mediate Th1/Th17 immune 
responses (Hardison and Brown 2012). There are a number of intracytoplasmic CLRs 
such as dectin 1/2, mannose receptors (MRs), DC-SIGN and Mincle involved in fungal 
binding and phagocytosis and the activation of innate immunity (Drummond et al. 
2011). CLRs are sub-divided into 17 sub-groups based on structure and origin (Hoving 
et al. 2014). Ligation depends on carbohydrate recognition domains (CRDs) or C-type 
lectin domain (CTLDs) and the effect is coordinated with those of TLRs in achieving 
immunity against diseases (Everts et al. 2009). The role of CLRs in helminth infection 
is dependent on MR and Th2 immune responses (Harnett et al. 2002; van Die and 
Cummings 2017). The MR has multiple carbohydrate recognition domains with a 
calcium-independent R type domain that binds glycans with a non-reducing terminal 
3-O-sulfated galactose or 3/4-O-sulfated-N-acetylgalactosamines (Gentil et al. 
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2012).The CRD of CLR can also interact with collagenase and may have a role in filarial 
infection that goes beyond immune modulation. 
2.3.1.4.1.4 Rig-1-like Receptors 
The RLRs have two homologues: melanoma differentiation-associated gene 5 (MDA5) 
and laboratory of genetics and physiology 2 (LGP2) (Sayed et al. 2017). They are 
cytoplasmic receptors that act as sensors of viral RNA and target PAMPs that escape 
detection by TLRs or act as a relay signal from TLRs specialised for detection of nucleic 
acids (Sayed et al. 2017). As with other receptors, RLRs have three domains. The RIG-
1 and MDA5 have N-terminal regions that contain caspase recruitment and activation 
domains (CARDS) (Loo and Gale 2011). Though LGP2 lacks CARDS, it functions in 
MDA5 signalling. The central domain which interacts with viral particles harbours 
DExD/H box RNA helices. RIG-1 recognises RNA sequences harbouring a 
triphosphorylated 5’end, while MDA5 is activated by double stranded RNA (polyIC) 
(Pichlmair et al. 2009). The ligands for LGP2 are yet to be discovered. The RLRs so far 
have no role in helminth infection and neither is there an evidence for their 
involvement in the control of Wolbachia products. 
2.3.1.4.2 The Role of Macrophages 
Macrophages are phagocytic leukocytes produced by the bone marrow (Delves et al. 
2011). During inflammation, activated local macrophages (Epelman et al. 2014) are 
reinforced by monocytes that have extravasated into body tissues during 
proinflammation. However, in helminth infections, resident macrophages are 
capable of replication via alternative activation and proliferation (Jenkins et al. 2011) 
to produce cytokine and chemokines that stimulates Th2 immune response (Allen et 
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al. 2008). Macrophages are universally present within all body tissues in many 
functional phenotypes. Two forms of macrophages exist based on their origin: 
Embryonically-derived tissue macrophages also known as sentinel cells or tissue 
scavengers and bone marrow derived monocytes transformed into macrophages 
only after extravasation (Epelman et al. 2014). Macrophages regulate Th1, Th2 and 
other cytokines and chemokines involved in tissue homeostasis. They are equipped 
with several receptors that detect abnormalities on cells or danger signals from 
obnoxious agents. In humans, classical activation of macrophages (M1) is stimulated 
by gamma interferon (IFNϒ), lipopolysaccharides (LPS) and granulocyte macrophage 
colony stimulation factor (GM-CSF), usually stimulated by non-self-proteins from 
bacterial and viral particles (Epelman et al. 2014). Human M1 macrophages express 
high levels of major histocompatibility complexes (MHC) class II and CD68 markers 
and secrete large amounts of proinflammatory cytokines such as IL-1β, tumor 
necrosis factor (TNF), IL-12, IL-18 and IL-23 that activate Th1 and Th17 cells to 
mediate cytotoxicity and the production of nitrous oxide from L-arginine (Gentil et al. 
2012). Macrophages routinely monitor nearby cells for normal function and cause 
infected cells or aged cells to die by apoptosis. M1 macrophages then engulf the 
apoptotic cells or pathogen by phagocytosis, process non-self-proteins from the 
digested pathogen, and present them via the MHC I pathway to cytotoxic CD8+ T-cells 
to activate Th-1 driven immune responses and ultimately memory cells to memorize 
the antigen for a faster response on second exposure (Zhang and Bevan 2011). When 
M1 macrophages sense danger, they produce Th1 cell attracting chemokines (CXCL 9 
and CXCL 10) and release them to direct neutrophils first to the site of infection 
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(Delves et al. 2011). MHC class II and CD68 co-stimulate CD80 and CD86 on M1 
macrophages. 
 The alternative activation mechanism of macrophages is predominant in response 
to helminth infections. There are four phenotypes of alternatively activated 
macrophages (M2). The M2a subtype is stimulated by IL-4, IL-13, helminths and yeast 
infections; M2b by immune complexes (ICs), IL-1R receptor ligand and LPS; and M2c 
by tumour growth factor beta (TGFβ), IL-10 and glucocorticoids (GCs). M2d are 
distinct from the others and stimulated by IL-6, leucocyte inhibition factor (LIF) and 
adenosine (Rőszer 2015). The M2a macrophages produce Th2 cell attracting 
chemokines CCL17, CCL22 and CCL24, while M2b macrophages produce chemokines 
CCL5, CCL10 and CCL16. The remaining M2c and M2d macrophage phenotypes 
produce chemokine CCL1 and CCR2, respectively. The cytokines produced by these 
M2 macrophage subunits vary, but they all produce IL-10. M2a, c and d release TGFβ 
M2b and d produce TNFα. The M2b macrophages secrete IL-1 and IL-6, as for those 
produced by M1 macrophages. Also, M2d macrophages share in the production of IL-
12 with M1 macrophages. M2 macrophages function as immune modulators and 
promote toleration of infection, tissue remodelling, phagocytosis, tumour formation 
and control of parasitism (Esser-von Bieren et al. 2013). Apart from their origin, there 
is no clear-cut major functional difference between blood-derived classical Ly6cHi 
monocytes and tissue macrophages. The origin and functions of tissue macrophages 
have been reviewed (Epelman et al. 2014; Rőszer 2015). Monocyte-independent 
proliferation of local macrophages into a novel macrophage phenotype with CXCR3 
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chemokines receptors has been shown to attract cytotoxic eosinophils to filarial 
helminths (Turner et al. 2018). 
In filarial infections, both Th1 / Th2 driven cellular immune responses are activated 
(Tamarozzi et al. 2011; Babayan et al. 2012). While the Th1 response activates 
cytotoxic CD4+ T- lymphocyte inflammatory responses to clear Wolbachia released 
by dead Mf around the worm, Th2 sets in to contain damages to surrounding tissues 
from persistent Th1 responses by influencing macrophages to release TGFβ and IL10 
cytokines (Specht et al. 2012) responsible for promoting encapsulation and tissue 
homeostasis (Allen et al. 2008). Classical activation of macrophages in onchocerciasis 
is caused by Wolbachia antigen via TLR2 and TLR6 to produce Th1 and Th17 pro-
inflammatory responses (Gentil et al. 2012). TLR2 forms a heterodimer with TLR6 to 
initiate a cascade of macrophage activation (Oliveira-Nascimento et al. 2012). 
Excretory and secretory worm products also influence macrophages and monocytes 
to stimulate vessel growth and alteration of lymphatic function (Weinkopff et al. 
2014). 
The role of macrophages in the pathogenesis of visual impairment and blindness are 
well-articulated in a review (Tamarozzi et al. 2011) and can serve as a typical example 
of its role during microfilaricidal disease control of larval stages. Macrophages are 
activated in the presence of Wolbachia via TLR-2 not linked to adaptor MyD88/Mal 
to release pro-inflammatory cytokines that attract neutrophils which release 
oxidative products (Mylonas et al. 2013). CxCR2 are released to direct neutrophils to 
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the site of infection. Permanent damage to the eyes is caused by the combined 
actions of macrophages and eosinophils.  
2.3.1.4.3 The Role of Neutrophils 
Neutrophils are the most abundant innate immune cells and the first granulocytes to 
be recruited at the site of infection (Delves et al. 2011). They are polymorphonuclear 
(PMN) leucocytes produced in the bone marrow and stored in the circulatory system 
for about 24 hours but could last up to 5.4 days. As the lifespan of PMN leukocytes is 
short, they are massively recruited from the bone marrow following an infection. 
Inactivated neutrophils enter the body tissues where they die by apoptosis after a 
few days. The structure and functions of human and cattle neutrophils and other 
immune cells was updated in a published review (Makepeace et al. 2012). Mature 
human neutrophils have two types of toxic granules based on size: the dominant 
large primary azurophil and smaller secondary specific granules (Bainton and 
Farquhar 1966). At the pro-granulocyte stage, only azurophils are active. A third 
granule is present in bovine neutrophils which contains cationic proteins with 
antimicrobial properties (Gennaro et al. 1983). 
During the respiratory burst, myeloperoxidase (MPO) encoded by the MPO gene 
located on chromosome 17, is the major enzyme released from azurophil granules 
(Delves et al. 2011). It is the most abundant protein and toxic enzyme of neutrophils  
(Schultz and Kaminker 1962). The expression of MPO is induced by granulocyte 
colony stimulating factor (G-CSF) via GM-CSF and TNFϒ. It utilises hydrogen peroxide 
to generate hydrogen hypochloride (Harrison and Schultz 1976) and other reactive 
58 
 
 
oxygen species which kills the pathogen. Antimicrobials such as lysosome hydrolase, 
defensins, bacteriocidal permeability increasing protein (BPIP), elastases and 
cathepsin G are also stored in azurophils  (McFarlane et al. 2008), which constitutes 
about 5% of the neutrophil’s dry weight. The specific neutrophil granules contain 
lactoferrins and metalloprotease 9 or gelatinase B. The last set of specific granules 
are actually secretory vesicles containing serum albumin. Based on specific activities 
of granules, some authors consider neutrophils as having four types of granules (Lacy 
2006). Elastases and gelatinases released by azurophils facilitate the migration of 
neutrophils through the extracellular matrix to the site of infection. 
Neutrophils possess numerous PRRs, mostly TLRs and NLRs used to sense PAMPs or 
DAMPs on pathogens, and damaged or senescent cells with high specificity as earlier 
reviewed under receptors (Section 2.3.1.4.1.2). Cytokines released by sentinel cells 
activate neutrophils to become polymorphonucleated and chemokines attract them 
to the site of infection. On rare occasions, the neutrophil could acquire MHC class II 
to initiate adaptive immune responses by contributing to antigen processing and 
presentation. At the site of infection, activated PMN neutrophils produce cytokine IL-
8 to increase vascular permeability and recruit more neutrophils (Brattig et al. 2001). 
The mechanism of neutrophil degranulation is mediated via the G-protein coupled 
(GPC) signal transduction pathway after binding of GPCR to IL-8 or F-Met-Lev-Phe 
(Lacy 2006). Degranulation results in toxic respiratory burst by exocytosis 
accompanied by the release of more cytokines to recruit additional neutrophils or 
M2 macrophages to modulate damage caused to neighbouring tissues. There are four 
factors that regulate exocytosis. The commonest factors are calcium and 
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polyphosphorinositol (which is catalysed to phosphatidylinositol 3-kinase (PI3K)-ϒ) 
levels regulated by calcium signalling and phospholipid signally pathways. Exocytosis 
promoted by Β-arrestin or a group of cytosolic phosphoproteins promotes 
degranulation of primary and secondary granules, while guanosine triphosphatase 
(GTP) regulates the degranulation of cytokines or mediators (Lacy 2006). 
In the event of overexpression of MPO by neutrophils, as in most autoimmune 
disorders and chronic diseases, a Th2 adaptive immune response is initiated and 
vascular permeability increased (Strzepa et al. 2017). In helminth infection, tolerance 
is mediated by CLRs via mannose receptor  (Hardison and Brown 2012). However, in 
filarial diseases, the role of neutrophils in both worm killing and survival has not been 
fully elucidated but depends on the endobacteria, Wolbachia which are released into 
host tissues during parturition (Kozek 2005), alongside secretions (Landmann et al. 
2010; Melnikow et al. 2011) or as surface proteins via the cuticle (Armstrong et al. 
2014). Natural death or drug induced death of Mf leads to release of many Wolbachia 
in the skin which are responsible for the pathology observed during infection 
(Seidenfaden et al. 2001; Tamarozzi et al. 2011). The principal PAMPs from Wolbachia 
are WSP and wBmPAL, which are surface membrane proteins and ligands to TLRs on 
neutrophils. WSP activates TLRs 2/4 and wBmPAL activates TLRs 2/6 to cause 
inflammation and oedema of affected tissues (Brattig et al. 2004). Because worm 
tissues cannot be engulfed by phagocytes, neutrophils accumulate around them and 
their lifespan is extended by WSP (Brattig et al. 2001; Hansen et al. 2011). A cross 
section of a healthy Onchocerca nodule will portray the worm(s) surrounded by 
concentric rings of neutrophils (Brattig et al. 2001; Hansen et al. 2011)  and a few 
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eosinophils not very close to the worm surface (Wildenburg et al. 1996). This 
relationship may be responsible for the longevity of the worms. 
2.3.1.4.4 The Role of Eosinophils 
Eosinophils are granulocytes with a bi-lobed nucleus. They are potent innate immune 
cells against multicellular organisms, fungi and viral infections. Eosinophils are 
activated by IL-5 (Abraham et al. 2004) and attracted to the infected site by RANTES 
or eotaxin (Pearlman et al. 1999). Degranulation and the release of toxic substances 
at a target via micro-tubules requires direct contact with the invader (Klion and 
Nutman 2004). Activated eosinophils also release cytokines to stimulate mast cells to 
release histamines amongst other toxic substances (Urb and Sheppard 2012). The 
histamines released are responsible for pruritus (Remme 1995) and/or sclerotic 
keratitis (Wildenburg et al. 1994). The scratching and wounding of the itchy skin 
predispose the skin to secondary bacterial infection. After treatment with IVM 
(O'Connell et al. 2011) or DEC, there is increase in IL-5 within the lymph nodes and 
eosinophilia before the appearance of the symptoms (Klion and Nutman 2004). A 
dead onchocercoma contains dead calcifying worms, active inflammation, 
macrophages, giant cells and eosinophils adhered to the degenerating cuticles of Mf 
(Brattig NW et al. 1991). In chronic inflammation, disintegrating Mf and neutrophils 
were encapsulated within an abscess (WHO-Update 1981; Trees 1992; Johnson et al. 
1995). There seem to be some correlations between female worm gravidity with 
intra-uterine Mfs and eosinophils (Seidenfaden et al. 2001). In the early infection, the 
blood eosinophil level increases (Wildenburg et al. 1994) but as the worm matures, 
it decreases. The main granule of the eosinophil contains major basic proteins (MBP) 
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(Plager et al. 1999) capable of immobilising Mf of all the larval stages but not L4 and 
active unproductive adult O. volvulus (Strote et al. 1990). There is sufficient evidence 
to show that eosinophils can  immobilise Mf of all the larval stages except L4 
(Wildenburg et al. 1996). For eosinophils to effect worm killing, they need to adhere 
to the parasite’s cuticle (Melo and Weller 2010) and degranulate toxic substances 
such as eosinophil cationic protein and eosinophil peroxidase onto the parasite 
(Hansen et al. 2011). Eosinophils appear to be much more efficient when their target 
is immobilised within lymph nodes (Hoerauf et al. 2005). 
 Adaptive Immunity 
Resting T-lymphocytes play a pivotal role in adaptive immunity, during which a 
specific encounter with an infection is tackled by effector cells (Zhang and Bevan 
2011) and memorized by B cells (Harris and Gause 2011) in readiness for an 
anamnestic response on a second occurrence (Isobe et al. 1986; Andersen et al. 
2006). T lymphocytes (T cells) are white blood cells produced in the bone marrow but 
matured in the thymus glands or in tonsils, while B lymphocytes (B cells) mature in 
the bone marrow of mammals (Harris and Gause 2011) or Bursar of Fabricius of birds. 
Upon stimulation, naïve T cells split into many subsets of cells depending on the 
antigen identified. The main T cell subsets are T helpers (Th), T (cytotoxic) killers and 
T regulatory cells (Berger 2000). T helper cells, also known as T4 cells or CD4+ cells 
because of the presence of the CD4+ glycoprotein molecule on its surface, interacts 
with antigen presented by MHC class II to produce co-stimulants to activate 
macrophages (Rudd et al. 2010) and other effector cells, help suppress or regulate 
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immune responses, and cause maturation of B-cells into plasma and memory B cells. 
CD8+ cells or T killer cells are cytotoxic to cells infected with viruses or other 
intracellular pathogens and tumours (Zhang and Bevan 2011) when ligated to MHC 
class I molecules in the presence of a co-stimulus (Andersen et al. 2006). T cell-
restricted immune responses are specific and follow different pathways depending 
on the molecular biology of the antigen (Berger 2000). In filarial infections, the ratio 
of Th1- and Th2- lymphocytes determine the fate of the parasite (Babayan et al. 2012; 
Gentil et al. 2012). Wolbachia surface proteins stimulate a Th1- proinflammatory 
response (Brattig et al. 2004) that tends to protect the worm (Hansen et al. 2011). 
The activation of CXCRs on macrophages by IL-4 mediate Th2 responses and 
eosinophil degranulation (Turner et al. 2018). Numerous experiments on mice and 
jirds have affirmed the role of T- lymphocytes in the effective control of skin Mf 
(Carlow Clotilde et al. 1988; Allen and Maizels 2011; Harris and Gause 2011; Gentil et 
al. 2012). 
2.3.2 Mechanisms of Immune Evasion by Filarial Parasites 
The penetration of parasites into the vertebrate host is met with an innate immune 
response from sentinel cells. However, filarial parasites survive within vertebrate 
hosts for years (as long as 10 to 15 years in onchocerciasis) due to 
immunomodulatory effects. In laboratory models, significant number of L3s of L. 
sigmodontis (Goff et al. 2000) and L. loa (Wanji et al. 2002) escape aggressive immune 
attack within body tissues upon invasion by entering into the lymphatic vessels 
(Babayan et al. 2003; Bain and Babayan 2003), while in O. volvulus, the L4 stage takes 
advantage of its morphological architecture of a distinctive cuticle to stop eosinophil 
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adherence (Brattig et al. 1994; Selkirk et al. 1998). The principal challenge for the 
survival of adult worms is the ability to resist the oxidative environment created by 
the neutrophil respiratory burst and eosinophil degranulation onto the worm cuticle 
(Brattig et al. 1994; Selkirk et al. 1998). B. malayi synthesizes glutathione peroxidase  
to protect its cuticle from the damaging effects of free oxygen radicals by reducing 
phospholipid hydroperoxides (Tang et al. 1995). Glutathione peroxidase is regulated 
independently from selenium which is incorporated as vitamin E into worm cuticle 
from the host’s extracellular fluid (Selkirk et al. 1998). Other antioxidants such as 
thioredoxin peroxidase, are expressed in most stages of O. volvulus (Lu et al. 1998; 
Dzik 2006) and in nodule fluid of O. ochengi (Armstrong et al. 2016), and are highly 
up-regulated.  
Another mechanism of immune evasion is by active secretion of homologues of anti-
inflammatory cytokines, such as macrophage migration inhibitory factor (MMIF) 
which was observed in B. malayi, W. bancrofti and O. volvulus and shown to be 
capable of inhibiting up to 75% of monocyte and macrophage migration, thereby 
affecting macrophage chemotaxis in an identical way to human MMIF (Pastrana et al. 
1998). Other major cytokine homologue secreted by macrophages such as TGF-β and 
galectins (González-Miguel et al. 2015) were isolated from nodule fluids obtained 
from O. ochengi (Armstrong et al. 2016).  There are other immune modulatory 
products including ALT2 reviewed under vaccine candidates whose contribution to 
the prolongation of worm lifespan have been targeted for vaccine research (Anand 
et al. 2011; Sam et al. 2011). 
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The last category of immune evasion mechanisms is the principal benefit of 
mutualism between the worm and its endosymbiont bacteria, Wolbachia, in its 
nodule-dwelling hosts, O. volvulus and O. ochengi, characterized by the neutrophilic 
“protective coating” on the viable worm’s surface (Tamarozzi et al. 2016). Wolbachia 
attract neutrophils to the worm’s immediate surroundings and increases its lifespan. 
Infiltrated neutrophils form extracellular traps (NET) around the worm to contain the 
spread of cytotoxic substances into host tissues. By so doing, the neutrophils, through 
an unknown mechanism, contribute to the enhancement of a state of tolerance of 
the worm (Brattig et al. 2001). Thus, the mutualism extends the worm’s lifespan. 
Wolbachia is absent in O. flexuosa, a sessile nodule-forming filaria of deer that does 
not attract neutrophils (Plenge-Bönig et al. 1995). Adult O. flexuosa lives for only 
about 18 months while surrounded by eosinophils (Wildenburg et al. 1996). 
Antibiotic-treated worms after neutrophil depopulation do not usually survive for 
more than a year using the cattle model (Langworthy et al. 2000; Gilbert et al. 2005; 
Nfon et al. 2006; Hansen et al. 2011), or up to two years after doxycycline therapy in 
humans (Hoerauf et al. 2008b; Walker et al. 2015).  
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Chapter 3 Efficacy of Combining 
Immunotherapy with Mutated Onchocystatin 
and Sublethal Oxytetracycline Chemotherapy 
on O. ochengi in Cattle 
 
3.1 Introduction 
Antibiotic of the tetracycline family was first shown to have a lethal anti-filarial effect 
on a cattle filarial worm, Onchocerca ochengi (Langworthy et al. 2000; Gilbert et al. 
2005). Treatment is successful only when the antibiotic is administered intermittently 
over six months, as in cattle, or as a 4 - 6 week continuous daily regimen in humans 
(Hoerauf et al. 2008b). Macrofilaricidal effects depend on abrogation of the 
relationship between the filarial host and its endosymbiotic bacteria, Wolbachia 
(Langworthy et al. 2000). Wolbachia is found within host cells of the hypodermal cord 
and the female reproductive tracts (Bandi et al. 1999; Hoerauf et al. 1999; 
Langworthy et al. 2000; Gilbert et al. 2005). O. volvulus, the lone causative organism 
of human onchocerciasis, will not complete its lifecycle in species other than humans 
and great apes. So, O. ochengi, its closest biological relative (Morales-Hojas et al. 
2006), has been an exemplary experimental model for pharmacological research on 
onchocerciasis (Trees 1992; Trees et al. 2000). Antibiotics of the tetracycline family 
function by interfering with protein synthesis and therefore have the ability to 
penetrate cell membranes to target the ribosomes (Chopra 1994). Previous studies 
monitoring the post-therapeutic depletion of Wolbachia from O. ochengi nodules 
revealed that the bacteria were eliminated from all worm histological sections at 24 
weeks after the onset of treatment, when the last monthly dose of adulticidal 
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oxytetracycline therapy (ADT) was administered (Gilbert et al. 2005). Meanwhile, 
with sub-lethal therapy (SLT), a few months after oxytetracycline chemotherapy 
terminated, Wolbachia was still present within the ovaries (Gilbert et al. 2005; Nfon 
et al. 2006). In the human trial protocols, depletion of Wolbachia from O. volvulus 
was first evident after 24 weeks and the bacteria were cleared from most of the 
worms at 40 weeks after onset of treatment (Hoerauf et al. 2008b). The exact 
mechanism of worm death after the depletion of Wolbachia has not been clearly 
elucidated. 
In the cattle model, worm death has been attributed to immunological changes 
associated with the replacement of neutrophils by activated eosinophils around the 
worm surface (Nfon et al. 2006; Hansen et al. 2011) resulting from the sustained 
removal of Wolbachia endobacteria during the ADT regimen (Langworthy et al. 
2000). Depletion of Wolbachia endobacteria after ADT antibiotic therapy  in cattle, 
lead to worm death within 52 weeks (Makepeace et al. 2006) while continuous daily 
oral doxycycline administration in humans cause adult worm death 24 to 36 weeks 
post treatment (Hoerauf et al. 2008b). In humans or small animal models continuous 
doxycycline administration resulted in embryostasis, sterility (A. Hoerauf et al. 2000a; 
Hoerauf et al. 2003; Turner et al. 2010), cellular apoptosis, and a sustained drop in 
microfilarial load (Landmann et al. 2011) before death of worms long after therapy 
ended (Hoerauf et al. 2008b). 
The potential use of antibiotic therapy in control programs will greatly be enhanced 
if the duration of treatment is shortened. However, studies to identify other potential 
antibiotics such as chloramphenicol and ciprofloxacin (Achim Hoerauf et al. 2000) or 
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macrolides such as azithromycin (Hoerauf et al. 2008a) with superior macrofilaricidal 
effects to the tetracyclines were initially unsuccessful. Thus, rifampicin used to treat 
tuberculosis was no more effective than tetracyclines in treating onchocerciasis in 
humans (F.O. Richards et al. 2007; Specht et al. 2008) and in cattle (Bah et al. 2014). 
The availability of tools such as Wolbachia-infected insect cell-lines and small animal 
filarial models has enabled the evaluation of novel antibiotics, e.g., corallopyronin A, 
for efficacy against Wolbachia (Schiefer et al. 2012). Wolbachia cell-lines have also 
been used to test and repurpose existing drugs belonging to the tetracycline, 
fluoroquinolone, and rifamycin families (Johnston et al. 2014; Taylor et al. 2014). 
Nonetheless, the development of a vaccine against filarial diseases remains a 
complementary or alternative option for the eradication of onchocerciasis. 
Antibody-mediated cytotoxicity (ADCC) is one of the immune mechanisms employed 
in the control of helminth infections (Allen and Maizels 2011; Harris and Gause 2011). 
B lymphocytes are stimulated by Th2 lymphocytes to produce antibodies against 
specific antigens present on the worm surface (Paul and Zhu 2010). When these 
cytotoxic antibodies are produced and the surface of the parasites is coated with 
them, the ability of larvae of H. polygyrus bakeri to penetrate gut mucosa and the 
migration of adults are affected (Harris and Gause 2011). The number of bonds and 
strength of the links between antibody and the immune cells mediating cytotoxicity 
such as type 2 immune cells (eosinophils, basophils, mast cells, or macrophages) 
improves the efficiency of ADCC. The Fc receptors of the effector immune cells couple 
with the Fc portions of antibody complexes (IgE, IgG1, IgG3 or IgM) already coated 
on worm surfaces to activate release of toxic granules (David et al. 1980). 
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Putative immunes (PI) and treated patients living in filarial endemic areas have high 
serum IgG isotypes and IgE (Soboslay et al. 1997). Specifically, high IgG3 levels are 
larvicidal in vitro and may be responsible for PI status in human (Amambua et al. 
2006). Filarial nematodes, in order to survive in the definitive host, have evolved 
mechanisms that interfere with surface antigen presentation to immune cells (Allen 
and Maizels 2011). One major protein involved in worm protection is a cysteine 
protease inhibitor (CPI), or cystatin (Gregory and Maizels 2008), which acts as an 
immunomodulator (Pfaff et al. 2002). Cystatins are present in both animals (Murray 
et al. 2005) and plants (Gregory and Maizels 2008). Onchocystatin is a cystatin from 
Onchocerca species, which is also known as Ov7 or CPI-2 (Lustigman et al. 1992). Its 
presence on the cuticle of adult female worms and most other stages of O. volvulus, 
except mature Mf (Lustigman et al. 1991), makes it a potential vaccine target. 
Onchocystatin also plays an important role in parasite development by arresting the 
activity of cysteine proteases at the end of each moult (Gregory and Maizels 2008). 
Onchocystatin also has a role in immune evasion (Pfaff et al. 2002), blocking the 
major histocompatibility complex (MHC) class II site on the antigen presenting cells 
(APC) and their ability to process antigen via papain-like proteases and asparaginyl 
endopeptidase (Villadangos and Ploegh 2000; Manoury et al. 2001). 
Cytophilic antibodies (IgG3) generated by PI target onchocystatin, retard larval 
development and affect worm viability, and thereby could potentially play a vital role 
in the long term control and prevention of onchocerciasis (Cho-Ngwa et al. 2010). 
Vaccines produced against mutated onchocystatin (LsCPI) and abundant larval 
transcript-1 (LsALT) induced significant prophylactic protection in the L. sigmodontis 
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mouse model when co-administered with Th2 enhancers (Babayan et al. 2012) and 
in the gerbil (Arumugam et al. 2014a). Mutation of a key asparagine residue in CPI-2 
made the vaccine highly immunogenic (Murray et al. 2005). However, gerbils 
vaccinated with unmodified BmCPI-2, failed in preventing new infections even 
though there were post vaccination changes in the adult worm migration pattern 
(Arumugam et al. 2014b). 
In this experiment, we tested for the first time the hypothesis that immunotherapy 
with mutated OoCPI-2 in cattle prior to sub-lethal chemotherapy might enhance the 
efficacy of this relatively short antibiotic treatment. 
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3.2 Materials and Methods 
 
3.2.1 Ethical and Safety Considerations 
The Ethics Committee and the Regional Programmes Committee of the Institute of 
Agricultural Research for Development (IRAD), Wakwa Regional Centre authorized 
the fieldwork of this study. All procedures performed on the experimental cattle in 
Cameroon were mild in severity and were equivalent to those authorized by a Home 
Office Project License on Animals (Scientific Procedures) Act, 1986 for experimental 
infections of cattle in the United Kingdom. All laboratory procedures were conducted 
according to the safety norms put in place by the various laboratory safety officers. 
3.2.2 Materials 
 Experimental Animals 
Thirty-Five Ngaoundere Gudali zebu cattle (Figure 3.1, Bos indicus) of good body 
condition scores (BCS ~ 3.5/5) were purchased from local markets across the Vina 
Division for the experiment. Each animal harboured at least 24 intradermal O. 
ochengi nodules and was confirmed free from other skin disorders such as 
dermatophilosis and Demodex infestation before recruitment based on clinical 
examination.  
 Experimental Site 
Sampling of the experimental cattle was carried out at IRAD Wakwa (Figure 3.1). The 
sampling pen was located less than 100 m from the Wakwa Veterinary Research 
laboratory.  This facilitated the rapid and immediate transfer of samples to the 
laboratory for preliminary analysis or processing for storage after collection. The 
transmission rate of O. ochengi at this site (Figure 3.1) is negligible (Achukwi et al. 
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2000; Tchakouté et al. 2006), as previous vaccine trials requiring similar 
environmental conditions reported no new infections (Njongmeta et al. 2004; 
Bronsvoort et al. 2005; Achukwi M et al. 2006; Makepeace et al. 2009). 
 
 
Figure 3.1: A. Ngaoundéré Gudali Zebu cattle used for the experiment. B. Extract of google 
map of IRAD Wakwa showing the grazing zone of the experimental herd (C-black circle) in 
relationship to River Vina (5km) where the O. ochengi transmission rate is high. N1 National 
road no. 1.  
  
At IRAD Wakwa, research activities are routinely being conducted on livestock, 
agriculture, and animal health in the High Guinea Savannah climate, corresponding 
to Cameroon’s agro-ecological zone II (Figure 3.2). It is situated some 10 km from 
Ngaoundéré Metropolis and the nearby Wakwa village plays an important role in the 
dissemination of agricultural research results in the Adamawa Region of Cameroon 
located between Latitude 7° 19’ 39 N and Longitude 13° 35’ 4 E (Figure 3.1). Wakwa 
72 
 
 
is 1,000 m above sea level and has an annual rainfall of 1,000 to 2,000 mm (Figure 
3.2) with temperatures varying between +10 and +35 oC. The cattle grazed within a 
perimeter of 4-kilometre radius from their sleeping point (Figure 3.1). 
 
 
Figure 3.2: Agro-ecological map of Cameroon. The Wakwa Research Centre is made up of 
two Stations (Wakwa and Banyo) and four antennae (Mbe, Meiganga, Tibati and Ndokayo). 
The values in mm at the limits to agro-ecological zones refer to annual rainfall. 
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 Health Care Management of Experimental Cattle 
3.2.2.3.1 Vaccination 
The recruited cattle were vaccinated against Black Quarter’s Disease and 
Haemorrhagic Septicaemia using Symptovax® and Pasteurellovax, ® respectively. The 
vaccines were produced by the National Veterinary Laboratory of Cameroon 
(LANAVET). The animals were observed for a month before the start of the 
experiment. 
3.2.2.3.2 Preventive Therapy 
During the stabilisation period, all the cattle were treated with diaminazine aceturate 
(SANGAVET®) against trypanosomosis, an endemic disease condition. SANGAVET is 
also active against babesiosis. In February 2012, after the time-point at 36 weeks 
(T36), all the animals were given intramuscular doses of vitamin AD3E (3 ml per 100 
kg body weight) to stabilise them during the extreme dry season. Tick control was 
routinely carried out by weekly spray with alpha cypermethrin (Butox®) during the 
rainy season or fortnightly during the dry season. Our sampling techniques included 
surgical extirpation of nodules. The sutured wounds were protected from flies and 
potential myiasis by the application of Battles Summer Fly Cream™. 
3.2.2.3.3 Handling of Infections During Experiment 
Two cases of abortions occurred within the second month of the experiment. Cow 
232 of the onchocystatin immunochemotherapy (OVT) group aborted shortly after 
receiving the sub-lethal oxytetracycline regimen. This cow received no further post-
abortion treatment. However, when cow 233 of the control group aborted, it was 
administered a procaine penicillin marketed as Combikel® (20 ml deep 
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intramuscularly). The causes of the two abortions were not determined. Towards the 
end of the experiment, the cows 209, 211, 222, 227 and 231, which were highly 
emaciated with a BCS less than 2.5, were de-wormed with levamisole boluses (7.5 
mg/kg) in February 2012. 
3.2.2.3.4 Husbandry and Feed Supplementation 
The cattle were grazed on Bracharia ruziziensis, Stylosanthes guianensis and natural 
grass paddocks everyday between 9:00 AM and 6:00 PM. During the day, the 
herdsman monitored the cattle. At night, they were confined at the Centre’s sleeping 
pen and guarded by a night watchman who ensured that the animals did not escape 
out of the 3 – 4 km safe perimeter ring to graze. While grazing, the cattle had contact 
with other animals of the Centre and of the neighbourhood. 
During the dry season, characterised by feed shortage due to bush burning, 
supplementary hay produced mainly from Bracharia ruziziensis and Stylosanthes 
guianensis were fed to the cattle. In addition, a maintenance ration of cotton seed 
cake (500 g per cattle per day) was fed once daily between 7:00 and 9:00 AM to all 
cattle. To ensure that the weaker animals had equal access to feed, the cattle were 
fed in five sub-groups with the weaker animals grouped together. Salt was available 
ad libitum. During the rest of the day, the cattle grazed on the degraded paddocks 
and along streams free from black flies. 
3.2.3 Methodology 
 Experimental Design 
A randomised repeated measure experimental design was set up with 5 experimental 
groups of 7 cattle each and parameters collected at 6 predetermined time-points (T) 
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(Table 3.1). Randomization of age-stratified cattle by ear tag was performed with the 
aid of random numbers on a scientific calculator. The four treatment groups had 
immunochemotherapy (OVT) as the main test group; immunotherapy (OVC) as the 
vaccine control; Adulticidal therapy (ADT) as the positive antibiotic control and the 
sublethal antibiotic therapy (SLT) as the negative antibiotic control. The fifth group 
was untreated. Data were collected one week before antibiotic treatment only from 
the vaccinated groups. At the commencement of treatment (T0), then at 4, 8, 12, 36 
and 52 weeks, data were collected from all the groups. The treatments administered 
were vaccine and / or antibiotics (Table 3.1). 
Table 3.1: Characteristics of experimental groups and treatment regimens 
Mean Age Body Weight
Males Females (years)  ± SD (Kg ± SD
Untreated control (CON) 1 6 6.2 ± 3.7 268 ± 44 None
Sub-lethal antibiotic 1 6 5.7 ± 2.3 283 ± 48 Oxytetracycline 10 mg/kg IV, daily
therapy (SLT) daily for 14 days
Adulticidal antibiotic 0 7 5.9 ± 1.6 268 ± 25 Oxytetracycline 10 mg/kg IV, daily
therapy (ADT) for 14 days; then 20 mg/kg IM,
monthly for 5 months
Onchocystatin vaccine 1 6 7.1 ± 3.5 300 ± 43 0.5mg recombinant onchocystatin;
control (OVC) 50% IM, 50% SC
Onchocystatin vaccine with 1 6 6.4 ± 2.5 261 ± 40 0.5mg recombinant onchocystatin;
antibiotic therapy (OVT) 50% IM, 50% SC; 7 day pause, then
oxytetracycline 10 mg/kg IV, daily
for 14 days
Group (abbreviation)
Sample
Treatment
 
IV, intraveneous; SC, Subcuteneous route; SD, Standard deviation. 
 
 Onchocystatin Vaccination of Experimental Groups 
Two experimental groups (14 cattle) were destined for vaccination. Both groups were 
vaccinated a week before the start of chemotherapy. For inoculation into cattle, 2.5 
ml (7.5 mg) of the recombinant mutated onchocystatin (produced by Creative 
Biolabs, Shirley, NY, USA) was diluted in 12.5 ml sterile Dulbecco’s PBS (Sigma) and 
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formulated in 15 ml alum adjuvant (Imject, Life Technologies, Paisley, UK) at a 1:1 
ratio to have 14 1-ml doses of 0.5 mg each. The alum adjuvant was thoroughly mixed 
by shaking, before adding to the vaccine drop-wise while gently swirling the 
receptacle with the other hand. The mixing was done over a period of 30 minutes 
before fourteen 2-ml syringes were loaded and protected in sheaths. All procedures 
were carried out in a sterile hood. The loaded syringes were then immediately 
transported to the field for vaccination as indicated in Table 3.1. 
 Antibiotic Chemotherapy 
The OVT, SLT and ADT groups received intravenous injection of oxytetracycline 
(Terramycin® LA, Zoetis, London, UK) chemotherapy (SLT) at T0. The ADT group was 
then followed up with 5 monthly intermittent doses of Terramycin® LA from T4 
onward (Table 3.1). Previous studies showed that ADT therapy (Table 1) killed 80 % 
of treated worms in 52 weeks (Gilbert et al. 2005) with important changes occurring 
at T8, T12, T36 and T52 (Nfon et al. 2006; Hansen et al. 2011). 
3.2.4 Specific Experimental Designs 
To minimise cost, subsets of the samples were processed to respond to different 
specific objectives of the study (Table 3.2). 
3.2.5 Production, Preparation, and Application of 
Recombinant Vaccine 
The mutated onchocystatin nucleotide sequence was synthesized using the O. 
ochengi (OoCPI-2) protein sequence published in GenBank ACB70196.1 (Makepeace 
et al. 2009) as the basis for codon optimisation and cloned in Escherichia coli by a 
contract research organisation (Creative Biolabs, Shirley, NY, USA). Mutation of 
onchocystatin was achieved by replacing the amino acid, asparagine (required for 
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enzymatic activity) located at position 44 of the published wild-type sequence with 
leucine. Leucine is a non-acidic residue that enhances immunogenicity (Babayan et 
al. 2012). Unlike the OoCPI-2 sequence, this critical residue is located at position 66 
in the L. sigmodontis and position 78 (Figure 3.3) in the B. malayi cystatin orthologues 
(Nfon et al. 2006), respectively, because of the variable N-terminal extension in these 
proteins. 
Table 3.2: Specific objectives and analytic techniques. 
 
 
The synthetic construct was cloned into the pET-30a (+) vector (EMD Millipore, 
Billerica, MA, USA) and expressed as a 41 kDa Schistosoma japonicum glutathione S-
transferase fusion protein with a histidine tag in E. coli strain BL21 (DE3). Soluble 
recombinant GST-onchocystatin was recovered at a purity of >90% using nickel-
nitrilotriacetic acid agarose resin, and endotoxin was reduced to a level of <0.1 EU/ml 
with the ToxinEraser Advanced Endotoxin Removal Kit (GenScript, Piscataway, NJ, 
USA). Initially, 1 mg of the mutated OoCPI-2 vaccine was produced, tested in mice by 
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Dr Simon Babayan in Edinburgh and confirmed to be immunogenic before scaling-up 
to 30 mg, from which a portion was used during this field trial (Table 3.1). 
 
 
Figure 3.3: Onchocystatin sequence. Arrow indicates location of the critical residues for 
enzymatic activity corresponding to position 44 in O. ochengi and 66 in B. malayi. Figure kindly 
provided by Dr Simon Babayan. 
 
 Sampling Techniques 
At each time-point, due to the large sample size, sampling was done from 6 AM to 3 
PM and spread over three days. The vaccine treated (OVT) and ADT animals were 
sampled on day 1; SLT and vaccine control (OVC) on day 2, and the CON group on day 
3. The animals to be sampled each day were confined in a specially constructed pen 
with a crush through which the animal passed to enter a roofed enclosure for sample 
collection. 
3.2.5.1.1 Animal Restraint During Sampling 
Each animal was restrained in lateral recumbency, with the hind limbs tied wide apart 
and one fore-limb attached to the horn and fixed to a pole (Figure 3.4). The sampling 
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procedure on each animal lasted 15 minutes. After sampling, the tail was passed 
between the thighs and held firmly by an assistant as the hind limbs, forelimbs and 
the head were released before it was helped to stand up. 
 
 
Figure 3.4: Experimental bull. Restraint position for identification of nodules from the scrotal 
area encircled towards the flanks (A) and within the thighs (B). The same posture is used 
during nodulectomies of nodules (C) tattooed at three points. 
 
3.2.5.1.2 Nodule Identification 
On lateral recumbency and the hind limbs wide apart (Figure 3.4), nodules were 
searched for from around the udder (females) or scrotum (males), then outward 
laterally to the flanks and inner thighs, distally to the tail and anteriorly to the 
umbilicus and chest regions (arrows A, B on Figure 3.4). An archetypal O. ochengi 
nodule is usually compressible but firm, spherical and intradermal. Hard and/or 
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discoloured nodules were avoided, as these are signs of natural worm death and 
calcification. The 24 nodules considered with high confidence to be of O. ochengi 
origin were tattooed (C) after shaving with a clipper. The tattooing was by 
intradermal injection of approximately 0.5 ml of veterinary tattoo ink (Cox®) at 3 
equilateral points around each nodule using an 18-gauge needle. The location of each 
tattooed nodule was mapped and labelled on a sex-specific “hide map”. Nodule 
clusters were excluded from the studies as they can be difficult to isolate from one 
another during surgery. Digital video clips of mapped nodule positions were also 
recorded. 
3.2.5.1.3 Blood Collection 
Jugular blood was collected into sterile, 10-ml red-capped (additive-free) Vacutainer 
tubes via 18G Vacutainer needles. The collected blood samples were allowed to clot 
at ambient temperature for at least an hour, and then refrigerated at 4oC overnight 
before serum extraction using centrifugation at 3,000 rpm for 5 minutes. The sera 
were deep frozen in two aliquots at -80oC. 
3.2.5.1.4 Skin Snipping 
Three skin biopsies weighing ~3mg each were collected from each animal at positions 
A, B and C along the mid-ventral abdomen (Figure 3.5) into separate 1.5 ml Eppendorf 
tubes containing sterile RPMI 1640 media (Sigma). The media was supplemented 
with 200 IU/ml penicillin and 200 μg/ml streptomycin (Sigma). Before snipping, the 
sampling sites were first swabbed with 70% ethanol and shaved with a blade. 
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Figure 3.5: Collection of skin snips. A, B and C are standardised locations for skin snipping. 
The sampling sites were first swabbed with 70% ethanol and shaved with a blade before 
snipping of a portion of the skin. 
 
3.2.5.1.5 Nodulectomy 
Two of four nodules selected by prior randomisation of all nodule locations excised 
at each time point were used for viability studies. The hide maps or digital video clips 
were used to confirm nodule location before removal. The surrounding skin was 
clipped, shaved and disinfected with 70% ethanol. Local anaesthetic (1% lidocaine; 
Willcain®, Dechra Veterinary Products) was injected intradermally in the tattooed 
area (Figure 3.5, c) before nodulectomy. The excised intradermal nodules were 
immediately transported to the laboratory in 7-ml bijou tubes containing sterile 
phosphate buffered saline (PBS, Sigma) by one of the field assistants for processing. 
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Each wound was closed with chromic catgut, and summer fly cream (Battle, Hayward 
& Bower Ltd) was applied to protect from flies, hence preventing myiasis. The sutures 
were removed ten days after nodulectomy. 
3.2.6 Parasitological Analyses for Worm Viability 
In the laboratory, the nodules were carefully extracted from excess dermal tissues 
with a round-bellied surgical blade. Undamaged nodules were processed for worm 
viability studies. The diameter was measured across two perpendicular planes with a 
pair of Vernier callipers and the average value recorded. The second nodule reserved 
for histopathology was injected with a portion of 10% neutral buffered formalin (NBF) 
using an insulin syringe and stored submerged in the formalin at room temperature. 
 Determination of Skin Mf Density 
The skin snips were incubated at 37oC for 48 hours. Released Mfs were counted three 
times at 6, 24 and 48 hours from the medium under a stereo microscope. Fresh RPMI 
medium was added to the skin snip after each count. During the third refill (day 2), 
0.5% collagenase was added to the sterile RPMI 1640 medium and the snips weighed 
on an analytical balance (Acculab Atilon®). During Mf counting the species observed 
were recorded (O. ochengi, O. gutturosa, O. dukei, O. armillata and/or others) as 
previously described (Naessens et al. 1988). 
 Nodule Dissection 
The incision in the nodule capsule, made with a scalpel blade, was carefully widened 
to expose the female worm mass, which was gently pulled out with a pair of forceps 
or bluntly scrapped onto a glass slide for identification, ageing and determination of 
motility. It is very easy to distinguish between male and female Onchocerca worms, 
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as the females are much larger than the males. Male worms are highly mobile and 
can be easily extracted from the coiled female worm mass. Using forceps, they were 
placed into a 24-well tissue culture plate containing sterile RPMI 1640 medium. 
 Determination of Worm Motility (viability)  
The entire male worms and cut heads of female worms were incubated for 30 
minutes at 37oC in sterile RPMI 1640 medium using tissue culture plates (Nunc, 
Roskilde, Denmark). Motility was observed under low-powered magnification on a 
CETI® dissecting microscope and scored on a three-point (0, 1 or 2) scale as previously 
described (Nfon et al. 2006; Hansen et al. 2011). Worms with zero motility score were 
assumed to be dead, and those with scores of 1 (sluggish/moribund) or 2 (normal 
activity) were viable. The heads of the female worms were returned to the rest of the 
body after this evaluation. 
 Determination of Worm Age and Fecundity 
The worms were aged as young, medium, or old based on the complexion of the 
cuticle. Old worms were brownish-orange in complexion, medium-aged worms were 
lighter (yellowish), while the young worms were smaller and milky in complexion. 
The female worm was removed from the nodule capsule, placed on a depression slide 
containing a drop of PBS, and carefully loosened to expose all worm segments with 
the aid of a pair of smooth tip forceps and a needle. The worm was examined under 
a NIKON SMZ800® dissection microscope from the head to the tail to estimate the 
gravidity of the uteri on a four-point scale (0, 1, 2 and 3). Depending on the proportion 
of the uteri filled with motile larvae, non-gravid worms had zero fecundity, while 
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worms with less than half, two-thirds, or fully gravid uteri were scored as 1, 2 or 3, 
respectively. 
3.2.7 Serology 
 The Determination of IgG Response to O. ochengi 
Onchocystatin 
Antibody responses to onchocystatin were determined using an ELISA protocol 
developed from an existing isotype-specific bovine IgG assay (Langworthy et al. 2000; 
Bronsvoort et al. 2005), with modifications (only total IgG was measured). Prior to 
running the test, antigen, serum and conjugate concentrations were optimised by 
checkerboard titration using pooled O. ochengi positive bovine sera (n = 5) from a 
previous experiment (Gilbert et al. 2005) and a negative serum sample from a British 
cow. Optimal conditions comprised a coating concentration of 5 μg/ml mutated 
onchocystatin, a test serum dilution of 1/50 and a monoclonal anti-bovine IgG [clone 
IL-A2, horseradish peroxidase (HRP) conjugate] concentration of 1/50,000 (Hansen et 
al. 2011). 
 ELISA Procedure 
On day one, the antigen, recombinant mutated onchocystatin protein was 
immobilised onto ELISA plates (Maxisorp). The antigen was diluted to 5 μg/ml in fresh 
coating buffer after optimisation by checkerboard titration. The dissolved antigen 
was dispensed in 100 μl aliquots into the ELISA plates, which were covered with 
adhesive plate sealer, incubated at room temperature for one hour and then 
refrigerated at 4oC overnight (24 hr). 
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On the second day, the coating buffer was discarded from the ELISA plates and freshly 
prepared wash buffer was used to remove unbound antigen five times. Each washing 
comprised of incubating the ELISA plate with wash buffer for five minutes before 
discarding it and refilling the plate with fresh wash buffer. After the final wash, the 
ELISA plate was tapped onto absorbent material several times to eliminate all residual 
liquid. Fresh blocking buffer (200 μl) was added into each well and the plate was 
covered with adhesive plate sealer, incubated at room temperature for one hour, and 
then overnight at 4oC. 
The serum samples were then prepared for use on the third day by removing any 
antibodies raised against the GST moiety of recombinant onchocystatin. The process 
of pre-adsorption whereby sera were incubated with E-coli GST lysate [(Promega®, 
Bio-Rad Laboratories, Hemel Hempstead, UK) containing an irrelevant GST and His-
tagged protein] to which soya milk was added for two hours at ambient temperature, 
followed by incubation at 4oC overnight was performed. Final concentrations were 2 
mg/ml (protein) for the E. coli lysate, 20% soya milk and 10% serum. The supplied E-
coli GST lysate was reconstituted by adding 7 ml of wash buffer to the vial, incubated 
at room temperature for 5 minutes, then mixed by swirling and the final volume 
corrected to 10.7 ml. This was stored as 2.5 ml aliquots in bijou bottles at -20oC. 
On day three, the pre-adsorption sera (1/10 dilution) was further diluted to a final 
concentration of 1/50 with blocking buffer. Following washing as described above, 
100 l of each control or sample serum was added into assigned wells with coated 
antigen, while an equivalent volume of blocking buffer was added to the conjugate 
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and sample blank wells. The samples were incubated at room temperature for two 
hours prior to washing as before. Monoclonal anti-bovine IgG conjugated to HRP was 
diluted to 1/50,000, and 100l was added into each well except for the sample blank. 
Following addition of blocking buffer to the blank wells, samples were incubated at 
room temperature for 2 hours and then washed as earlier described. 
Each well was loaded with 100 l of substrate ATBS and incubated at room 
temperature in the dark for 30 minutes. Optical densities (OD 405 nm) were obtained 
on an Infinite F50 microplate reader (Tecan, Männedorf, Switzerland) at 10, 20 and 
30 minutes during the final incubation. The 10-minute reading gave the best response 
results which were expressed as “per cent positivity”; i.e., the OD of the test serum 
divided by the OD of the positive control pool, multiplied by 100. 
3.2.8 Immunohistology 
To quantify nodule eosinophilia, five nodules fixed in 10% buffered formalin were 
randomly selected using an online service (www.random.org) from each 
experimental group. One half of the fixed nodule (cut along the longest diameter with 
a scalpel blade) was embedded in paraffin, cut into 4 μm sections using a microtome, 
and mounted onto glass slides. The sectioned nodules were washed with distilled 
water, deparaffinised in glacial acetic acid (1 in 1,500 dilution) for 30 seconds and 
washed again with distilled water. Thereafter, they were rehydrated (by passing 
through descending concentrations of ethanol) before a final rinse (in distilled water) 
followed by stained with Giemsa (1 in 45 dilutions in distilled water) for one hour. 
Eosinophils were counted across the longest cross-sectional diameter of nodule on 
an Axio Imager M2 microscope (Zeiss, Oberkochen, Germany) equipped with Zen 
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2012 software (Zeiss) at 400 magnifications. Counts were restricted to a rectangular 
microscopic view (approximately 0.04mm2) along a central transect. Only eosinophils 
identified by bright pink intracellular granules (Langworthy et al. 2000; Gilbert et al. 
2005; Hansen et al. 2011) were counted and normalised as mean counts per 
rectangular view. 
3.2.9 Statistical Analysis 
Data analysis was carried out in SPSS version 22 (IBM Corporation, Armonk, NY, USA). 
The parametric variables measured on continuous scale were checked for 
homogeneity, normality, and outliers. Worm viability was estimated from worm 
motility on a binary scale and analysed using the Cochran–Mantel–Haenszel test, 
available under the cross-tab procedure on SPSS with time-point as a layered factor 
and exact Chi Square statistics to determine fitness.  The test statistic of choice for 
parametric data is repeated measures ANOVA. However, a non-parametric 
Friedman’s two-way ANOVA by ranks and a Kruskal-Wallis one-way ANOVA were 
used because the data could not be normalised even after log-transformation (see 
section on data QC). Statistics were accepted as significant when the omnibus P-value 
was <0.05, and post-hoc pairwise comparisons were calculated using the Dunn-
Bonferroni test, with 2-tailed asymptotic adjusted p-values of <0.05 considered 
significant. Correlation analyses were conducted using the Spearman procedure. 
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3.3 Results 
 
3.3.1 Sample 
Five hundred and thirteen O. ochengi worms isolated from 210 onchocercomata 
were analysed for viability (Table 3.3). 
Table 3.3: Summary of worm characteristics 
 
a CON, Untreated Control; SLT, Sublethal Chemotherapy; ADT, Adulticidal Chemotherapy; 
OVC, Onchocystatin Vaccine Control; OVT, Onchocystatin Vaccine with antibiotic Therapy. 
b Time after start of chemotherapy. c Average numbers of worms per nodule per time-point. 
d Age was estimated on a four-point scale: 1, young; 2, middle; 3, old; or 4, dead. 
e Motility was scored on three-point scale: (0, no movement or dead; 1, reduced movement; or 
2, normal movements) recorded after incubation of worms for 30 min at 37°C. 
f Fecundity of female worms were scored on a four-point scale: 0 (non-gravid); and 1, 2 or 3 
for gravid worms containing a third, half, or a full uterine load of microfilariae, respectively. 
g Worms were considered viable when motility were scores ≥1. 
h This group displayed a statistically significant difference in total worm viability from the control 
(Cochran-Mantel-Haenszel test, P = 0.003). 
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All nodules except two (cow 204 at T4 with two females; and cow 238 at T52, with a 
resolved nodule) contained a single female worm. Twenty-seven percent of the 
dissected the 210 nodules had no male worm but 58.9% of the isolated worms were 
males giving an average male worm per nodule density of 1.5 (Table 3.3). 
 
Figure 3.6: Frequency distribution of nodule diameter. Summary data for the entire experiment 
(N = 210), displaying the observed distribution against a normal curve model generated by 
SPSS chart builder. 
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3.3.2 Parasitology 
The overall spread of data on nodule diameter was evaluated via frequency 
distribution, which illustrated an apparent normal distribution (Figure 3.6). The mean 
nodule diameter (6.2) and the median (6.1) were similar, but slightly higher than the 
mode of 5.8 (Figure 3.6). 
 Worm Viability 
Ninety-six percent of the 513 worms studied were alive (Table 3.3). Of the 16 (4%) 
dead worms obtained, most (14) were females and 62.5% were from the ADT group, 
including the two dead males recorded at T36. Interestingly, two ADT nodules at T52 
(cows 223 and 231) had 4 viable worms (Table 3.3) and the Mf load of the 
corresponding cows higher than others. One nodule (cow 239) in the control group 
at T52 had a dead female (Table 3.3) but the present of skin Mf in the cow indicates 
probable natural worm death from ageing. A Cochran Mantel-Haenszel test statistic 
was conducted on paired groups comparing treatments to the control taking into 
consideration time effect. There was an overall statistically highly significant 
reduction in adult worm viability in the ADT when compared to the untreated control 
(P = 0.003). Dead female worms were also recovered from the SLT (240 at T36 and 
T52), and OVT (241 at 52) groups (Table 3.3); however, Skin Mf were present and 
viability in these groups was not significantly different to that in the control. 
The ADT therapy significantly affected worm density per nodule site (Freidman’s 
ranked test, P = 0.017). However, paired comparisons (post-hoc tests) revealed no 
statistically significant differences between time-points. Time effect on ADT female 
worms were more significant (Friedman ranked test, P = 0.009) than on the males 
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(ADT, P = 0.034). Meanwhile, SLT therapy had more significant (Friedman ranked test; 
P = 0.049) time effect on male worm distribution. 
 Female Worm Fecundity 
There was no statistically significant difference between group treatment effects on 
female worm fecundity (Kruskal-Wallis test, P > 0.05). However, in Friedman analysis, 
ADT therapy statistically significantly (P = 0.036) reduced worm fecundity in the ADT 
group over time, even though paired comparisons did not reveal significant 
differences between any paired time points. The lowest median fecundity scores of 
the ADT group were recorded at T36 and T52 (Table 3.3). Low but insignificant 
median fecundity was also recorded in the CON and OVC groups at T36 and T12, 
respectively. There were significant correlations between fecundity scores and the 
number of viable worms in the CON (Spearman’s r = 0.49, P = 0.001), SLT (Spearman’s 
r = 0.49, P = 0.001), OVC (Spearman’s r = 0.31, P = 0.48) and ADT (Spearman’s r = 0.69, 
P < 0.001) groups. The fecundity scores of the ADT group correlated positively with 
nodule diameter (Spearman’s r = 0.60, P < 0.001) and the number of male worms 
(Spearman’s r = 0.61, P < 0.001). There was also a weak but significant correlation 
(Spearman’s r = 0.37, P = 0.02) between fecundity and nodule diameter in the OVC 
group. 
Female worms from cows 215 of OVC and 205 of SLT had zero fecundity, even though 
male worms were present in nodules at most of the time points. Consequently, the 
Mf load of these animals was zero throughout. 
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 Nodule Diameters 
Changes in diameter of nodules (onchocercomata) is an indirect measure of the 
effect of treatment on worm viability (Langworthy et al. 2000; Bronsvoort et al. 
2005). Significant reduction in nodule diameters (Friedman ranked test, P = 0.026) 
was recorded only in the ADT treatment group (Figure 3.7). Nodule diameters tended 
to decrease as worm viability (Spearman’s r = 0.49, P = 0.001) and Mf density 
(Spearman’s r = 0.51, P = 0.001) reduced. Median nodule diameter (4.9 mm, ADT) at 
T36 was significantly lower than that at T4 (6.4 mm) of the same treatment group (P 
= 0.009, Friedman ranked test) and that in the OVC group at T36 (5.9 mm; Kruskal 
Wallis H test, P = 0.035). The SLT therapy had a significant omnibus reduction (P = 
0.025) in nodule diameter, but in post-hoc tests, no significant effect was detectable 
between pairs of time-points. 
 
Figure 3.7: Effect of immunotherapy and/or antibiotic treatments on Onchocerca ochengi 
nodule diameter. Data are displayed as medians at 95% confidence interval (n = 7). The dotted 
horizontal lines represent the 5th and 95th percentiles of the untreated control data (n = 42). 
Points marked by different letters (within a group) or different symbols (between groups) are 
statistically significant (P = 0.009, Friedman’s two-way ANOVA by ranks; P = 0.035, Kruskal–
Wallis one-way ANOVA; respectively). SLT, sub-lethal antibiotic therapy; ADT, adulticidal 
antibiotic therapy; OVC, onchocystatin vaccine control; OVT, onchocystatin vaccine with 
antibiotic therapy. 
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Figure 3.8: Effect of immunotherapy and/or antibiotic treatments on Onchocerca ochengi 
microfilarial density. Medians are displayed at 95% confidence interval (n = 7). Points marked 
by different letters within a group are statistically significantly different (P < 0.05 for CON, P < 
0.001 for ADT; Friedman’s two-way ANOVA by ranks), as are points marked by different 
symbols between groups (P < 0.05; Kruskal–Wallis one-way ANOVA). CON, untreated control; 
ADT, adulticidal antibiotic therapy; OVC, onchocystatin vaccine control; OVT, onchocystatin 
vaccine with antibiotic therapy; SLT, sub-lethal antibiotic therapy. 
 
 Skin Microfilaria (Mf) Density 
In this study, the group that received ADT had the highest pre-treatment Mf densities 
(Figure 3.8). The median ADT Mf load was statistically significantly higher (P = 0.027; 
Kruskal-Wallis H test) than that of the CON group at T8. Though there was no 
significant between-group difference in Mf densities at T0 and T52 due to the wide 
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within-group variations, the mean Mf density of the ADT group was about two-fold 
higher when compared to the other groups at T0, but almost zero at T52 (Figure 3.8, 
ADT). Sub-lethal therapy also statistically significantly reduced skin Mf density (P = 
0.036), although pairwise (post-hoc) comparisons were not significant. 
The Mf density of the ADT group dropped significantly (P < 0.005) from T0 levels, with 
median Mf count of > 1000 /100mg skin to zero at T52 (Figure 3.8). Notably, four of 
five ADT animals with dead female worms were negative for skin Mf at T52. Pairwise 
comparisons within ADT revealed statistically significant differences between T52 
and T0 (P = 0.012), T12 (P = 0.015) or T4 (P = 0.032); and between T36 and T0 (P = 
0.032) or T12 (P = 0.040), as illustrated in Figure 3.8. Vaccination alone or in 
combination with antibiotic chemotherapy did not significantly affect Mf load. 
Interestingly, there were two cattle (cows 205 and 215) of the SLT and OVC groups, 
respectively, with zero Mf counts throughout the experiment. It was only in the ADT 
group that Mf density had significant positive correlation with nodule diameter and 
fecundity (Section 3.3.2.3), and with number of males (Spearman’s r = 0.37, P = 0.02) 
and total viable worms (Spearman’s r = 0.49, P = 0.001). 
3.3.3 Immunology 
 
 IgG Antibody Response to Vaccination 
To determine whether vaccination with onchocystatin generated anti-onchocystatin 
antibodies, serum specific IgG levels were quantified. As expected, the normalised 
anti-onchocystatin IgG levels of the CON sera did not change over time (Figure 3.9) 
and remained approximately equivalent to the positive control pool. 
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Figure 3.9: Effect of immunotherapy with or without oxytetracycline treatment on anti-
onchocystatin antibody levels. Data are displayed as medians (n = 7) and represent per cent 
positivity relative to a control serum pool (arbitrarily designated 100%) prepared from five 
untreated, O. ochengi-infected cattle from a previous experiment. The horizontal reference line 
(IgG level, 131%) represents the omnibus median of 126 samples. Points marked by different 
symbols between groups (P = 0.037; Kruskal–Wallis one-way ANOVA) and those marked by 
different letters within groups (P = 0.010, Friedman’s two-way ANOVA by ranks) are 
statistically significant. CON, untreated control; OVC, onchocystatin vaccine control; OVT, 
onchocystatin vaccine with antibiotic therapy. 
 
Vaccination generated a significant response in both the OVC (P = 0.000) and OVT (P 
= 0.006) groups relative to the CON. Although the omnibus test between the CON, 
OVC and OVT groups was statistically significant at weeks 5 (P = 0.019), 9 (P = 0.040) 
and 13 (P = 0.044) post-vaccination (PV), it was only in the OVC group that a post-hoc 
statistically significant increase in the anti-onchocystatin IgG levels relative to the 
CON group was apparent at weeks 5 and 13 PV (P = 0.037;Figure 3.9).However, at 9 
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weeks PV, none of the pairwise post-hoc comparisons exceeded the critical 
probability. Antibody responses in the OVT group were highly variable, particularly at 
9 weeks PV, but significantly higher than the pre-vaccination level (P = 0.010, 
Friedman’s ranked test). One animal from this group (#232) displayed greatly 
elevated IgG levels throughout the experiment (Figure 3.9). By 37 weeks PV, antibody 
profiles had returned close to baseline levels in most vaccinated animals. 
 
 
Figure 3.10: Effect of immunotherapy with or without oxytetracycline treatment on eosinophil 
counts within nodules. The total number of eosinophils counted from all the fields of the longest 
transect of each onchocercoma was normalised as average count per microscopic view 
(approximately 0.04 mm2). The data were plotted as median normalised eosinophil counts 
(NEC) at 95% confidence interval (n = 5). The broken reference line is the median NEC value 
of the CON group. The NEC of the adulticidal (ADT) or sub lethal (SLT) antibiotic-treated 
groups and the vaccinated control (OVC) or immunochemotherapy (OVT) groups were 
compared to the untreated control (CON) group. Points marked by different letters within a 
group are statistically significantly different (P = 0.013, Friedman’s two-way ANOVA by ranks). 
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 Immuno-histology:  Intra-Nodular Eosinophil 
Infiltration 
To assess whether the increase in serum anti-onchocystatin antibodies resulted in 
increased intranodular eosinophil load, eosinophil quantification from histological 
sections of nodules was performed (Figure 3.11). As expected, ADT generated a 
significant increase (P = 0.013) in eosinophil counts at 36 weeks PV (Figure 3.10) 
relative to the time zero for this group. Compared to the control, there was no 
significant increase in the ADT group at T36; nevertheless, the ADT median eosinophil 
count was 2.4-fold greater than that for CON. The vaccinated groups initially had 
lower nodule eosinophil counts than both the CON and the ADT groups (Figure 3.10). 
However, immunochemotherapy generated the highest, albeit insignificant, 
eosinophil response at T12. Vaccination alone generated a slow increase in intra-
nodular eosinophil counts, but the median value at T36 was below that of the CON 
group (Figure 3.10). 
To determine if there were any associations between intra-nodular eosinophil counts 
and parameters of worm viability, we conducted a correlation analysis and 
ascertained that it was only in the ADT group that normalised eosinophil counts 
correlated negatively but significantly with Mf load (Spearman’s r = -0.58, P = 0.02). 
It was difficult to accurately measure the distance of eosinophils to the worm surface 
in histological sections. The eosinophil counts were categorised into three sub-groups 
(Figure 3.11) based on the proximity of worm sections (A), the capsule boundary (C), 
and neither of these features (B) to determine if a treatment attracted more 
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eosinophils towards the worm surface than did the others. No statistically significant 
differences were observed in the sub-groups between and within treatment. 
 
 
Figure 3.11: Eosinophil count fields regrouped as fields with worm sections (A) or capsular 
tissue (C), and fields with neither worm sections nor nodule capsular tissue (B). The 
micrographs were taken with an Axio Imager. M2 microscope (Zeiss) at 400 from an OVC 
Giemsa-stained nodule transect at T12. Black arrows indicate eosinophils 
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3.4 Discussion 
 
This study attempted to answer for the first time whether sublethal antibiotic 
chemotherapy (SLT) can be enhanced by boosting immune responses targeting 
onchocystatin, an important immunomodulator. Our data suggest that vaccination 
before SLT chemotherapy did not recruit sufficient eosinophils to kill the adult 
worms, even though there was a significant increase in anti-onchocystatin IgG 
antibody responses post-vaccination. There was a very wide within-group variation 
in IgG antibody responses, which did not correlate with any of the measures of worm 
viability. However, median antibody levels were never elevated by more than 40% in 
the OVC and OVT groups relative to the CON group. Previous studies have shown that 
sustained depletion of endobacteria Wolbachia from all worm tissues, including the 
ovaries, after antibiotic therapy is responsible for the death of adult O. ochengi 
(Gilbert et al. 2005) by reversing the neutrophil/eosinophil balance created by the 
presence of Wolbachia in favour of eosinophils (Hansen et al. 2011). However, worm 
killing occurs most effectively when oxytetracycline is administered over several 
months (Langworthy et al. 2000; Gilbert et al. 2005; Hansen et al. 2011). The 
eosinophil is the principal immune cell harbouring the capability to kill large extra-
cellular parasites (Delves et al. 2011). Eosinophil degranulation occurs when specific 
antibodies bound to the target cross-link Fc receptors on the cell surface, although 
activation by interleukin-5 from Th2 cells and other sources is required for optimal 
activity (Horie et al. 1996). 
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Onchocystatin was used in this study because it is an important potential vaccine 
candidate for the control of onchocerciasis (Lustigman et al. 1992; Gregory and 
Maizels 2008; Makepeace et al. 2009). It is produced by the adult worms and all of 
the larval stages except mature Mf (Lustigman et al. 1991; Manoury et al. 2001). 
Onchocystatin interferes with the normal functioning of antigen presenting cells 
(APC) and their communication with T-helper lymphocytes, which in turn reduces the 
production of cytotoxic antibodies from B-cells (Villadangos and Ploegh 2000; Pfaff 
et al. 2002). This tips the balance in favour of regulatory T lymphocytes that activate 
B-lymphocytes to produce non-complement fixing IgG4 antibodies (Hoerauf et al. 
2005). As an immunomodulator, onchocystatins are essential for worm longevity and 
growth (Gregory and Maizels 2008). 
The efficacy of onchocystatin vaccines has been tested on several other filarial 
parasites. In the gerbil model for Brugia malayi, the migratory pattern of the adult 
worms was affected (Arumugam et al. 2014b) following immunisation with wild-type 
BmCPI-2, but when mutated BmCPI-2 was used, significant prophylactic and anti-
fecundity effects were achieved (Arumugam et al. 2014a). In the mouse-Litomosoides 
sigmodontis model, the combined use of mutated Ls-CPI and Ls-ALT in a DNA vaccine 
approach had significant prophylactic effects especially when adjuvants that boost 
the Th2 arm of the immune response were used (Babayan et al. 2012). In this study, 
we used alum, a gold-standard adjuvant for stimulation of Th2 immunity in both 
human and veterinary vaccine production (Lindblad 2004; Mohan et al. 2013). This 
study measured total IgG levels, which in cattle comprises only IgG1, IgG2 and IgG3 
subclasses. There were high within-group variations in the response to vaccination, 
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perhaps due to genetic differences between animals and/or the existing O. ochengi 
parasite load. In addition to onchocystatin, there are multiple active 
immunomodulatory proteins expressed by filarial nematodes such as galectin-1 
(Hewitson et al. 2008), ShK toxin domain proteins (Armstrong et al. 2014; Armstrong 
et al. 2016), and transforming growth factor- homologues (Armstrong et al. 2016). 
This redundancy is likely to be a major reason why targeting onchocystatin failed to 
increase the efficacy of the short antibiotic treatment. 
Several independent immunomodulatory mechanisms exist that combine to protect 
helminth infections and prevent anaphylaxis. Sentinel immune cells such as 
macrophages produce IL-10 that prevents the development of acquired resistance in 
schistosomiasis (Wilson et al. 2011) and in filarial diseases (Specht et al. 2012), while 
Th2 cells become intrinsically hypo-responsive during chronic infections (van der 
Werf et al. 2013). This state of hypo-responsiveness is not dependent on IL-10 alone 
(Taylor et al. 2005), but represents a lack of ability of CD4+ effector T-cells to 
proliferate and produce IL-4, IL-5 and IL-2 cytokines (van der Werf et al. 2013). 
Successful immunochemotherapy of chronic filarial infections in the future may 
require mechanisms that reverse intrinsic Th2 hypo-responsiveness by blocking PD-1 
(CD279) receptors (van der Werf et al. 2013) and Foxp3+ T-regulatory cells expressing 
CD25+GITR+ (Taylor et al. 2005). 
In vitro studies in mice have shown that immunochemotherapy is achievable in the 
control of a chronic bacterial diseases (brucellosis) by vaccination with B. melitensis 
outer membrane vesicles at a two-week interval alongside sub-therapeutic doses of 
doxycycline and gentamicin chemotherapy (Jain-Gupta et al. 2014). Indeed, 
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immunochemotherapy as a strategy has been effective against a range of other 
pathogens when used as chemically-abbreviated infection or infection-treatment-
vaccination against malaria (Peng et al. 2014), and in the control of bovine theileriosis 
(Cox 1992). In cutaneous leishmaniosis, immunochemotherapy with heat-inactivated 
parasites and sodium stibogluconate favours a Th1 response and rapid healing of skin 
lesions of patients (Musa et al. 2008). In the case of schistosomiasis, there were 
synergistic effects when sub-curative doses of praziquantel were administered 
alongside a Schistosoma mansoni (Sm28GST) DNA vaccine (Dupré et al. 1999), a S. 
mansoni tegument nucleosidase vaccine (Rofatto et al. 2013), or a recombinant 
membrane-anchored tegument protein vaccine against Schistosoma japonicum 
(SjTP22.4) in laboratory mice (Zhang et al. 2012). In children suffering from 
schistosomiasis, simple anthelminthic chemotherapy using praziquantel results in 
accelerated development of acquired immunity (Mutapi et al. 1998; Bourke et al. 
2014). However, there was no post treatment immunisation of O. ochengi-infected 
cattle treated with ivermectin (Njongmeta et al. 2004), effective oxytetracycline 
antibiotic therapy (Nfon et al. 2007), and melarsomine (Tchakouté et al. 2006). In 
humans undergoing doxycycline therapy in endemic areas, new infections occurred 
as worms in the treated nodules were dying (Hoerauf et al. 2009). 
The antibody (IgG) responses in this study peaked at weeks 5 and 9 post vaccination 
in the OVC and OVT groups, respectively. Previous immunisation trials used naïve 
calves to test multivalent sub-unit vaccines (including immunomodulatory proteins, 
such as unmodified onchocystatin) and attenuated larvae (Tchakouté et al. 2006; 
Makepeace et al. 2009). The recombinant vaccine trial elicited significant immune 
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responses, which peaked at month 4 after two booster doses, ultimately controlling 
Mf load but not adult worm burden (Makepeace et al. 2009). The median antibody 
production levels in the current study remained at about 40% higher than that of the 
CON group and peaked at 9 weeks before slightly declining. Subsequent studies 
should evaluate the effect of one or more booster doses of the vaccine on worm 
viability; however, induction of tolerance to the antigen is a risk in infected animals 
(Botros et al. 1996). 
Although we only measured specific IgG in this experiment, there might have been 
IgE involvement in ADCC reactions against filariae as in other animal models (Baldwin 
et al. 1993; Abraham et al. 2004). However, we measured nodule eosinophil load, 
which may have interacted with IgE levels (Abraham et al. 2004). A significant 
increase in nodule eosinophilia was observed only in the ADT group, even though the 
OVT group with lower eosinophil counts at T0 recorded a higher median count than 
the ADT group at T12. A high within-group variation in the OVT group eosinophil 
counts was probably responsible for the non-significant immunochemotherapeutic 
effects observed. The total IgE level in other bovine nematode infections is frequently 
found to be inversely correlated with worm burden and/or faecal egg counts 
(Gershwin 2009). In human filariasis, low Mf loads are inversely related to IgG1, IgG2, 
IgG3 and IgE serum levels (Kurniawan et al. 1993), although IgE levels are also strongly 
associated with post-therapy immunopathology of filarial diseases (Brattig 2004). The 
interaction of helminths with granulocytes is critically important in host protection, 
immunopathology and/or parasite establishment (Makepeace et al. 2012). 
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In this study, the anti-onchocystatin antibody response had very low and insignificant 
correlation coefficients with Mf density, fecundity and number of viable worms. 
Antibody responses were not evaluated in the ADT group, which had significant 
changes in all the parameters of worm viability measured. To the best of our 
knowledge, the role of bovine IgG isotypes in ADCC reactions against filariae has not 
been investigated, but it is clear that both IgG1 and IgG2 can mediate bovine 
eosinophil-mediated ADCC to juvenile Fasciola hepatica in-vitro (Duffus and Franks 
1980). 
The recorded reduction in worm viability by the ADT regimen in this study was lower 
than that (80%) previously reported for this gold standard protocol (Gilbert et al. 
2005), probably due to the natural adult worm death in the control group. However, 
our result was similar to that (60%) observed in cattle subjected only to prolonged 
intermittent antibiotic therapy (Gilbert et al. 2005). The current study used twice as 
many animals per treatment than previous studies on O. ochengi (Langworthy et al. 
2000; Gilbert et al. 2005; Nfon et al. 2006; Hansen et al. 2011), where host mortality 
among the experimental groups was recorded before the studies were completed. 
The earliest worm mortality was observed at 8 weeks of ADT from an animal in which 
dead worms were consistently recovered at later time-points. This pattern was 
repeated in the four responding animals that had first mortalities at T36. The two 
cows that responded poorly to the treatment maintained high worm viability at all 
the time-points, although there was a notable but statistically insignificant decline in 
their Mf densities at T36 and T52, perhaps indicating some effects on the worms’ 
embryogenesis. In addition, these were the only two animals of the ADT group with 
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viable male worms at T52. Since our evaluation could not definitively identify dying 
worms, it could not be concluded whether they were in the process of dying or not. 
In human studies, significant depletion of the endobacteria Wolbachia was observed 
at 6 months after treatment, and macrofilaricidal effects several months later 
(Hoerauf et al. 2008b; Hoerauf et al. 2009). The nodules of the five antibiotic-
susceptible cattle that had Mf load of zero were in the process of degeneration, 
making the identification of males impossible. 
The standardisation of the expected number of male worms per nodule site is vital 
for the evaluation of their viability. Although there were only 2 viable males from 7 
nodules in the ADT at T52, 100% male worm viability was recorded because no visible 
dead male worm could be identified from the degenerated nodules. Previous work 
have also encountered this problem of male/nodule ratio (Langworthy et al. 2000; 
Gilbert et al. 2005; Nfon et al. 2006; Hansen et al. 2011). Male worms are motile and 
migrate from one nodule to another. We recorded a maximum of nine males per 
nodule with an average of 1.5 males per nodule site. Subsequent studies should 
model the expected number of males per nodule site using data from all the previous 
studies conducted on the O. ochengi model over the last 20 years. 
The strong positive association between observed nodule diameter, Mf densities, 
fecundity, and the number of viable worms observed only in the ADT group indicates 
that the parameters measured and analysed were true estimates of viability. 
However, to model the contribution of each measurement of viability, larger datasets 
will be needed, and parameters monitored for a longer time to ensure total worm 
mortality in the macrofilaricidal group. 
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Antibiotic therapy tended to initially precipitate early maturation and release of Mf. 
ADT treated cattle had a significantly higher Mf load at T8 than did the control group. 
In previous studies, (Gilbert et al. 2005), Mf load tended to increase from T0 to T4 
before dropping around T12. The initial response to a stress factor from the adverse 
environment generated by chemotherapy may be to stimulate embryogenesis or an 
early maturation and release of Mf before terminating in infertility, sterility (Hoerauf 
et al. 2001; Hoerauf et al. 2003; Gilbert et al. 2005; Hoerauf et al. 2009) and eventual 
death (Hoerauf et al. 2009). 
Two cows had no skin Mf at all time-points, though they had at least one male in a 
nodule with a female worm at all time-points except at T12. Indeed, the worms had 
good motility and viability scores, but either no intra-uterine Mf were found, or they 
were in a state of degeneration. Occult filarial infections or amicrofilarial are common 
in animal models and most human filarial infections (Nanduri and Kazura 1989; Elson 
et al. 1995). These extreme data or outliers were not excluded from statistical 
analysis and contributed to the wide between group variations observed. 
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3.5 Conclusions 
 
Immunotherapy using mutated onchocystatin did not enhance the efficacy of 
sublethal antibiotic chemotherapy against O. ochengi because the immune responses 
generated, and nodule eosinophilia were not sufficiently strong to affect adult worm 
viability. The positive control antibiotic regimen was adulticidal as expected, and 
results confirmed the role that eosinophils play in worm killing. The presence of 
infected cows that appeared to be refractory to oxytetracycline treatment in the ADT 
group, and an amicrofilaremic cow in the SLT and OVC groups, may warrant further 
investigations in subsequent studies.  
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Chapter 4 Proteomics of Oxytetracycline 
Treated Adult Female O. ochengi  
 
4.1 Introduction 
Doxycycline, a tetracycline family antibiotic, is recommended for the treatment of 
individual cases of human onchocerciasis of patients no longer exposed to reinfection 
and during strategic mass drug administration (MDA) in regions where ivermectin is 
counter-indicated due to severe adverse effects resulting from co-infection with 
Loaisis (Hoerauf et al. 2008b; Wanji et al. 2009). The major limitation of the inclusion 
of doxycycline in MDA control programs for onchocerciasis is its long therapeutic 
regimen (Hoerauf et al. 2009). In addition, doxycycline is counter-indicated in infants 
and pregnant women. The mechanism of action of tetracycline antibiotics is 
associated with its high affinity for 30S ribosomes, leading to inhibition of interactions 
with aminoacyl-tRNA and thereby impeding protein synthesis  (Tritton 1977; Chopra 
et al. 1992). However, the exact mechanism of Wolbachia depletion and 
macrofilaricidal effects of the antibiotic are not known. The elucidation of the mode 
of action of effective oxytetracycline therapy on Wolbachia and anti-Wolbachia 
interactions with the worm will help repurpose tetracyclines. Hence, disrupting 
Wolbachia’s symbiotic relationship with filaria parasites is the focus of much research 
(Taylor et al. 2014). The ability to modify the chemical structure and pharmacokinetic 
properties of tetracycline (Gurevich et al. 1964) led to the production of semi-
synthetic derivatives such as doxycycline and minocycline. Predictions made from 
modelling pharmacokinetic and pharmacodynamics data from rodents indicate that 
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minocycline can be re-purposed to be more efficacious than doxycycline against 
Wolbachia in lymphatic filariasis caused by Brugia malayi (Sharma et al. 2016).  
In the bovine onchocerciasis, the viability of O. ochengi is determined by the type of 
immune cells surrounding the worm (Hansen et al. 2011). Though the pathogenesis 
related to nodule formation is not clearly understood, it is evident that normal 
nodules are richly supplied with blood vessels and the worm surface is coated with 
neutrophils that do not appear to harm the adult worms (Hansen et al. 2011). 
Neutrophils are recruited by macrophages on encountering foreign bodies via 
cytokines to help immobilise and destroy the invader as a first-line approach to 
combat the pathogen (Delves et al. 2011). Macrophages, as natural scavengers, are 
typically the first immune cell type to encounter any immunogen or foreign organism 
that invades a tissue and they also routinely phagocytose dead and abnormal cells. 
In normal onchocercomata, the filarial endosymbiont Wolbachia release 
peptidoglycan-associated lipoprotein (wPAL) whose N-terminal lipopeptide activates 
TLR-2/6 and cytokine IL-8 to trigger a neutrophilic response (Tamarozzi et al. 2016). 
In chronic conditions or on encounter with extracellular bacteria, neutrophils 
undergo a form of cell death in which the nuclear DNA and associated basic proteins 
serve as neutrophil extracellular traps (NET), thereby preventing the spread of 
infection (Tamarozzi et al. 2016). In the bovine onchocercoma, NET formation have 
not been reported but there is an amorphous, acellular deposit on the worm’s cuticle 
called the Splendore-Hoeppli phenomenon (Nfon et al. 2006). 
Neutrophils are equipped with three types of granules that contain enzymes and 
other antimicrobial proteins (Delves et al. 2011). The primary azurophillic granules 
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produce antimicrobial proteins which are either oxidative (myeloperoxidase) or non-
oxidative [defensins, bactericidal permeability increasing (BPI) protein and cathepsin 
G] in nature. The secondary specific granules produce more non-oxidative enzymes 
such as lysozyme (absent in bovine neutrophils), lactoferrins and alkaline 
phosphatase than the oxidative enzymes, cytochrome B558. Myeloperoxidase (MPO) 
plays an important role during the respiratory burst on phagocytosed organisms 
(Dahlgren and Karlsson 1999). The third type of granules, secreted independent of 
azurophils, contain two cationic polypeptides (bactenectin and indolicidin) with 
potent antimicrobial activity (Renato et al. 1983; Selsted et al. 1992; Selsted et al. 
1993).  
Eosinophils are effector immune cells that induce cytotoxicity, release mediatory 
cytokines in helminthiasis (Horie et al. 1996; Klion and Nutman 2004) and have 
exceptional capabilities to breakdown extracellular tissues with an arsenal of toxic 
substances, such as major basic protein (MBP) and eosinophil cationic protein (ECP) 
stored in a ready-to-use form in granules (Delves et al. 2011). Other eosinophil 
proteins include arylsulphatase B, phospholipase D, histaminase, and preformed 
cytokines, chemokines and growth factors that, when effectively regulated, exert 
multiple functions to contain allergy, viral infections, inflammatory disorders and 
helminthiases, while ensuring minimal damage to surrounding tissues (Klion and 
Nutman 2004; Delves et al. 2011). Eosinophils therefore play additional roles in the 
maintenance of cell integrity and wound healing, and serve as linkage between the 
innate and adaptive immune responses (Melo et al. 2008; Shamri et al. 2011). The 
release of eosinophils into blood vessels is mediated by IL-5 and / or IL-4 (Pearlman 
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1997; Pearlman et al. 1999) and are activated to confer complement dependent (the 
preferred site of attachment is on C3b-opsonised parasites) or antibody-dependent 
(IgG or IgE-opsonised parasites) cell-mediated cytotoxicity (Chandrashekar et al. 
1990), leading to a piecemeal degranulation (PMD) responsible for regulating the 
release of cytokines and other proteins during the inflammatory response (Melo et 
al. 2008; Melo and Weller 2010; Delves et al. 2011). Eosinophils also exert 
degranulation by classical exocytosis (Logan et al. 2002) and cytolysis following cell 
lysis to release entire granules within the extracellular space (Melo et al. 2008) but 
PMD is of importance because of the regulatory role it plays in causing inflammatory 
diseases and in regulation of tissue homeostasis (Melo and Weller 2010). PMD is the 
main effector mechanism of eosinophils evident by well-structured microtubule 
subunits within specific granule vesicles or larger sombrero vesicles that permits 
selective recruitment of cytokines and/or MBP to be transported for release at 
cytoplasmic membrane (Melo and Weller 2010).  
Mast cells are granulocytes found in most tissues of the body especially the skin, 
respiratory tract and the digestive system. They act as one of primary defence cells 
and share some functions with macrophages and eosinophils (Urb and Sheppard 
2012). The spontaneity of reactions by mast cells are responsible for their frequent 
association with allergic reactions. Mast cells contribute to parasite killing in much 
more diverse ways than eosinophils and have been associated with the release of 
antimicrobials such as cathelicidins (Di Nardo et al. 2003) and proteoglycans that 
regulate cellular activity by induction of apoptosis (Rönnberg et al. 2012). However, 
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previous cytology of bovine onchocercomata showed that mast cells did not 
contribute significantly to worm killing after antibiotic therapy (Nfon et al. 2006). 
In contrast with their mammalian hosts, the physiological systems and behaviour of 
filarial worms are poorly understood (Bain 2002). The inability to grow filarial worms 
in-vitro in culture media throughout their lifecycle has severely limited studies on 
filarial biology. Intra-nodular Onchocerca parasites are in close contact with blood 
vessels, collagen and connective tissues in addition to the innate immune cells. Their 
mode of nutrition is not clearly understood, but there is evidence of periodic 
engulfment of blood (George et al. 1985). In the case of Litomosoides sigmodontis, 
worms have been shown to actively ingest blood at early adulthood, shortly after the 
fourth moult (Attout et al. 2005). Female worms of O. volvulus or O. ochengi are 
highly entangled and cannot be physically separated from host tissues without 
inflicting traumatic injuries on the parasite, although enzymatic digestion with 
collagenase to free the worm is possible. 
To better understand the biology of filarial nematodes and particularly the principles 
underpinning the worm’s dependence on endosymbiotic bacteria Wolbachia for its 
survival, there has been rapid development in the sequencing and updating of the 
genomes of both filariae and other nematode genomes (Laetsch et al. 2012; Mavingui 
et al. 2012; Scott et al. 2012; Choi et al. 2016). 
The basis for mutualism between Wolbachia of O. ochengi (wOo) and its filarial host 
differs from that of Wolbachia of Brugia malayi (wBm) in the ability of wBm, but not 
wOo, to synthesize riboflavin.  However, both strains can synthesise haem and might 
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supply ATP to the worm host (Foster et al. 2005; Wu et al. 2009; Darby et al. 2012). 
Wolbachia cannot synthesise lipid A needed for their own membrane formation and 
may depend on its host parasite for the supply of other lipids (e.g., cholesterol), as 
well as amino-acids required for energy metabolism (Elodie  Ghedin et al. 2007). An 
estimated 11,508 and 12,143 proteins were predicted from the complete genome 
assembly of human Brugia malayi (95 MB) and O. volvulus (97 MB), respectfully 
(Elodie  Ghedin et al. 2007; Cotton et al. 2016). Computer simulation of metabolic 
capabilities of O. volvulus and that of L. loa highlighted mutualism in purine 
metabolism in O volvulus and Wolbachia and 16 potential drug targets (Cotton et al. 
2016). Analysis of the predicted wBm proteins suggested four categories of genes 
could be targeted to disfavour underlying mutualism between the parasite and its 
endosymbionts (Holman et al. 2009). 
The complete proteome of O. ochengi was characterised across the major stages of 
the lifecycle and in nodule fluid recently, providing baseline data (Armstrong et al. 
2016). The use of proteomics to evaluate post-antibiotic changes in the lymphatic 
filaria Brugia malayi revealed significant changes only in the endosymbiont 
Wolbachia proteins in a study conducted in Mongolian jirds (Dangi et al. 2009). In an 
alternative approach using a mosquito cell line, doxycycline-treated arthropod 
Wolbachia (exposed to the antibiotic for three days only) revealed upregulation of 
nucleotide and energy metabolism, while outer membrane proteins were 
downregulated (Darby et al. 2014). This provided some insight into the mechanisms 
used by Wolbachia to tolerate antibiotic exposure. However, given the important 
differences in the genomes between the arthropod and filarial Wolbachia strains, it 
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was necessary to conduct the current in vivo long-term, longitudinal study using a 
natural filarial worm infection. 
In the preceding chapter, morphological (worm viability and fecundity, Mf density, 
nodule diameter and nodule eosinophil counts) and immunological (serology) 
changes were used to ascertain worm death in response to oxytetracycline antibiotic 
chemotherapy. This current study is the first analysis of in vivo proteomic changes in 
antibiotic-treated female Onchocerca worms. Proteomic changes associated with 
oxytetracycline-treated O. ochengi filarial parasites have never been reported. Given 
the importance of proteomic technology in systems biology, its use in the 
characterisation and modelling of cell death mechanisms is progressing rapidly 
(Chernobrovkin and Zubarev 2016). Advances made in bioinformatics have facilitated 
the modelling of interactions between proteins, while linking expansive genomic and 
proteomic datasets to highlight important biological processes (Szklarczyk et al. 
2015). These analyses are aimed at testing the hypothesis that eosinophils and 
neutrophils play an important role in the antibiotic-mediated killing of O. ochengi 
filarial worms.  
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4.2 Materials and Methods 
 
4.2.1 Experimental Animals 
Twenty-one cattle, a subset of the 35 Ngaoundere Gudali zebu cattle (Figure 3.1, Bos 
indicus) described in section 3.2.2.1 of this thesis were used for this study (Bah et al. 
2015). The cattle were aged 6.26 ± 0.46 years by dentition and weighed 278.7 ± 6.9 
kg. The ethical considerations, feeding, health care and general management of the 
animals were reported in section 3.2.2.3. 
Cow 233 of the control group aborted during the early phase of the experiment and 
was administered a procaine penicillin-based antibiotic, Combikel® 40 L.A Kela (20 ml 
deep intramuscular injection). The cause of the abortion was not determined. 
4.2.2 Experimental Design 
A randomized block repeated measure experimental design of twenty-one cattle 
partitioned into three groups of seven cattle each was constituted for this 
experiment. Two treatments [Sublethal tetracycline therapy (SLT) and Adulticidal 
therapy (ADT)] were compared to an untreated control at 0, 12 and 36 weeks from 
the start of therapy (Table 4.1). 
The choice of the time-points (T0, T12 and T36) depended on previous findings, 
indicating important changes leading to the survival or death of adult worms (Gilbert 
et al. 2005). The experiment was designed to closely monitor proteomic changes 
within female worms following effective therapy (ADT), while comparing them to 
ineffective chemotherapy (SLT), and the untreated control (CON) undergoing natural 
ageing or worm death. 
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Table 4.1: Experimental block for female worms collected from each treatment group 
(total N = 63). 
Treatment (number of cattle) 
Time (Weeks) 
T0 T12 T36 
ADT (n = 7) ADT_T0 ADT_T12 ADT_T36 
SLT (n = 7) SLT_T0 SLT_T12 SLT_T36 
CON (n = 7) CON_T0 CON_T12 CON_T36 
 
We hypothesized that neutrophil proteins associated with immune processes which 
enhanced worm survival and prevented apoptosis of worm cells would be 
downregulated after antibiotic treatment. Conversely, worm proteins that facilitate 
resistance to stressors and enhance survival would be expected to be upregulated. 
Also, eosinophil proteins and processes that are detrimental to the worm should be 
upregulated. The experimental design permitted statistical analysis to compare 
changes over time within the ADT group vis-à-vis those of the control and the 
ineffective therapy. 
4.2.3 Parasitology 
 Sampling Techniques and Parasitological 
Evaluation of Worms 
See Chapter 3, section 3.2.5.1 and 3.2.6. 
 Handling and Evaluation of female Worms in the 
Laboratory 
In the laboratory, the nodules were carefully extracted from the dermal tissues, the 
worms removed from the nodule, and the female worm examined for motility 
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(viability) and fecundity. The whole, individual female worms were frozen at -80oC 
immediately after evaluation in a minimal volume of sterile PBS. Samples were 
transported in liquid nitrogen from laboratory facilities at Wakwa to Yaoundé and 
flown on dry ice to Liverpool. 
4.2.4 Proteomics 
 Nematode Worm Solubilisation 
Female worms were thawed on ice and soluble whole body extract (fOoWBE) 
obtained as previously described (Armstrong et al. 2014; Armstrong et al. 2016). Each 
female worm was added to 1 mL of freshly prepared lysis buffer [50 mM Tris, 6 M 
urea, 1.5 M thiourea and 66 mM dithiothreitol (DTT, Sigma®)], Complete Protease 
Inhibitor Cocktail (Roche®), a 1:1 mixture of 1 mm glass and 0.1 mm zirconia-silica 
beads (1 mL) and homogenised for four, 1-min cycles at top speed in a Mini-
Beadbeater (Biospec, Bartlesville, OK, USA). Between each cycle, the homogenate 
was incubated on ice for 2 min. Soluble proteins were precipitated from the 
supernatant with an equal volume of 20% (w/v) TCA in acetone during incubation on 
ice for 1 hour, then centrifuged at 12,000 g for 20 min at 4°C. The protein pellet 
obtained was washed with 1 ml ice-cold acetone and incubated at -20°C for 10 min 
twice, then rinsed in 200 μl acetone for 10 min at 4°C. After each wash, the proteins 
were pelleted by centrifugation at 12,000 g and incubated at room temperature for 
2 – 5 min to completely dry. 
 Re-solubilisation of Protein 
The protein pellet was re-suspended in a minimum of 200 μl of re-solubilisation 
buffer (25 mM ammonium bicarbonate, 6 M urea, 1.5 M thiourea in HPLC grade 
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water) by repeated flushing of the pellet with buffer using a pipette without 
vortexing. The re-suspension was completed by sonicating the sample for five 
minutes (with a between-cycle rest on ice for two minutes) in an ice-water bath over 
four cycles or more, until the pellet was completely dissolved. The re-suspended 
fOoWBE solutions were stored at -20°C while setting aside an aliquot (50 μl) for 
quantification and tryptic digestion. 
 Protein Quantification 
The concentration of protein obtained from fOoWBE was determined using the 
Pierce Coomassie Plus (Bradford) Protein Assay (Thermo Scientific). A standard 
consisting of bovine serum albumin solutions (25, 20, 15, 10, 5 and 2.5 μg /mL) was 
prepared using the manufacturer’s guidelines (Thermo Scientific). Worm protein 
samples (10 μl) were prepared in triplicate for the Bradford Protein Assay by serial 
dilutions from an initial 1:100 dilution to 1:200, 1:400 and 1:800. An equal volume 
(150 μl) of each sample and Coomassie Plus stain was thoroughly mixed, incubated 
for 10 min at room temperature in the dark, and protein concentrations read at 595 
nm on a TECAN® microplate reader. Protein concentrations were determined by 
linear regression using Magellan software (Tecan). 
 Tryptic Digestion 
To minimise interference in the tryptic digestion process, the urea molarity of each 
sample containing 100 µg protein was reduced to at most 1 mMol by dilution in at 
least 160 μl HPLC water. Proteomic-grade trypsin complex (Sigma®) dissolved in 10 
μl of 9 mMol (33 mg/ml) iodoacetamide (Sigma®) and 10 μl of 3 mMol DTT was added 
to samples at a protein:trypsin ratio of 50:1 and incubated overnight (12 – 16 hours) 
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at 37°C. Digestion was stopped by adding trifluoroacetic acid (TFA) at 1 μl per 200 μl 
of sample to reduce the pH. To confirm effective digestion (i.e., absence of protein 
bands), an aliquot (40 μl) of each digested soluble fOoWBE was analysed using SDS-
PAGE set at 200 volts and 70 mA for 50 minutes and stained with Coomassie Blue 
G250 (EzblueTM Gel stain, Sigma) after heating at 90oC for 5 min. A 5 μl aliquot of Bio-
Rad® protein ladder was added to the first and last wells of the gel to serve as an 
undigested control. 
4.2.5 Mass Spectrometry 
 Desalting and Concentration of Peptides 
The digested peptide samples were spun at 14,000 g for 30 min at 4°C, the 
supernatants removed by drying in a vacuum evaporator, and the pellet re-
suspended in equilibration solution [0.5% TFA in 5% acetonitrile (ACN)]. Sample 
solution (2% TFA in 20% ACN), wash solution (0.5% TFA in 5% ACN) and elution 
solution (70% ACN) were prepared. Each sample was reconstituted in 400 µL of 
equilibration solution. Thermo Scientific Pierce® C18 Spin Column containing reverse-
phase resin with minimum (10 ng) and maximum (30 µg) peptide-binding capacity 
was activated with 200 µL ACN and used to desalt the sample in four steps (Thermo 
Scientific protocol). The activated C18 Spin Column was wetted with 200 µL of 
equilibration solution, and the column was spun twice at 1,500 g at each stage and 
the wash discarded. 
During the sample binding phase, the first flow through was re-introduced into the 
column to maximize peptide binding, centrifuged twice as described above, and the 
second flow-through discarded. The columns were then washed twice with wash 
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solution and the peptides eluted into a new receiver tube with 20 µL aliquots of 
elution buffer. The eluate was vacuum dried, and the purified peptides re-suspended 
in 3% (v/v) ACN, 0.1 % (v/v) TFA to a concentration of 0.2 μg/μl for analysis by mass 
spectrometry (MS). 
 NanoLC MS ESI MS/MS Analysis 
Liquid chromatography (LC)-MS was run by Dr Stuart Armstrong (Armstrong et al. 
2014). Briefly, the concentrated peptide was analysed by on-line nanoflow LC using 
the nanoACQUITY-nLC system (Waters) coupled to a linear trap quadrupole (LTQ)-
Obitrap Velos (ThermoFisher Scientific, Bremen, Germany) MS equipped with the 
manufacturer’s nanospray ion source. The nanoACQUITY UPLC BEH130 C18 analytic 
column used had a 1.7 µm particle size and 15 cm × 75 µm capillary diameter. The 
column was maintained at 35°C with a flow-rate of 300 nL/min and the gradient for 
in-gel digests consisted of 3 - 40% ACN, 0.1% formic acid for 90 min then a ramp of 
40 - 85% ACN, 0.1% formic acid for 3 min in positive ionisation mode. Full scan MS 
spectra (m/z range 300 - 2000) acquired by the Orbitrap at a resolution of 30,000 
were analysed in data-dependent mode, and the top 20 most intense ions from MS1 
scan (full MS) were selected for tandem MS by collision-induced dissociation (CID). 
All product spectra acquired in the LTQ ion trap and Orbitrap (with maximal injection 
times set to 50 ms and 500 ms, respectively) were imported into Progenesis QI 
(version 4.1, Nonlinear Dynamics, Newcastle, UK) for protein identification and 
quantification. 
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 Protein Identification and Quantification 
The spectra in Thermo RAW format imported into Progenesis QI were aligned by the 
software default settings and alignment scores verified. Samples with alignment 
scores of less than 50% were omitted from the statistical analysis. Peaks with a charge 
state between +2 and +7 were filtered in, spectral data transformed into Mascot 
generic format (mgf) with Progenesis LC–MS (version 4.1, Nonlinear Dynamics) and 
all peptides in the sample identified using the Mascot [version 2.5.1, Matrix Science, 
P <0.05, <1% false discovery rate (FDR)] search engine. Tandem MS data were 
searched against gene models from the Wolbachia symbiont, wOo (UniProt release 
2015_07; 766 protein sequences); the bovine host (Bos taurus, UniProt release 
2016_08; 24,214 protein sequences); and a general contaminant database (GPMDB, 
cRAP version 2012.01.01; 115 protein sequences). Data were also searched against a 
revised Onchocerca database generated using the ProteoAnnotator pipeline (Ghali et 
al. 2014) as detailed by Armstrong et al. (2016), which contained 13,419 gene models 
from O. ochengi 
(http://parasite.wormbase.org/Onchocerca_ochengi_prjeb1809/Info/Index) and 
572 from O. volvulus (Cotton et al. 2016). The search parameters were at a precursor 
mass tolerance of 10 ppm and a fragment mass tolerance of 0.8 (LTQ-Orbitrap Velos) 
while permitting two missed tryptic cleavages. The fixed modification was 
carbamidomethylation (cysteine) and oxidation (methionine) was set as a variable 
modification. The results from the Mascot search were validated using the learning 
algorithm Percolator and the decoy database function embedded within Mascot. The 
FDR was set at <1% while individual Percolator ion scores of >13 indicated identity or 
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extensive homology (P < 0.05). Mascot search results were imported into Progenesis 
QI as XML files for calculation of relative protein abundance by the default Hi-3 
method (Silva et al. 2006). The abundance of each peptide was calculated from its 
constituent peptide ions and normalised across samples by average intensity using 
the Normalyzer software package, such that the protein signal was the average 
abundance of the three top-ranked peptides (Chawade et al. 2014). 
 
Table 4.2: Experimental designs for Progenesis statistics. 
 
T time from day 0 (T0) though week 12 (T12) and 36 (T36) after first treatment to ADT 
(adulticidal oxytetracycline therapy), SLT (sub-lethal oxytetracycline therapy) and the CON 
(untreated control) cattle. n sample sizes varied between groups and within groups due to 
elimination of some samples due to quality control at progeneisis. 
 
4.2.6 Bioinformatics and Other Statistical Analysis 
The raw abundances of the identified proteins were subjected to several within-
group and between-treatment comparisons using Progenesis statistics (Table 4.2). 
The percentage score of the significant proteins was calculated with respect to the 
summed number of proteins from all experiments. Duplicates of proteins that were 
significantly regulated in more than one statistical comparison were removed from 
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the final tallies. Prior to analysis, two animals (cows 238 and 231) from the ADT group 
were excluded from all within-group statistics (Table 4.2: Tests 1 & 2) as their samples 
did not align with the others in Progenesis. However, cow 231 had a low alignment 
score (33%) only at T12; therefore, in the between-group comparisons, the other 
time-points (231_T0 and T36) were included (Table 4.2). It should be noted that worm 
of the sample resisted treatment at T52. Within group statistics (Table 4.2) were 
equivalent to repeated-measures ANOVA and between groups, one or two-way 
ANOVA. 
Outputs from these analyses were edited to remove proteins with zero or only one 
unique peptide to reduce the probability of false protein identifications and to 
increase the accuracy of quantitative comparisons. Where the statistical power of 
Progenesis analyses was above 80%, proteins with significant differential expression 
(DE) having a q-value of ≤0.05 and a fold change (FC) of ≥1.5 were classified as 
upregulated and/or downregulated. To determine from which component of the 
worm these DE proteins may have originated, they were searched against 94 O. 
ochengi and 498 bovine proteins found in nodule fluid (NF) as reported (Armstrong 
et al. 2016) and also against 343 proteins expressed in the Splendore-Hoeppli 
phenomena (SHP) (Armstrong, Hetzel and Makepeace, unpublished data). The 
predicted protein-protein interactions (PPI) and biological enrichment amongst the 
DE proteins were searched in String (http://string-db.org/). The String output 
includes Pfam (http://pfam.xfam.org), InterPro and KEGG pathway (Kanehisa et al. 
2010) statistics for functional protein domain and pathway predictions (Szklarczyk et 
al. 2015). String edge lengths were shortened by reducing the confidence interval (CI) 
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to increase the likelihood of identifying PPI. WormBase Parasite 
(http://parasite.wormbase.org/) was also used to locate conserved domain 
information for Onchocerca proteins, including uncharacterised proteins (Howe et al. 
2016). Dendrograms to illustrate peptides or proteins with similar trends were 
obtained from PCA correlations of selected protein profiles to facilitate enrichment 
analysis. The biological processes of highly enriched pathways with significant false 
discovery rates (FDR, P < 0.05) were obtained and summarised based on Pfam and 
InterPro domain database output. 
Progenesis-reviewed protein statistics and experimental results were exported as 
.csv files for further statistical analyses (Table 4.2). SPSS version 24 statistical package 
was used to run correlations between raw protein abundance, worm viability and 
motility index. SPSS Chart Builder was used to plot changes in worm protein weight 
over time. Heatmaps of regulated proteins were plotted to summarize FC and protein 
origin using GENE-E freeware (https://software.broadinstitute.org/GENE-E).  
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4.3 Results 
 
4.3.1 Undigested Worm Protein 
The average weight (±SD) of extracted protein from 63 female O. ochengi worms was 
2.44 ± 1.07 mg (Figure 4.1). One-way ANOVA of within ADT statistics showed that 
worms had significantly higher extracted protein weight at T0 than at T12 or T36 (p < 
0.01) and between the groups, SLT mean protein yield was higher than that of ADT 
(p = 0.013) at T36. 
 
 
Figure 4.1: Undigested protein profile of female O. ochengi worms (N = 63). Key:  ADT - 
Adulticidal oxytetracycline therapy; SLT - Sublethal oxytetracycline therapy; CON - Untreated 
control; # refers to groups with significant differences (p < 0.05); a, b – time-points with 
significant differences (p < 0.05). 
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Although repeated measure ANOVA (RANOVA) analysis, which is the most 
appropriate statistical analytical tool for multiple comparisons, yielded no significant 
differences, we validated the significant results of the one-way ANOVA at T52 based 
on the fact that female worms of the ADT group degenerated while nodule size 
significantly dropped at T52. Wider within group variations in extracted soluble 
protein from ADT worms at T12 compared to those of SLT and CON (Figure 4.1) might 
have accounted for the insignificant difference obtained from the RANOVA results. 
These findings suggest that worm proteins abundance could be proxy a measurement 
for worm viability (r = 0.31, p = 0.017) as measured by motility. 
 
 
Figure 4.2: Origin of protein extracted from female O. ochengi filarial parasite of cattle. 
 
4.3.2 Digested Protein 
Two thousand, five hundred and twenty-seven proteins were identified from 12,189 
peptides obtained from MS-MS analysis. The identified proteins (Figure 4.2) 
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originated from cattle (1,583), O. ochengi (796) and Wolbachia (21). Fifty percent of 
them retained with two or more unique peptides (Figure 4.3, C) and comprised 35%, 
51% and 58% of the respective Wolbachia, O. ochengi and bovine proteins. Peptide 
counts were positively skewed (Figure 4.3, A & B). 
 
 
Figure 4.3: Descriptive statistics of (A) peptide count per protein, (B) distribution showing 
positively skewedness of large sample with unique peptides and (C) proportion (50%) of 
accepted counts of further Progenesis (n = 2,548). 
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Figure 4.4: Heat map of significant DE proteins (FC ≥ 1.5, q < 0.05) from between groups at T 
36 (left) and within ADT (right) test statistics. Wolbachia had only downregulated proteins. 
Unlike in cattle, more worm proteins were upregulated than down regulated. 
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 Regulated Proteins 
Across the seven statistical comparisons performed, a total of 203 proteins exhibited 
significant DE. The results from two of the seven statistical analyses (Table 4.2) 
presented (Figure 4.4) accounted for more than two-thirds of the DE proteins, 
including bovine beta haemoglobin and cytochrome c oxidase sub-unit seven, which 
were the only two proteins identified by comparison 1 (Table 4.2). An uncharacterised 
protein with acc. ID G3N0V0 and Rho GDP-dissociation inhibitor 2 were significantly 
regulated in six of the seven comparisons, and 14 other proteins were significantly 
regulated in five comparisons. In summary, 124 DE proteins had significant DE in at 
least two comparisons, thereby inflating the actual number of DE proteins (Figure 4.2). 
About 40% of downregulated proteins and 50% of upregulated proteins were 
between the effective ADT and ineffective SLT groups (Figure 4.4). 
There were strong correlations between the subgroups of regulated proteins (Figure 
4.5, A). While upregulation tended to disorganise protein abundance (Figure 4.5, B), 
downregulation by ADT lowered protein abundance to the same level (Figure 4.5, C) 
thereby increasing similarity between them (Figure 4.5, B). Although most of the 
significant DE proteins occurred at T36, PRG 3, (a homologue of eosinophil major 
basic protein) had its highest abundance at T12 (Figure 4.4). More than half (119) of 
the DE proteins been found in nodule fluid (76) and/or SHP (84) and are highlighted 
in Table 4.3, Table 4.4 and Table 4.5. Forty-one of the NF proteins were also reported 
in SHP (Armstrong, Hetzel & Makepeace, unpublished). 
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Figure 4.5: Between groups normalised peptide ions and protein abundance profiles (p < 
0.002; FC ≥ 1.5) at T36. Downregulation by ADT (A) tended to normalise protein abundance 
profiles. The upregulated peptide ions abundance profile (B) illustrates significant differences 
between ADT and SLT (Dark bar). A Dendrogram of peptide ions illustrating two pedigrees of 
regulated peptide clusters (C).  
 
4.3.2.1.1 O. ochengi Regulated Proteins 
Twenty-two female O. ochengi proteins had significant DE. Seventeen were 
upregulated and 5 downregulated (Table 4.3). About half of the O. ochengi DE 
proteins (11) had previously been found in nodule fluid (10) and/or SHP (3) and are 
highlighted in Table 4.3. 
131 
 
 
Table 4.3:  Onchocerca ochengi regulated proteins post oxytetracycline therapy. 
 
Source: represents the different worm stages from which the protein identified previously 
(Armstrong et al. 2016).Keys: AF, adult female; iuMF, intra-uterine microfilaria; AM, adult 
male. vL3, vector-derived infective larvae; NF, nodule fluid. # Protein found in Splendore-
Hoeppli deposit and ᵻ NF. 
 
4.3.2.1.1.1 Upregulated O. ochengi Proteins 
Several of the upregulated proteins belonged to the worm’s integumentary system 
comprised of the cuticle, although most were potential excretory-secretory products 
(constituents of NF proteins), accounting for 53% of the upregulated proteins (Table 
4.3). The NF proteins presented identified amongst the regulated worm proteins in 
Table 4.3 were enzymes involved in redox pathways, the pentose phosphate 
pathway, glycolysis, and regulation of apoptosis. 
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An uncharacterised protein with accession OVOC3356 may be a properdin-like 
protein based on the description of the human homologue (source: UniProtKB; acc: 
P27918) and has 101 orthologues from 47 other nematodes including C. elegans. In 
mammals, properdins are serine proteases that play an important role in 
complement activation in cell-mediated immunity and participate in tissue 
regeneration (Hourcade 2006). Serine protease inhibitors, also known as serpins 
(Stanley and Stein 2003), were upregulated 3.4-fold (q < 0.05) relative to the control 
group. They are anti-inflammatory proteins essential for the maintenance of 
haemostasis (Almonte and Sweatt 2011). Gelsolin stimulates the biosynthesis of actin 
filaments and prevents loss of cytoskeletal monomers in humans (Kwiatkowski et al. 
1986), while lipocalins transport small fatty acid molecules (Flower et al. 1993) 
associated with inflammation and detoxification processes. 
4.3.2.1.1.2 Downregulated O. ochengi Proteins 
Five worm proteins were downregulated (Table 4.3) at T36 between the ADT and CON 
groups. One of these, galectin (nOo.2.0.1.t04471), was an NF protein also found in 
SHP, while globin-like protein (nOo.2.0.1.t11149) was a second downregulated NF 
protein (Armstrong et al. 2016). Globin and two other proteins catalyse processes in 
the respiratory system, while galectin and dipeptidase C regulate growth. Galectins 
are abundantly expressed in all tissues both within intracellular and extracellular 
spaces where they bind to glycosylated proteins and lipids to regulate inflammation 
and metabolism in humans (Brinchmann et al. 2018) and promote survival of 
parasites by immune modulation and breakdown of blood clots at all developmental 
stages (Kamhawi et al. 2004; Yang et al. 2008; González-Miguel et al. 2015; 
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Brinchmann et al. 2018).  Dipeptidase C (aminopeptidase) was the most 
downregulated protein (Table 4.3) and functions in the digestion of peptides and 
oligopeptides. It may be an important source of amino acids for protein synthesis 
(Taylor 1993). 
In summary, changes within worm proteins suggest downregulation of respiration, 
homeostasis, growth, and metabolism while immune-related environmental stress 
and antioxidant activities were upregulated. 
Table 4.4: Downregulated Wolbachia proteins from female O. ochengi filarial parasite. 
 
 
 Wolbachia Proteins 
Changes in Wolbachia protein abundance, being the principal target of 
oxytetracycline chemotherapy, were expected to exhibit the most significant 
reduction. A total of seven Wolbachia proteins had two or more unique peptides, of 
which six were significantly downregulated by ADT (Table 4.4; Figure 4.4). These 
reliably-quantified proteins were identified as the most abundant proteins in 
Wolbachia strain wOo in a previous study (S.L. O'Neill et al. 2013). Whereas the 
within-group protein profile of the ADT treated worms (Figure 4.6, B) illustrated that 
Wolbachia proteins were downregulated at T12 and remained low through T36, 
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there was no significant change in these proteins from within the SLT (Figure 4.6, C) 
and CON (Figure 4.6, D) groups. 
 
 
Figure 4.6: Profile of Wolbachia downregulated proteins post-oxytetracycline chemotherapy. 
A. Comparison between treatment groups at T36. In B, C, and D, protein profiles are displayed 
for the adulticidal therapy (ADT), sublethal therapy (SLT), and untreated control (CON) groups, 
respectively. 
 
Transmembrane proteins I7IAG3_9RICK and I7JEM6_9RICK and I7ITT2_9RICK a 
peptidoglycan-associated lipoprotein (PAL) were the most significantly 
downregulated Wolbachia proteins (WP). The WP with the highest FC (Table 4.4) was 
a transmembrane protein of molecular weight 25.1 KDa and comprises 237 amino-
acids encoded by the wOo_07860 gene (UniProt 2015). Transmembrane helices 
function as signal transducers and transporters of ions and other substances into the 
cell by endocytosis (Yin et al. 2007). The other two outer membrane proteins and PAL 
are responsible for neutrophil chemokinesis (Turner et al. 2009) and which on 
activation produce IL8 (Bazzocchi et al. 2003). In addition, some WSP form functional 
complexes with enzymes that are involved in glycolytic pathways (S.L. O'Neill et al. 
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2013) and shown to play important role in the symbiotic relationship with the host 
with respect to energy dependency (Voronin et al. 2016). 
Table 4.5: Post antibiotic upregulated bovine proteins included those previously identified in 
Splendore-Hoeppli deposit and NF. 
 
# Proteins previously found in Splendore-Hoeppli deposit; † previously detected in nodule fluid 
or #†both. 
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 Bovine Proteins on Female O. ochengi  
One hundred and sixty-five of the significant DE proteins were of cattle origin. There 
were fewer upregulated (Table 4.5) than downregulated DE proteins (Table 4.6). The 
majority (107) of these proteins were similar to those of NF (Armstrong et al. 2016) 
or SHP (Armstrong, Hetzel & Makepeace, unpublished). Thirty-nine of them were 
common to both NF and SHP. 
Table 4.6: Antibiotic Downregulated cattle proteins with significant DE included those 
previously identified in Splendore-Hoeppli deposit and NF. 
 
# Proteins previously found in Splendore-Hoeppli deposit; † previously detected in nodule fluid 
or #†both. 
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Table 4.7: Functional enriched biological processes post antibiotic therapy in female O. 
ochengi worms.  
 
Keys: ID, identity; obs, observed; GC, Gene count; FDR, False discovery rate. Analysed on 
String. 
STRING analysis (Szklarczyk et al. 2015) suggested significant protein-protein 
interactions (Table 4.8, Figure 4.7), 32 functional enrichments, and 85 biological 
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processes (Table 4.7) involving 44 cell components. Pfam and Interpro searches 
identified five and fourteen protein families and domains, respectively, with 
significant enrichment (Table 4.8). 
Table 4.8: Enriched Protein domains and features amongst 166 regulated cattle proteins. 
 
Keys: ID, identity; obs, observed; GC, Gene count; FDR, False discovery rate. Analysed on 
String generated Pfam and Intrapro protein enrichements. *Associated chronic conditions. 
 
4.3.2.3.1 Upregulated Proteins of Cattle Origin 
Proteoglycan-3 precursor (PGR3) had the highest upregulated FC at T12 (Figure 4.4, 
Table 4.5). This is the most important finding as PGR3 is an eosinophil major basic 
protein (MBP) homologue with a C-type lectin-like domain and is a key 
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helminthotoxic eosinophil granule protein (Specht et al. 2006; Gombart 2009; 
O'Connell et al. 2011). PRG-3 is also expressed in mast cells (Rönnberg et al. 2012) 
but in this context, its upregulation is in agreement with previous hypothesis that 
eosinophil degranulation contributes to worm killing (Nfon et al. 2006; Hansen et al. 
2011). However, this important protein did not appear to have any significant PPI 
with the others (Table 4.8) probably because sufficient experimental work has not 
been done to document interactions between bovine granulocytes. The upregulated 
proteins had significant enrichments (FDR <0.001) in the phagosome (map04145), 
antigen processing and presentation (map04612), and metabolic pathways 
(map01100) involving genes (CYP3A4 and GLS) that were specifically associated with 
microbial metabolism in diverse environment (map01120) alongside downregulated 
proteins (Table 4.9). Immunoglobin domain (BOLA-DRB3 and Bota) proteins with the 
conserved InterPro signature IPR003006, calcium binding S100A4 (PF01023), and 
annexin A2 (PF00191) were among the enriched DE protein families (Table 4.8). They 
contributed to cellular processes regulating transport, organelle organisation and the 
immune system (Table 4.7) and may be related to increase apoptosis of neutrophils 
after antibiotic treatment. 
Vimentin is an intermediate filament protein and component of the cytoskeleton that 
facilitates the maintenance of cell shape and cellular integrity (Yue et al. 2016). Along 
with S100A4, vimentin contributed in many functional enrichments associated with 
the stabilisation of cytoskeletal interactions (Table 4.7). Protein S100A4 is both a 
cytoplasmic and nuclear protein and forms complexes with annexin A2 via double 
calcium binding to regulate several cellular processes during cell proliferation, 
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migration, and apoptosis (Mirsaeidi et al. 2016). Heterogeneous nuclear 
ribonucleoprotein M (HNRNPM) is associated with mammalian targets of rifampicin, 
plays key role in cell survival and growth as well as affect muscle differentiation (Chen 
et al. 2017). 
 
 
Figure 4.7: STRING network of regulated bovine protein genes in O. ochengi filarial worm after 
oxytetracycline therapy PPI (P = 0.000). Red nodes represent 64 proteins with significant 
enrichment in biological processes (Go.0008150). Encircled nodes are upregulated proteins 
(A) CSTD, upregulated between SLT and CON, was downregulated by ADT time-course 
analysis; neutrophil proteins (B); components of blood (C), and proteins involved in 
metabolism (D). 
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Based on curated data containing 122 annotated proteins, HNRNPM and NHP2-like 
protein 1 had the strongest link via manually-curated metabolic and signalling KEGG 
pathways (July 2014) for the spliceosome. While HNRNPM and NHP2-like protein 1 
are involved in alternative mRNA splicing, processing, and transcript regulatory 
processes, lamin A/C are key components of the nuclear lamina that regulate nuclear 
shape and apoptosis. NHP2-like protein 1 is a component of the spliceosome 
intermediate C Complex (Morimoto and Boerkoel 2013) that contributes in the 
maturation of mRNA splicing initiated by HNRNPM. The role of these upregulated 
proteins in this plethora of biological functions that involves majority of 
downregulated proteins (Table 4.7) will be discussed. 
4.3.2.3.2 Downregulated Proteins of Cattle Origin 
The downregulated proteins were mostly proteins that surrounded the worm based 
on high similarity with NF and SHP proteins (Table 4.6). They were proteins of the 
innate immune response (GO.0002376), specifically neutrophils, with capabilities to 
both positively and negatively regulate biological processes (Table 4.7). The main 
enriched protein families and domains were cathelicidins, Ras, serpins and annexins 
(Table 4.8) that play key roles in Fc gamma receptor-mediated phagocytosis 
(map04666), leucocyte migration (map04670), and chemokine signalling 
(map04062), amongst other functions that affect carbon and amino acid biosynthesis 
(Table 4.9). 
Two proteins, haemoglobin beta (D4QBB4_BOVIN/HBB) and cytochrome oxidase 
(Q3T061|COX7R_BOVIN), were the only proteins with significant DE from the within-
group statistics (Table 4.2, Analysis 1). Haemoglobin beta interacts with Haptoglobin 
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and haemoglobin sub-unit (Figure 4.4, C) which are haemolytic products of the 
inflammatory response (GO.0045087) and function in the transportation 
(GO.0006810) of oxygen needed for aerobic respiration, while cytochrome oxidase is 
the final enzyme in the mitochondrial respiratory chain. These findings may indicate 
that worms normally contain host blood in the gut, and antibiotic treatment 
interferes with ingestion of host fluids. 
4.3.2.3.3 Pfam and InterPro Protein Domains and Features of 
Bovine Proteins 
Table 4.8 summaries regulated protein domains and features with significant 
enrichment from amongst the DE proteins on the Pfam and InterPro databases 
(considered to be well-curated data). Cathelicidin (PF00666), serpin (PF00079), Ras 
family signal transducers (PF00071) and S-100/ICaBP type calcium binding domain 
(PF01023) were the protein families identified by Pfam. These proteins also had 
InterPro conserved signatures (IPR018216; IPR001751; IPR018252; IPR003006) and 
are involved in cell-mediated immunity (GO.0042742) and modification of the 
morphology of other organisms (Figure 4.6, GO.0035821), which refers mainly to 
antibacterial responses. Immunohistochemical evidence from  the current study 
(Chapter 3) revealed a significant reduction of neutrophils at 36 weeks after ADT 
therapy, suggesting that the cathelicidins were neutrophil proteins (Bah et al. 2015). 
However,  macrophages and epithelial cells can also be induced to produce 
cathelicidins (Di Nardo et al. 2003; Liu et al. 2006). CATHL-2, -5, -7 (CAMP) and 
neutrophilic granule protein (NGP) were the four cathelicidins with enrichments 
(Figure 4.7B). CATHL2 is a potent antimicrobial released during defence response that 
interferes with the respiratory chain and energy-dependent activities. The other 
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cathelicidins target both Gram-positive and negative bacteria, while also serving as 
chemotactic agents and contributing to wound healing (Zanetti 2004). 
Table 4.9: KEGG pathways of functional enrichment in antibiotic regulated proteins. 
 
Keys: ID, identity; obs, observed; GC, Gene count; FDR, False discovery rate. Analysed on 
String generated KEGG enrichements. *Associated chronic conditions. 
 
NGP is cathelicidin and cysteine-type endopeptidase inhibitor of angiogenesis and 
lymphoangiogenesis found in cytoplasmic vessicles as well as in the extracellular 
space, which  was co-expressed with CAMP, CATHL2, CATHL5 and CATHL4. CATHL4 is 
a very potent extracellular microbicide. There were several other uncharacterised 
bovine neutrophil proteins identified in the network (Figure 4.7, B). Neutrophil 
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elastase precursor (ELENA) was a primary node that interacted with most of the 
neutrophil proteins (Figure 4.7). Cathepsin D and AZU1 (uncharacterised 
chymotrypsin family protein from the azurophil granule lumen) are both serine-type 
endopeptidases that may be involved in neutrophil-mediated bacteria killing (Zimin 
et al. 2009). In addition, CD177 and PRTN3 (similar to myeloblastin) are neutrophil-
derived proteins involved in clot formation and neutrophil degranulation (Figure 4.7). 
Beta-defensin C7 (O18815) was another downregulated product that may originate 
from neutrophil degranulation and is an antibacterial protein which is active in the 
extracellular space (Selsted et al. 1993). It was 3.5-fold downregulated (p < 0.05) in 
the ADT group compared to the control group and is also a component of SHP 
(Armstrong, Hetzel and Makepeace, unpublished). Neutrophil cytosol (NADPH 
oxidase) factor-1, NCF-2 and cytochrome P450 are necessary for superoxidase 
production (Reeves et al. 2002). However, cytochrome P450 was upregulated, 
whereas NCF-1 was downregulated. 
RAS proteins regulate cell division and cytoskeletal transport of proteins into the 
nucleus, and RNA out of the nucleus. Thirty-three proteins linked with myosin and 
actin cytoskeleton reorganisation (Table 4.9; map04810) were downregulated. KEGG 
analysis indicated that RAS proteins also function in Fc-gamma-mediated 
phagocytosis (map04666) and in B-cell receptor signalling (map04662). 
Downregulated serine protease Inhibitors, annexins and proteins with S100 cacium 
binding domains are immunomodulators and regulators of apoptosis, reflecting  
suppression of the neutrophil population at 36 weeks from onset of oxytetracyline 
therapy.  
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4.4 Discussion 
Proteomics is a branch of high-throughput biology amenable to systems biology 
analysis (Weston and Hood 2004), and is used to predict functional processes within 
an organism (Souchelnytskyi 2005). Since the discovery of tetracycline antibiotics as 
efficacious macrofilaricides for filariae living in symbiosis with Wolbachia 
(Langworthy et al. 2000; Gilbert et al. 2005), the exact mechanism of adult worm 
death after depletion of these endobacteria is not known, beyond the understanding 
that neutrophils are depopulated as eosinophils degranulate on the worm’s surface 
(Hansen et al. 2011).  
Using proteomic analysis of female worms subjected to adulticidal oxytetracycline 
chemotherapy (ADT) with 60% efficacy at 52 weeks (Bah et al. 2015), we identified 
proteins from the worm, Wolbachia and cattle that are vital for worm survival. We 
also demonstrated for the first time that the ADT regimen reduced worm protein 
production in a similar way to Mf load and nodule diameter, until the point where 
worms were resolved by 52 weeks after treatment. Although tetracyclines interfere 
with bacterial protein synthesis by preventing amino-acyl tRNA from attaching to the 
30S ribosome (Tritton 1977; Chopra and Roberts 2001), the changes in proteins 
observed were due largely to the downregulation of proteins originating from cattle. 
In its intranodular lifestyle, female filarial parasites are highly entrapped in 
collagenous tissues, while the worm’s cuticle is coated with SHP deposits (Nfon et al. 
2006). The contribution of this attached bovine material to worm mass has never 
been evaluated for O. ochengi previously, but the results of this study tend to 
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illustrate that cattle proteins in close apposition to the worm could constitute more 
than two-thirds of total protein content. In a stage-specific proteomic analysis of O. 
ochengi (Armstrong et al. 2016), collagenase digestion of the nodule reduced bovine 
protein identifications from 70% to 30% implying that part of the bovine proteins 
might be ingested alongside host fluid during feeding and are within the worm. 
In the current study, more than half of the downregulated proteins were either 
proteins previosuly detected in SHP, NF or both. SHP is an eosinophilic-stained 
deposit and a probable product of neutrophil degranulation on the worm cuticle 
(Nfon et al. 2006). The NF proteins constitute an important source for the 
identification of excretory-secretory products that could serve as biomarkers for the 
diagnosis of onchocerciasis (Armstrong et al. 2016). Our observation is that 60% of 
regulated proteins present in NF were also detected in SHP, which suggests that many 
soluble proteins in the the nodular environment are also found in insoluble 
complexes. Moreover, neutrophil extracellular traps (NET) could be a major source 
of NF and SHP proteins. NET formation was recently reported in human 
onchocercomata (Tamarozzi et al. 2016). It is probable that NET formation also occurs 
in the cattle O. ochengi model. However, further studies will be needed to test this 
hypothesis. 
STRING analysis of the regulated cattle proteins found in solubilised female worms 
indicated that proteins of the immune system having significant functional 
enrichment in Fc-gamma mediated phargocytosis were all downregulated, but 25% 
of phagosome proteins were upregulated. The abundant phagocytic immune cell 
surrounding the female filarial worm in its intranodular niche is the neutrophil 
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(Hansen et al. 2011). The upregulation of phagosome proteins may reflect a change 
in neutrophil activity to digest material released by dying worms. At the onset of 
infection, at least three Wolbachia proteins (GroEL, PAL and WSP) attract and 
stimulate neutrophils to initiate protective inflammatory response in favour of the 
worm (Hansen et al. 2011). Moreover, WSP inhibits apoptosis in neutrophils 
(Bazzocchi et al. 2007). The downregulation of the most abundant Wolbachia 
proteins (Darby et al. 2012) by week 12 preceded those of some neutrophil proteins 
by week 36 after the start of adulticidal chemotherapeutic  treatment and worm 
death (Gilbert et al. 2005; Nfon et al. 2006; Hansen et al. 2011). Previous 
immunohistochemistry of ADT-treated onchocercoma reported complete depletion 
of the Wolbachia by eight weeks after treatment start (Gilbert et al. 2005). This failure 
to detect persisting bacteria was probably due to a drop in protein abundance to a 
level below the threshold for detection by the staining technique. Therefore, the 
complete depletion of Wolbachia was not essential to trigger neutrophil apoptosis 
and nor was a radical depopulation of neutrophils a precondition for worm death. 
The only Wolbachia protein for which the abundance was not significantly reduced 
by ADT was chaperone protein Dnak (I7JF32_9RICK). The role of this protein in 
Wolbachia’s ability to resist antibiotic therapy will have to be assessed in future trials 
before evaluating its chemotherapic potential as target for new drug development. 
The most downregulated Wolbachia protein was a member of a transmembrane 
protein family (I7IAG3_9RICK). It weighs 25.1 KDa and comprises 237 amino-acids 
encoded by the wOo_07860 gene (Consortium 2015). Transmembrane helices 
function as signal transducers and transporters of ions and other substances into the 
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cell by endocytosis (Yin et al. 2007). The other three downregulated Wolbachia 
proteins included those known to act as chemoattractants for neutrophils. In in-vitro 
studies on the effects of doxycycline on Wolbachia in a mosquito cell line using 
directional RNA-seq and label-free quantitative proteomics,  membrane proteins 
were also downregulated (Darby et al. 2014). 
Energy supply is one of the basis for mutualism between Wolbachia and its worm 
host (Voronin et al. 2016). Worm proteins involved in energy regulation such as 
transaldolase, transketolase, glycosyl hydrolases (Henrissat 1991; Song et al. 2013) 
and glucose-6-phosphate dehydrogenase were upregulated. They catalyse reversible 
reactions in the pentose-phosphate pathway (Voronin et al. 2016) and provide 
substrates for the tricarboxylic acid cycle (Lindqvist et al. 1992; Thorell et al. 2000). 
The endosymbiotic intracelluar α-proteobacteria lack key enzymes needed to convert 
glucose into pyruvate and therefore, depend on the host filarial parasite for energy 
(Melnikow et al. 2011; S.L. O'Neill et al. 2013). In Brugia malayi, two Wolbachia 
surface proteins wBm0432 and wBm0152 may interact with worm vacuoles to form 
functional complexes with enzymes of the glycolytic pathway and cytoskeletal 
proteins (S.L. O'Neill et al. 2013). Wolbachia also depends on the catabolism of amino 
acid from its worm host for energy (Foster et al. 2005; Darby et al. 2012). Dipeptidase 
C (aminopeptidase), the most downregulated worm protein after ADT, functions in 
the digestion of peptides and oligopeptides and provides amino acids for protein 
synthesis (Taylor 1993). It was first characterised in Drosophilia melanogaster and is 
essential for larval growth, development and locomotion (Hiraizumi et al. 1992; Howe 
et al. 2016). The gene encoding dipeptidase C has 189 orthologues, distributed across 
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53 nematodes and 20 platyhelminth parasites (Howe et al. 2016) and is an important 
target for evolutionary change in helminths. 
We were unable to analyse the PPI between species to determine whether the 
regulated worm proteins interacted with those of Wolbachia. However, two worm 
mitochondrial proteins (ubiquinone cytochrome C oxidoreductase and succinate 
dehydrogenase iron sulphur sub-unit) were among the downregulated worm 
proteins alongside a globin-like protein involved in oxygen transportation. A number 
of the regulated proteins including globin-like protein (nOo2.0.1.t11149) and 
galectin, a beta-galactoside binding protein have been previously described in NF 
(Armstrong et al. 2016). Several galectins are  produced in large quantities by all 
filarial lifecycle stages (Armstrong et al. 2014) and helminth parasites to serve as 
immune modulators (Dzik 2006; Brinchmann et al. 2018), and may disrupt the host’s 
coagulation pathway (González-Miguel et al. 2015). In nematodes, globin-like 
proteins have low affinity for CO and instantly dissociate to the ferric form in the 
presence of oxygen. Thus, they cannot reversibly bind to oxygen but may act as an 
oxygen sensor with anti-oxidant properties against reactive oxygen species (ROS) 
within the neurons of C. elegans, rather than as an oxygen transporter (Geuens et al. 
2010). Different forms of globins regulated by different genes coexist within 
nematodes (Vinogradov et al. 2006). The mechanism of transportation of oxygen in 
worms is poorly understood. Haem binds with globins to form a complex that 
transports oxygen from areas of high to low concentration. However, nematodes do 
not produce their own haem (Foster et al. 2005; Luck et al. 2016) but are capable of 
importing exogenous haem (Luck et al. 2016), which may be absorbed through the 
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cuticle alongside other nutrients and oxygen from cattle (Hoogewijs et al. 2004; 
Geuens et al. 2010). Previously, the supply of haem to the worm by the endosymbiont 
Wolbachia, particularly during reproduction and larval development in the vector 
when there is a high demand for energy, was thought to be the bases for worm-
bacteria mutualism (Wu et al. 2009). However, many filarial nematode species thrive 
without symbiosis with Wolbachia. The dependence on external haem for survival of 
filarial worms could be targeted to hasten worm death, particular during antibiotic 
chemotherapy (Luck et al. 2016). 
Some of the regulated proteins we identified were involved in biological processes 
that activate or prevent apoptosis within worms. They included ubiquinol 
cytochrome c oxidoreductases and succinate dehydrogenase. These are 
mitochondrial proteins (Matsuno-Yagi and Hatefi 1996) that regulate energy 
metabolism during oxidative phosphorylation and electron transfer (Rao et al. 2012). 
Cytochrome c is a haem-containing protein that blocks mitochondrial apoptosis-
induced channel (MAC) in a voltage-dependent manner and is released into the 
cytosol during apoptosis (Guo et al. 2004). This initiates the apoptosome or caspase-
activating complex to activate caspase 9, then caspases 7 and 3 (Green and Reed 
1998). However, the exact role of this downregulated ubiquinol cytochrome c 
oxidoreductase subunit in the mitochondrial respiratory process of filarial nematode 
is not known. Uncharacterised bovine proteins belonging to the glutaminase and 
cytochrome P450 3A4 families, which were also upregulated in our findings, are 
proteins involved in metabolism. They are associated with respiration in xenobiotic 
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pathways (R-BTA-211981) and may signify a host response to the antibiotic treatment 
or to toxic products released by dying worms (Szklarczyk et al. 2015). 
By association with NF (Armstrong et al. 2016), most of the upregulated worm 
proteins were excretory-secretory products with capabilities of regulating cell death. 
Cuticlin 1, an intra-uterine microfilaria (iuMf) protein of O. ochengi was first reported 
in Caenorhabditis elegans L1 to be essential for larval development (Sebastiano et al. 
1991). Together with other forms (CUT3 and CUT5), they contain a zona pellucida 
protein  domain of unknown exact molecular function (Sapio et al. 2005), but 
contribute to modelling worm shape at different stages of development. The 
upregulation of cuticulin and other collagen related proteins could be interpreted as 
an attempt by the worm to overcome external stress created by aggressive immune 
attack or internal stress resulting from the depletion of the endosymbiont Wolbachia. 
The upregulation of mitochondrial enzymes that regulate apoptosis included voltage-
dependent-anion-channel-2 (nOo.2.0.1.t06017), which controls movement of 
metabolites in and out of the mitochondria (Rostovtseva and Bezrukov 2015), and 
thioredoxin peroxidases (Zhang et al. 1997). In addition, peroxiredoxin 6, a 
component of SHP (Armstrong and Benjamin unpublished), acts as an antioxidant 
(Fisher 2010), while disorganised muscle protein 1 (a vaccine candidate for B. malayi) 
stimultes a proinflammatory reaction (Kushwaha et al. 2014). There are several 
mechanisms that can lead to the activation of apoptosis, including extrinsic, intrinsic 
caspase-dependent (physiologic), or pathological caspase-independent mechanisms 
(Galluzzi et al. 2012). 
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Protein OVOC2486 is a novel uncharacterised protein containing six ShK-toxin 
domains (McNulty et al. 2015; Armstrong et al. 2016), and belongs to a unique group 
of filarial ShK-domain proteins which were first described from L. sigmodontis. In light 
of functional assays of nematode-derived ShK peptides, it probably exerts 
immunomodulatory activity by blocking Kv1.3 potassium channels in effector-
memory T-cells (Chhabra et al. 2014). Most of the non-structural upregulated 
proteins were antioxidants, reflecting a worm response to reduce damage caused by 
ROS  (Armstrong et al. 2016). However, these compensatory mechanisms did not 
prevent worm death after protracted chemotherapy. 
Some organs of the filarial parasite may have been more affected than others by 
antibiotic therapy. Proteins of the cuticle and muscle tissues (cuticlin 1, gelsolin, 
laminin, cuticle collagen and muscle protein 1) were upregulated, while respiration-
associated proteins were downregulated. All of the worm regulated proteins had 
previously been identified in intra-uterine microfilariae (Armstrong et al. 2016) and 
were shared proteins suggesting that post-ADT reduction in worm microfilarial load 
(Bah et al. 2015) contributed significantly to the worm regulated proteins observed. 
This also implies that the effect of adult worm degeneration was not detectable at 
T36. Antibiotic chemotherapy first affects the female reproductive organs causing 
sterility before worm mortality (Bandi et al. 1999; Gilbert et al. 2005; Hoerauf et al. 
2008b; Supali et al. 2008; Landmann et al. 2011; Bah et al. 2014). The digestive system 
of O ochengi, which depends entirely on its bovine host for nutrition, is poorly 
developed (Buttner and Mac Donald 1985). There was no evidence of significant 
changes in digestive tract tissues. However, limited ingestion of fluid and blood does 
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occur during some stages of development of Litomosoides sigmodontis (Attout et al. 
2005), while most nutrients may be absorbed directly via the endocytic compartment 
of the cuticle and by simple diffusion (Luck et al. 2016). Therefore, those changes in 
proteins of bovine origin observed which were not associated with immune processes   
around the worm, might be attributed to a decrease in feed intake. The reduction in 
blood component (Figure 4.7) observed was dominated by products of haemolysis of 
red blood cells and had very strong PPI with proteins involved in immune-related 
biological processes. 
The main goal of searching for functional enrichments using only proteins that have 
significant FCs after antibiotic treatment was to highlight hidden biological processes 
that could facilitate the elucidation of mechanisms of worm death and thus potential 
new drug targets. We expected proteins from eosinophils to be upregulated and 
those from neutrophils to be downregulated (Hansen et al. 2011; Bah et al. 2015). 
The most upregulated protein was proteoglycan 3 (PRG3) precursor, an eosinophil 
major basic protein that regulates cytokine biosynthesis and activates neutrophil 
degranulation based on the Uniprot enzyme and pathway database (R-BTA-
6798695). The top BLASTp hit to this protein in humans is to AAD24471.1 (prepro-
major basic protein homolog) with 57% identity (Plager et al. 1999; Plager et al. 
2001). The expression of this protein is highly restricted to eosinophils and basophils 
in humans (Plager et al. 1999), but in this study, we speculate it may have originated 
from eosinophils, which were significantly increased as observed from 
immunohistochemistry of extracted onchocercomata (Bah et al. 2015). A previous 
study reported insignificant changes in nodule basophils after antibiotic 
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chemotherapy (Nfon et al. 2006). STRING analysis, however, did not find significant 
biological processes or PPI associated with PRG3 precursor. This may be due to the 
limited conditions under which the protein is expressed (Plager et al. 1999). STRING 
is a bioinformatic tool that provides information on protein families, genes and 
biological processes in partnership with other databases that specialise in describing 
biological events based on curated or experimental evidences (Szklarczyk et al. 2015). 
It is however necessary that future studies should apply immunohistochemistry using 
anti-PRG3 (or antibodies against all the upregulated cattle proteins of uncertain 
origin) to locate the cells expressing PRG3 and other uncharacterised, regulated 
proteins within the onchocercomata. Such study should also ascertain whether the 
upregulated neutrophil proteins (BOLA-DRB3, Bota, MRC1, NCF4 and TAP1) involved 
in the phagosome processes correlated with PRG3. Nonetheless, KEGG pathway 
analysis suggests that the underlying mechanisms resembled those involved in 
herpes simplex infection, tuberculosis, allograft rejection, graft-versus-host, 
autoimmune thyroid disease, or type I diabetes mellitus pathways. These are chronic 
conditions causing increased apoptosis of neutrophils. The upregulated phagosome-
related proteins (MRC1, TAP1, BOLA-DRB3, VIM and several other protein coded 
genes) regulate cell-mediated immunity. The common leucocytes involved in 
phagocyctosis are macrophages and neutrophils, and they are efficient in the control 
of bacterial and viral diseases, as well as in removing apoptotic cells or damaged 
tissue. Phagocytes can identify pathogens and then bind to engulf and inactivate 
them. Mannose receptor C type 1 protein (MRC1) recognises and binds to mannose, 
N-acetylglucosamine and fructose residues on the glycoproteins of pathogens. MRC1 
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also regulates the production of proteins that mediate endocytosis and neutralise 
engulfed pathogens within macrophages (Kim et al. 1992). The ABC transporting 
system (TAP1) found on the endoplasmic reticulum facilitates the transport of 
degraded cytosol-derived peptides generated by the proteasome. The TAP1 gene is 
co-expressed with Bota genes that encode the MHC class I receptors (Heise et al. 
2016), while the BOLA-DB3 gene encodes the production of beta chain MHC class II 
proteins involved in antigen processing and presentation (Oprzadek et al. 2015). The 
MHC class II protein is a versatile protein with variants that affect susceptibility to 
various infections (Ford et al. 2009). Neutrophil cytosol factor 4 is a potent 
superoxidase (phagocyte NADPH oxidase) which is active during the respiratory burst 
(Matute et al. 2009). 
Among the other upregulated bovine proteins, vimentin is an intermediate filament 
protein and component of the cytoskeleton that facilitates the maintenance of cell 
shape and cellular integrity (Yue et al. 2016). Both vimentin and S100 proteins are 
involved in the remodelling of neurofilaments and B-lymphocyte receptor signalling. 
Protein S100A4 is found as both a cytoplasmic and nuclear protein. It forms 
complexes with annexin A2 via double calcium binding to regulate several cellular 
processes during cell proliferation, migration and apoptosis (Mirsaeidi et al. 2016). 
One of the evidences of immune tolerance induced by filarial worm is the 
upregulation of tissue remodelling processes and associated proteins. 
Dihydropyrimidinase-related protein 3 (DPYSL3) is involved in cytoskeletal 
remodelling via interactions with class 3 semaphorins and plays a role in cell 
migration (Kanda et al. 2014). Its co-expression with fibrilin 1, an extracellular 
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glycoprotein that provides structural support within calcium-binding microfibrils in 
connective tissues is linked to a group of upregulated intranuclear and ribosomal 
proteins including lamin A/C; an inner nuclear envelope protein that mediates cell 
communication to promote cell growth by organisation of chromatins during cell 
division (Beck et al. 1990; Moriuchi et al. 2016). The co-expression with HNRNPM is 
justified by a weak experimental evidence (Lam et al. 2010). Cytoskeleton and 
intermediate filament proteins facilitate communication between the cytoplasm and 
outer membrane receptors via an uncharacterised ribosome-binding protein 
(LOC505941) situated on the outer membrane of the nucleus and endoplasmic 
reticulum. NHP2 like protein 1 is a component of the spliceosome intermediate C 
Complex (Morimoto and Boerkoel 2013) that contributes to the maturation of mRNA 
splicing initiated by HNRNPM.. 
Most regulated bovine proteins were observed to be downregulated in the current 
study. Cathepsin D (CTSD) is a protease that digests proteins within the highly-
acidified lysosome. As a NF and SHP protein found outside of the lysosome, cathepsin 
D may influence cell signalling processes that prevent apoptosis (Deiss et al. 1996; 
Benes et al. 2008)   The between-groups comparison of this study showed 
upregulation of CTSD precursor between SLT and CON, but time-course analysis 
showed significant downregulation between ADT at T0 and T36. CTSD precursor was 
co-expressed with upregulated vimentin and is an important constituent of SHP 
(Armstrong, Hetzel & Makepeace, unpublished). The depopulation of neutrophils and 
SHP (Gilbert et al. 2005; Nfon et al. 2006; Hansen et al. 2011) or NET (Tamarozzi et 
al. 2016) after antibiotic chemotherapy while eosinophils degranulate onto worm 
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cuticle are suggestive of a role in preventing the release of eosinophil 
chemoattractant essential for degranulation and worm killing. 
 
4.5 Conclusion 
The most depleted Wolbachia proteins were transmembrane proteins and PAL which 
have direct effect on neutrophil recruitment via TLRs. There were profound 
reductions in neutrophil-derived proteins such as cathelicidins, haptoglobin and 
defensin and proteins of bovine origin that depicted interruption of ingestion by 
worm. Downregulated worm proteins were excretory / secretory products, 
previously reported in NF and are known anti-inflammatory or immunoregulatory 
(galectin) and potential regulators of growth or apoptosis (amino dipeptidase). Most 
of the bovine proteins that adhered to worm surface were products of immune 
modulation associated with nodule fluid and SHP deposits with strong links to 
neutrophil degranulation. We predict that the ability of neutrophils to produce 
inflamatory cytokines suppressed in tolerance state was abrogated by upregulation 
of NGP after antibiotic therapy. An eosinophil major basic protein homologue was 
upregulated, thereby supporting the original hypothesis that worm death was due to 
depopulation of neutrophils while eosinophil degranulation increased. However, the 
complete depletion of both Wolbachia and neutrophils was not necessary to initiate 
the process of worm killing within the nodule. 
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Chapter 5 Transcriptomics of 
Oxytetracycline-treated O. ochengi within its 
Nodular Niche 
 
5.1 Introduction 
The transcriptomics of bovine onchocercomata (nodules) caused by O. ochengi, an 
intradermal parasite, was conducted for the first time. An onchocercoma is formed 
around an immobile, highly coiled and entangled female adult worm (Bwangamoi 
1969) encapsulated within fibro-collagenous connective tissues richly supplied with 
blood capillaries (George et al. 1985). Male worms are smaller, motile and migrate 
from one nodule to another and may not be present in all nodules. Some mature 
females may contain spermatozoa from males that have migrated out (Hildebrandt 
et al. 2014). An onchocercoma can be easily isolated from the dermis and for this and 
other reasons, O ochengi is considered to be the best research model for human 
onchocerciasis (Trees 1992). However, extraction of intact female worms for studies 
is a challenge to overcome. 
Although transcriptomics is perhaps best conducted on cells or tissue to facilitate 
interpretation of results, in this chapter, we processed entire nodules. The messenger 
RNA transcripts of any cell, tissue or an organism expressed at a given time is its 
transcriptome. The transcriptomics of onchocercomata will encompass 
transcriptomes of the worm, its endosymbiont (α-proteobacteria Wolbachia) and 
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bovine host tissues. WormBase ParaSite1 is a freely accessible website of parasitic 
helminth genomes (Howe et al. 2016) that contains high-quality resources for O. 
volvulus using data generated by the Wellcome Trust Sanger Institute (WTSI) and 
New York Blood Center (Cotton et al. 2016), and on O. ochengi generated by the 
University of Edinburgh2 and WTSI3. The Onchocerca parasites used for sequencing 
were obtained from Cameroon, where close to 9 million people are exposed to 
onchocerciasis (CAS 2012; Makepeace and Tanya 2016). The advent of post-genomic 
technology has rekindled the desire to identify biomarkers of filarial diseases and 
metabolic chokepoints that could enable drug repurposing and the monitoring of 
treatments (Luck et al. 2015; Armstrong et al. 2016; Bennuru et al. 2016). 
Transcriptomic studies generate huge quantities of data, but bioinformatic statistical 
tools are available to facilitate data processing and analyses to compare subjects 
under different treatments at the same time. Studies are ongoing to fine-tune the 
development of diagnostic tools that can differentiate infective larvae of Onchocerca 
spp. within the vector Simulium fly (Doyle et al. 2016) and identification of 
biomarkers for diagnosis of active disease or vaccine candidates with potential for 
disease control (Lustigman et al. 2017). 
Since prolonged treatment with antibiotics of the tetracycline family was first shown 
to be macrofilaricidal by targeting intracellular Wolbachia in cattle and human 
Onchocerca spp. (Langworthy et al. 2000; Hoerauf et al. 2008b) and a gold-standard 
                                                             
 
1 http://parasite.wormbase.org 
2 http://www.nematodes.org/genomes/onchocerca_ochengi/ 
3 https://parasite.wormbase.org/Onchocerca_ochengi_prjeb1204/Info/Index 
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macrofilaricidal antibiotic protocol established using cattle O. ochengi in the early 
2000s (Gilbert et al. 2005), the exact mechanism of worm killing is unknown. 
However, worm death is preceded by depletion of the endosymbiont Wolbachia, a 
reduction in the neutrophil population, and degranulation of eosinophils on the 
worm cuticle (Hansen et al. 2011). Hence, immunomodulation caused by the 
endobacteria has been proposed as the basis for symbiotic mutualism with the filarial 
parasite. 
The endosymbiont of Brugia malayi (wBm) belongs to Wolbachia supergroup D, while 
wOo of O. ochengi belongs to supergroup C. Earlier genomic studies seeking the basis 
for Wolbachia mutualism with its filarial host using B. malayi proposed nutritional 
dependency, since the worm cannot synthesize haem and riboflavin (Elodie Ghedin 
et al. 2007) while the endosymbiont genome encodes the necessary pathways for 
these cofactors (Foster et al. 2005). However, other nematodes lacking symbionts, 
including the filarial nematode Loa loa (Desjardins et al. 2013), thrive despite a similar 
inability to synthesise haem and riboflavin (Rao et al. 2005). Strain wOo cannot 
synthesise riboflavin as in B. malayi, but may generate energy in the form of ATP from 
purine biosynthesis to support the worm, particularly during embryogenesis (Darby 
et al. 2012). Recent transcriptome data from wBm suggests that this may be in the 
case for B. malayi too (Grote et al. 2017). In B. malayi, immunolocalisation studies 
revealed Wolbachia surface protein wBm00432 and wBm0152 in putative 
interactions with aldolase, enolase and other glycolytic processes to generate energy 
to the benefit of both the worm and bacteria (S.L. O'Neill et al. 2013; Voronin et al. 
2016). Proteomic analysis of wOo gene expression also confirmed the abundance of 
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Wolbachia immunogenic proteins that serve as ligands for mammalian TLRs (Darby 
et al. 2012) which is the basis for the immune mutualism, whereby the endosymbiont 
initiates pro-inflammation and attraction prolongation of neutrophils lifespan around 
worms, while Wolbachia continue to replicate within worms (Hansen et al. 2011). 
The current study reports for the first time the in vivo effects of oxytetracycline 
treatment on the nodule transcriptome using the O. ochengi research model for 
human O. volvulus. Previously, gene analysis of oxytetracycline-treated female B 
malayi filarial parasites in the jird laboratory model for human lymphatic filaria 
(Ghedin et al. 2009) revealed downregulation of worm genes involved in energy 
metabolism and cuticle biosynthesis, and upregulation of those involved in protein 
synthesis following depletion of Wolbachia proteins. A follow up in vivo study on 
doxycycline-treated B malayi (Rao et al. 2012) confirmed efficacy of the drug against 
Wolbachia by interference with ribosome function, and highlighted trends in the 
worm response to treatment which were dominated by upregulation of pathways 
involved in survival mechanisms, suggesting why treatment needs to be protracted 
for macrofilaricidal efficacy. Analysis of gene expression in an in-vitro study of 
doxycycline-treated Wolbachia in an arthropod cell line using directional RNA-seq 
and label-free quantitative proteomics revealed upregulation of phosphate ABC 
transporter ATPase (Darby et al. 2014), well-known for increasing resistance to 
microbicides. This provides a further explanation for the necessity for protracted 
antibiotic therapy to effectively deplete Wolbachia. 
The main objective of this chapter was to use transcriptomics to define the interplay 
between the worm, the bovine host and the Wolbachia symbiont over time and 
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during antibiotic chemotherapy to help determine the sequence of events that lead 
to worm death. The biological functions of the significantly expressed bovine genes 
may contribute to highlighting the environmental factors that precipitate worm 
death, as we expect bovine transcripts related to eosinophil activation to be 
upregulated and those associated with neutrophil proliferation to be downregulated. 
Changes within the worm will be analysed and linked with those observed in the 
endosymbiont Wolbachia. Meanwhile, the factors that enable the bacteria to 
tolerate treatment will be elucidated.  
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5.2 Materials and Methods 
 
The experimental site, management of cattle and ethical considerations were 
described in Chapter 3 under methodology section (3.2.1). The samples processed 
and analysed in this chapter were a subset of those obtained from the main study 
experimental design described in Chapter 3, Section 3.2.3.1. 
5.2.1 Experimental Animals and Design 
Nine cows, three each from the adulticidal therapy (ADT), sublethal therapy (SLT) and 
untreated control (CON) groups were randomly selected from the seven available per 
group (Table 5.1). The cows were aged 6.26 ± 0.46 years by dentition and weighed 
278.7 ± 6.9 kg on a weighing bridge (Marechalle™ PM 1000, France, ± 1 kg). Nodules 
collected at week 4 (T4), 8 (T8) and 52 (T52) post treatment were processed. 
Table 5.1: Experimental block for transcriptomic study (total N = 27). 
Treatment (number of cattle) Time T4 Time T8 Time T52 
ADT (n = 3) ADT_T4_227 ADT_T8_227 ADT_T52_227 
ADT_T4_231 ADT_T8_231 ADT_T52_231 
ADT_T4_238 ADT_T8_238 ADT_T52_238 
SLT (n = 3) SLT_T4_222 SLT_T8_222 SLT_T52_222 
SLT_T4_226 SLT_T8_226 SLT_T5_226 
SLT_T4_240 SLT_T8_240 SLT_T52_240 
CON (n = 3) 
 
CON_T4_217 CON_T8_217 CON_T52_217 
CON_T4_236 CON_T8_236 CON_T52_236 
CON_T4_239 CON_T8_239 CON_T52_239 
Sample size 9 9 9 
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5.2.2 Parasitology 
 Nodulectomy, Handling and Evaluation of Worms in 
the Laboratory 
See Chapter 3, section 3.2.5.1 and 3.2.6 
5.2.3 RNA Extraction and Sequencing 
Onchocercomata were carefully dissected from the dermis to remove all 
contaminating tissues, weighed, preserved in five volumes of RNAlater (Sigma), 
incubated at 4oC overnight, and frozen at -20oC for long term storage. 
Before RNA extraction, each nodule was homogenized at the IRAD Wakwa Veterinary 
Laboratory facilities. All operations were done at room temperature in a laminar flow 
cabinet using QIAGEN® RNeasy MIDI or MAXI kits, following the manufacturer’s 
procedures. Stored nodules in RNAlater were removed, soaked in 0.5 mL RTL lysis-
binding buffer solution in Petri dishes, and sliced into 1 - 2 mm3 pieces. The contents 
were transferred into 7-mL sterile cryogenic tubes for homogenization. Nodules 
weighing less than (or more than) 75 mg were homogenized at maximum speed for 
1 min in 2 (or 4) ml buffer RTL lysis-binding solution, respectively. Homogenization 
was performed to minimize foaming by reducing cycle time but increasing cycles of 
homogenization if required. To avoid cross-contamination of samples, the piston of 
the homogenizer was washed by running at maximum speed in 10% (v/v) Labtec 
detergent (Fisher Scientific), followed by rinsing in distilled water twice between each 
sample.  
Debris and fat present in the homogenates were spun out (5,000 x g for 10 min) and 
the supernatant transferred into a 10-mL conical centrifuge tube. An equal volume 
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of 70% molecular graded ethanol was added, mixed gently to precipitate nucleic acid, 
and filtered through an RNeasy spin column (4 mL of the homogenate a time) at 5,000 
x g for 5 min. Trapped nucleic acid on the silica-gel membrane was purified with wash 
buffer RW1, and DNA was digested with 160 μl DNase I incubation mixture (20 μl 
DNase I stock solution with 140 μl Buffer RDD), before washing again with buffer RW1 
and twice with buffer RPE as described in the QIAGEN® RNeasy MIDI or MAXI 
protocol. The remaining purified RNA was eluted from the spin column with RNase-
free water (100 μl for up to 75 mg and 150 μl for 76 - 150 mg tissues) twice into 
Qiagen-supplied RNase-free Eppendorf collection tubes. The RNase-free water was 
introduced directly on the membrane of the spin column and incubated for 1 min 
before centrifugation at 3,500 x g for 3 min. The eluted sample was split into two 
aliquots and immediately frozen at -80oC. The samples were transported to Liverpool 
on dry ice where they were stored at -80oC. 
RNA quantification was done at room temperature using RiboGreen® fluorimetry 
(Invitrogen, Paisley, UK), following the manufacturers’ protocol. Briefly, equal 
volumes of the standard rRNA or samples and RiboGreen® dye were mixed, 
incubated for 5 minutes in the dark, and ODs read at 520 nm on an Infinite™ 200 PRO 
multimode plate reader (Tecan, Männedorf, Switzerland). The integrity of the RNA to 
be submitted for sequencing was analysed using the Agilent RNA 6000 Nano reagent 
kit and the Agilent 2100 Bioanalyzer instrument (assay class Eukaryote Total RNA 
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Nano series II, version 2.5) as described by the manufacturer4. Only samples with at 
least 500 ng RNA in 26 μl with RIN scores >7.0 were sent to the Centre for Genomic 
Research (CGR) at the University of Liverpool for sequencing. 
The concentration of RNA in each sample prepared for batch sequencing was 
standardised at 5 ng/μl. Only 24 of expected 27 samples (Table 5.1) were processed 
as a run due to poor RNA yield and quality for the three ADT_T52 samples. Prior to 
sequencing, prokaryotic and eukaryotic ribosomal RNA in the samples was depleted 
using Ribo-Zero™ RNA removal kits following the manufacturer’s guidelines 
(Magnetic Gold Kit, Epidemiology; Illumina) and the RNA was purified by the ethanol 
precipitation method. RNASeq libraries were prepared using the strand-specific 
ScriptSeq™ v2 RNA-seq kit. The indexed libraries were paired-end sequenced by 
synthesis across seven lanes of Illumina HiSeq 2000 platform. Millions of mappable 
reads per lane were generated and the sequenced data subjected to QC, indexed, 
and saved as fastq files. 
5.2.4 Sequenced Data Analysis and Bioinformatics 
 
The sequence data were first directly mapped onto the Hereford (Bos taurus) 
reference cattle assembly5 and GFF files6. Reads that did not match the cow reference 
were filtered out using a NGSUtils / bamutils library and mapped onto the O. ochengi 
                                                             
 
4 http://rai.unam.mx/manuales/lbg_ARNGuideAgileny.pdf 
5 http://www.ncbi.nlm.nih.gov/assembly/GCF_000003055.6/FASTA 
6 ftp://ftp.ncbi.nih.gov/genomes/Bos_taurus/GFF/ 
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genome7, and finally, reads that mapped neither to cow nor O. ochengi were mapped 
to the Wolbachia symbiont of O. ochengi (wOo) genome8. Mapping was done using 
Bowtie2 because the Wolbachia genome does not have introns and there was no 
need for splice-aware mappers like TopHat. The read outputs were recorded as BAM 
files and queried along with the cattle GFF9, then the O. ochengi and the Wolbachia 
GFFs, treating all the reads as single-end. The number of reads falling within each 
transcript as annotated in the cattle, O. ochengi and Wolbachia GFFs (htseq-count 
parameter specification - --type transcript -i transcript_id -f bam) were counted using 
the htseq-count tool (Anders et al. 2015). The htseq-count produced a two-column 
text file for each dataset queried, the output files merged all the data files (104 in 
total), and the results were combined to produce a matrix-like representation in text 
form for each timepoint. 
The sequenced datasets were named (10-227_T8_140313_L006_R1.fastq.gz) to 
incorporate cow ear tag number (in 200s) and timepoint tags (T4, T8 or T52) in weeks 
post-treatment (Table 5.1). Each dataset was processed individually. At the end, the 
results from individual datasets were combined to produce a matrix-like text format 
with transcripts and their observed expressions across various animals. Three such 
text files (T4.txt, T8.txt and T52.txt) were produced, each representing observations 
                                                             
 
http://parasite.wormbase.org/Onchocerca_ochengi_prjeb1809/Info/Index, WBPS5 
8 ftp://ftp.ensemblgenomes.org/pub/bacteria/release-
30/gff3/bacteria_19_collection/wolbachia_endosymbiont_of_onchocerca_ochengi/Wolbachia_endo
symbiont_of_onchocerca_ochengi.GCA_000306885.1.30.gff3.gz 
9 ftp://ftp.ncbi.nih.gov/genomes/Bos_taurus/GFF/ 
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for a time point (Table 5.1). All the codes used, data, and results files obtained were 
stored locally on the CGR cluster. 
Differential expression (DE) analysis was carried out using the EdgeR package 
(Robinson et al. 2010) on bovine, O. ochengi and Wolbachia transcripts separately 
and pairwise comparisons between treatments and/or time points were conducted. 
Genes with low expression (cut-off value <5) were filtered out, the data normalized, 
and genes analysed for significant DE using the GLM approach with a fold change (FC) 
cut-off of ≥2 (equivalent to log2 FC ≥1) and a critical probability of p <0.01. Transcripts 
of bovine origin with significant DE were group searched on String DB against the 
bovine genome (Szklarczyk et al. 2015) for protein interactions and identification of 
significant biological processes.  
Genes with significant DE were subjected to Pfam enrichment (Pfam v. 30) analysis 
using the gathering threshold as a cut-off for functional enrichment as previously 
described (Armstrong et al. 2014). A hypergeometric test for enrichment of Pfam 
domains in the various sets of non-overlapping DE genes compared to the complete 
transcriptome was performed using R (phyper) (Falcon and Gentleman 2008), and 
corrected p values were obtained using the step-up false-discovery rate-controlling 
procedure (Benjamini and Hochberg 1995). Enrichment was considered statistically 
significant at p < 0.01.  
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5.3 Results 
 
5.3.1 Onchocercomata Transcript 
A total of 17,450 quantifiable gene transcripts were obtained from each of the 24 
onchocercomata. Three rejected samples from the ADT group at T52 had low 
extracted RNA concentrations and consequently failed QC for sequencing. Two-thirds 
(68%) of the gene transcripts obtained were from the worm, O. ochengi. Twenty-
eight percent were of bovine and 4% of Wolbachia origin. Table 5.2 summarizes the 
proportion of regulated (DE) gene transcripts counted with respect to source. After 
having removed duplicates from comparisons within fixed factors, between 
treatment groups, the number of transcripts expressed in both between treatment 
and time comparisons are reported. Note that substantial numbers of bovine (SLT) 
and worm (CON) transcripts were significantly regulated over time (Table 5.2). To 
ensure that only unique changes resulting from the antibiotic treatments were 
considered, a conservative approach was taken where overlaps in DE between 
longitudinal changes in the CON group and comparisons involving the SLT and ALT 
groups were identified and excluded from further analysis. 
5.3.2 Bovine Transcripts from Onchocercomata 
Bovine transcripts describe the worm’s environment, particularly immune cells 
trapped between the vascularised nodule capsule formed principally of extracellular 
matrix and the interface with the worm(s). Eighteen percent (890) of 4,872 bovine 
transcripts quantified showed significant DE. One hundred and forty-six of (16.4%) 
the DE bovine transcripts were unannotated. The SLT treatment group accounted for 
most of the regulated transcripts both at T8 and T52 (Figure 5.1, A, C). However, the 
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highest number of upregulated genes in the SLT group was seen at T8 (Table 5.2). 
Fifty-two percent of the DE bovine genes were affected by both treatment and over 
time. These statistics of the bovine response to antibiotic treatment signify the 
important role of the host response to parasite establishment. To determine which 
treatment was responsible for the changes, the identity of the DE transcripts by 
treatment was considered. 
Table 5.2: Summary statistics of quantifiable genes obtained from RNA Seq of bovine 
onchocercomata. 
 
*Total number of DE genes. Up↑ Upregulated GC; ↓ downregulated GC; N sample size. T; Time-
points X weeks after start of treatments; CON, untreated control; SLT, sub-lethal 
oxytetracycline therapy; ADT, adulticidal oxytetracycline therapy. 
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 Effect of Ineffective Chemotherapy (SLT) on Bovine 
Transcripts 
Of the 870 bovine DE transcripts (Table 5.2), 666 (76.5%) of them were results from 
the SLT treatment. The most regulated SLT transcripts with respect to the ADT group 
are presented (Table 5.3). String analysis as described in (section 5.2.4) revealed 
significant enrichment in four predicted protein domains: intermediate filament 
proteins (IPR001664), keratin type II (IPR003054), gamma-aminobutyric acid A 
receptor/glycine receptor alpha (IPR006028), and SEA domain (IPR000082). 
 
 
 
Figure 5.1: Overlap of DE bovine transcripts from treated onchocercomata with respect to T8 
vs. T52 changes in the control group (P < 0.01, log2 FC ≥1). CON, untreated control; SLT, 
sublethal oxytetracycline therapy; ADT, adulticidal oxytetracycline therapy; at weeks T8 and 
T52 after first treatment. Venn sets represents GC overlaps for SLT at T8 (A) and at T52 (C), 
or ADT at T8 (B). 
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Most of the transcripts encoded cellular components of membrane transporter 
protein complexes (GO: 1902495) and are most likely represent neuroactive ligand-
receptors (KEGG pathway: 04080) and extracellular ligand-gated ion channel activity 
(GO: 0005230) in immune cells. Enrichment in protein interactions were obtained 
only with the upregulated SLT bovine transcripts. 
 
Figure 5.2: Functional enrichments associated with worm and cow DE genes at P <0.01. 
Legend scale 0 (grey) = unchanged and 65 (red) = highest significant enrichment 
 
At T52, the vast majority of DE transcripts in the SLT group were upregulated (Table 
5.2), with significant enrichment in those coding for extracellular protein domains 
(SEA domain), intermediate filament proteins (keratin type II head) involved in post 
translational modification (Stewart 1990), and trypsin. Transcripts with the greatest 
FC were predicted multidrug resistance-associated protein 4 (LOC100294973) and 
protein 4-like (LOC100847574) (Table 5.3). They were downregulated at T8 from T4 
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and upregulated at T52 from T8. However, apolipoprotein F (APOF) and partial mRNA 
component of multidrug resistance-associated protein 4-like (LOC101902112) were 
initially upregulated at T8 before downregulation at T52. APOF is an inhibitor in the 
metabolism of plasma high density cholesterol of molecular weight 29 kDa (Day et al. 
1994; Lagor et al. 2012). Meanwhile, predicted multidrug resistance-associated 
proteins (PMRP) are members of ABC cassette transporter proteins associated with 
xenobiotic resistance (Keppler 2011). 
 
 
 Figure 5.3: Overlap of DE bovine transcripts from treated onchocercomata with respect to T4 
vs T8 changes in the control group (P <0.01, log2 FC ≥2). CON, untreated control; SLT, 
sublethal oxytetracycline therapy; ADT, adulticidal oxytetracycline therapy; at weeks T8 and 
T52 after first treatment. Venn sets represents GC overlaps for SLT at T4 (A) and at T8 (C), 
or ADT at T4 (B) and T8 (D). 
174 
 
 
Table 5.3: Most highly regulated bovine transcripts by SLT at T8 and T52. 
 
Value of Log2 fold change (FC) of DE transcripts at week four to (→) week eight (T8) or 52 
(T52) and from T8 to T52. NS not significant. 
 
Removing DE transcripts found in the untreated control over time from changes 
observed in the treatment groups (Figure 5.1), significant enrichment in glycoside 
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hydrolase family 22 (PF00062.18) at T8; and in trypsin (PF00089.24), keratin type II 
head (PF16208.3) and SEA (PF01390.18) protein domains at T52 (Figure 5.2) was 
apparent. The upregulation at T8 (an important turning point in worm recovery 
(Gilbert et al. 2005) of the glycoside hydrolases proteins may be an important indicator 
of the determinant role it plays in enhancing protective mechanisms for worm 
recovery and survival. While the trypsin, keratin and SEA proteins are evidence of 
establishment of normalcy in the intranodular milieu. 
Homeobox domain genes were amongst the upregulated transcripts in between-
group comparisons. They are known regulators of growth associated with repair of 
injuries, particularly angiogenesis in adults (Kachgal et al. 2012) and embryonic cell 
differentiation during early developmental processes (Sharma et al. 2013). 
Homeobox NKX2-6 (XM_003586411.1), fibroblast growth factor (FGF) 5 and NK2 
homeobox 6, were among the upregulated transcripts at T8, though not amongst the 
top most regulated, suggesting a probable reconstruction of damaged vessels from 
differentiating stem cells (Kachgal et al. 2012; Wang et al. 2015). Interleukin 1 family 
member 10 (theta), protein HP-25 homologs 1 and 2, serine peptidase inhibitor, Kazal 
types 1 and 4, and interferon omega-1 are probably neutrophil transcripts that were 
upregulated at T8. 
Early effects of antibiotics on bovine component of the nodule were discernible at T4 
by contrasting treatment against untreated control in pairwise comparison of SLT, 
ADT and CON (Figure 5.3). Although both antibiotic-treated groups had received the 
same dose of oxytetracycline at T4, the response to SLT and ADT was quite different 
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(Table 5.4). SLT upregulated immunoregulatory transcripts (chemokines C-X-C, 
leukotrienne) and tissue remodelling transcripts such as ASTL transcript variant 1, 
known to contribute in embryonic development (Acloque et al. 2012) as early as T4 
(Table 5.4). 
Proteins that regulate cell-mediated immunity such as leukotriene B4 receptor 2 
(LTB4R2) transcript variant X1 (Crooks and Stockley 1998), solute carrier family 5 
member 7 (SLC5A7), and multidrug resistance-associated protein 4 (LOC100294973) 
were amongst the most downregulated at T4 but upregulated at T8 or T52 (Table 
5.3). 
 Effect of Macrofilaricidal Chemotherapy (ADT) on 
Bovine Transcripts 
The effects reported here depend on observations recorded at T4 and T8, because 
T52 was excluded for sequencing. Results of the most regulated transcripts from 
longitudinal comparisons and between treatment and control are presented (Table 
5.5). At T8, only six transcripts were significantly upregulated and 11 downregulated 
in the longitudinal comparison (Table 5.2). However, only two transcripts were DE 
relative to the CON group at T8 amongst the 32 between-group significant changes 
(Table 5.5). The expression of voltage-dependent anion-selective channel protein 1 
(VDAC1) at T8, though the highest compared to T4 (Table 5.5), was not significantly 
different from that of the CON. VDAC1 is a mitochondrial outer membrane channel 
protein through which ATP is exported out of mitochondria (Choudhary et al. 2014). 
It regulates cell volume and apoptosis and is a biomarker for mitochondrial 
dysfunction (Palmeira et al. 2014). 
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Table 5.4: Treatment effects differences between the ADT and CON on bovine transcripts at 
week four (T4) 
 
NS, not significant difference; log2 FC, Log transformed fold change; → direction of FC  
 
Comparing transcript expression at T8 to those of CON, predicted multidrug 
resistance-associated proteins 4 (LOC100294973 and LOC100847574) expression was 
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significantly elevated in the ADT-treated nodules (Table 5.5) similar to that at T4 
(Table 5.4), implying that the response was already elevated at T4 and remained high 
through T8. Interestingly, in the SLT group it was downregulated. Multidrug 
resistance-associated protein 4 gene is either a protein coding gene or an intron 
(Zimin et al. 2009) belonging to sub-family C of ATP-binding cassette transporters. It 
is associated with resistance to antimicrobials (Keppler 2011; Dai et al. 2017). While 
histone H2B type 1-L (LOC523702) was upregulated at T8 by SLT (Table 5.3), histone 
H2A type 1 (LOC524236) was downregulated at T4 by both ADT and SLT (Table 5.4). 
These changes might reflect an increase in mitochondrial activity, energy 
metabolism, and oxytetracycline efflux from bovine cells, and mitochondrial stress 
caused by long-term tetracycline exposure. 
The most downregulated bovine transcripts by ADT treatment (Table 5.5) were 
membrane transporter proteins, signifying a reduction in the regulation of multiple 
cellular processes associated with drug metabolism (Fernández-Calotti et al. 2016), 
angiogenesis or tissue repair (FGF23), and the ability to regulate phosphate and 
vitamin D metabolism (Lanske and Razzaque 2014). Immune effectors such as T-cell 
receptor alpha chain V region HPB-MLT, ACTG2 and NKG2D ligand 4 or lymphocyte 
effector toxicity activation ligands were downregulated. NKG2D is one of the natural 
cytotoxicity receptors which allow natural killer cells to participate in the primary 
immune reaction to pathogens (Haik et al. 2016). Homeodomain transcripts were less 
expressed in the ADT than in the CON group. 
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Table 5.5: ADT regulated transcripts of bovine origin at 8 weeks after start of treatment 
 
NS = not significant; NA = not applicable; #N/A = Annotation note found; ADT T8/T4 FC at 
eight weeks from T4 within adulticidal therapy group. At T8 ADT/CON difference in transcript 
expression between ADT from the untreated control. 
 
The differences between the effects of SLT to those of ADT will enable a better 
identification of transcripts that depict resistance or recovery from treatment. 
Histone H2A type 1, gastrokine 1 and METTL6 were amongst the 14 most 
downregulated by ADT when compared to SLT (Table 5.4). Meanwhile, the level of 
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expression of multidrug resistance-associated protein 4-like, ATP-binding cassette 
transporter C4-like (LOC617079), leukotriene B4 receptor antimicrobial peptide NK-
lysin-like (LOC104968634), lysozyme C-2 (LYZ2) and C-X-C motif chemokine ligand 9 
(CXCL9) were higher than in the SLT group. CXCL9 is a ligand to CXCR3 of macrophages 
which together with IL-2 stimulates the activation of cytotoxic lymphocytes (Pan et 
al. 2006) and eosinophilic degranulation on worms (Turner et al. 2018; Zhang et al. 
2018). This could signify that there was activation of the monocyte-macrophage 
system to enhance the activity of cell-mediated immunity of the ADT, while 
regulators of tissue homeostasis and repair were upregulated by SLT. 
5.3.3 Onchocerca ochengi Transcripts 
The worm contributed the highest number of transcripts (11,938) from the 
onchocercoma (Table 5.2). Twenty percent (2,357) of the worm transcripts were 
significantly regulated and about 80% (1,721) were from the untreated control group 
(Table 5.2). Figure 5.4 illustrates that the relationship between longitudinally-
regulated GC of the untreated control to those of the different treatments. At T8, the 
SLT had the highest number of regulated transcripts in between-group comparisons 
(Figure 5.4), most of which were significantly regulated in CON at T52. At T8, the ADT 
worms had more than 500 upregulated genes in a pair-wise comparison with SLT, and 
this accounted for more than within-ADT group upregulated transcripts (Appendix 0; 
Table 5.2). 
Pfam analysis of the non-redundant O. ochengi transcripts revealed enrichments in 
homeobox domain and collagen helix gene families only at T8 (Table 5.2). Half of the 
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DE worm transcripts were uncharacterised, hypothetical, or novel proteins with no 
description. 
 Ineffective Chemotherapy (SLT): Effects on Worm 
Transcripts 
Cuticle collagen 6 or ROL-6 was upregulated at T8 (log FC = 6, p <0.01), while cullin-
1-like isoform 1 (log FC = 8, p <0.01) and collagen alpha-2 chain precursor (log FC = 8, 
p <0.01) were downregulated at T52. Others amongst the most downregulated genes 
at T52 (FC >8) were macrophage receptor MARCO (nOo.2.0.1.t11349-RA), antigen 
maltose binding protein (nOo.2.0.1.t13053-RA) and prolyl 4-hydroxylase 
(nOo.2.0.1.t12403-RA). 
Among twenty most-upregulated (FC > 6), worm transcripts both at T8 and T52, only 
four have a description: presenilin spe-4 (nOo.2.0.1.t13339-RA), zinc knuckle family 
protein (nOo.2.0.1.t13328-RA), glutamate dehydrogenase (nOo.2.0.1.t11374-RA) 
and receptor type guanylyl cyclase (nOo.2.0.1.t04747-RA). Heat shock protein 60 
(nOo.2.0.1.t09027-RA), DNA mismatch protein (nOo.2.0.1.t13793-RA), 
deoxyribonuclease TatD (nOo.2.0.1.t07516-RA) and a novel protein 
(nOo.2.0.1.t12987-RA) were upregulated at T52 but downregulated at T8. It is most 
likely that these genes make an important contribution to worm survival. 
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Figure 5.4: Overlap of DE O. ochengi transcripts from treated onchocercomata with respect to 
T8 Vs T52 changes in the control group (P < 0.01, irrespective of log2 FC≥2). CON, untreated 
control; SLT, sublethal oxytetracycline therapy; ADT, adulticidal oxytetracycline therapy; at 
weeks T8 and T52 after first treatment. Venn sets represent GC overlaps for SLT at T8 (A) 
and at T52 (C), or ADT at T8 (B). 
 
At T4, glutamate dehydrogenase, nematode cuticle collagen n-terminal domain 
containing protein (nOo.2.0.1.t04025-RA), three cuticlin 1 transcripts, homeobox-
domain containing protein (nOo.2.0.1.t02253-RA) and homeotic protein spalt-major 
(nOo.2.0.1.t10063-RA) were among the transcripts upregulated by SLT against CON. 
The most downregulated (FC>5) were uncharacterised genes alongside 
polyubiquitin-a-like isoform 1 (nOo.2.0.1.t12148-RA), a hypothetical protein similar 
to LOAG_09784 [Loa loa], major intrinsic protein (nOo.2.0.1.t08639-RA), circadian 
locomoter output cycles protein kaput-like (nOo.2.0.1.t05447-RA) and phosphatidate 
cytidylyltransferase (nOo.2.0.1.t07510-RA). 
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 Macrofilaricidal Effects (ADT) on Worm Transcripts 
Macrofilaricidal therapy upregulated 482 and downregulated 246 worm genes 
between T4 and T8, while 548 transcripts were upregulated when compared with SLT 
at T8 (Table 5.2). Amongst the 35 most upregulated genes at T8 in ADT (FC >6) were 
antigen maltose-binding protein (nOo.2.0.1.t12597-RA), collagen alpha-1 chain-like 
(nOo.2.0.1.t12681-RA), cre-tag-297 protein (nOo.2.0.1.t11709-RA), 
amidophosphoribosyl transferase (nOo.2.0.1.t13865-RA), nematode cuticle collagen 
n-terminal domain containing protein (nOo.2.0.1.t10208-RA), HSP 60, cuticlin 1, 
cytochrome c oxidase subunit I, and cell death specification proteins 1 
(nOo.2.0.1.t01803-RA) and 2 (nOo.2.0.1.t06269-RA). Cell death specification protein, 
(CES)-1 and CES-2 are regulators of programmed cell death in neurons (Wang et al. 
2006). Instead, cuticle collagen 6 (nOo.2.0.1.t12333-RA) and homeobox protein dlx-
1 (nOo.2.0.1.t04757-RA) were downregulated. Although antigen maltose-binding 
protein (nOo.2.0.1.t12597-RA) had the most significant within-group time effect at 
T8 and between-group comparison with CON at T4, it was not significantly different 
to the control at T8. This implies that there was a similar increase of the gene 
expression within the untreated control group over time. 
Between-group comparisons of ADT to SLT revealed tenfold upregulation of 
macrophage receptor MARCO (nOo.2.0.1.t11349-RA) and six other novel transcripts 
(nOo.2.0.1.t08607-RA, nOo.2.0.1.t10492-RA, nOo.2.0.1.t08121-RA, 
nOo.2.0.1.t13462-RA, nOo.2.0.1.t10494-RA and nOo.2.0.1.t11104-RA). Other highly 
upregulated transcripts at T8 were antigen maltose-binding protein, prolyl 4-
hydroxylase, cre-tag-297 protein, CES 2, nematode cuticle collagen n-terminal 
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domain containing protein and many other uncharacterised transcripts. These genes, 
except HSP 60, were downregulated by the SLT. 
5.3.4 Wolbachia Endosymbiont Transcripts from Bovine 
Onchocercomata 
Wolbachia had the least number of transcribed genes (640) quantified from bovine 
onchocercomata (Table 5.2), although this represents expression from 99% of the 
intact genes in the tiny wOo genome (Darby et al. 2012). Ninety-seven (15%) genes 
had significant DE, of which 29 were significant outcomes from both the between-
treatments and time comparative statistics (Table 5.2). The greatest number of 
regulated Wolbachia transcripts (Table 5.2), accounting for about 59 % of its 
regulated genes, were from the SLT group. List of upregulated Wolbachia transcripts 
is attached (Appendix 0). 
 Effects of Ineffective Antibiotic Chemotherapy (SLT) 
on Wolbachia  
The highest numbers of upregulated genes from SLT Wolbachia transcripts were 
between T4 and T52 (51), and the most regulated are presented (Table 5.6). The first 
significant process resulting from SLT was characterised by downregulation of 
transcripts associated with aerobic respiration at T8 (Figure 5.5B, Table 5.6), such as 
cytochrome c oxidase (cox11) and ferredoxin. Cox11 is a mitochondrial respiratory 
chain complex component (KEGG ko00190) required for copper binding. 
Downregulated pre-protein translocase, an internal membrane protein regulator and 
zinc-binding DnaK suppressor genes (Figure 5.5) are key evidence of the early 
response to antibiotic-induced stress geared at conservation of energy. At T4, only 
one hypothetical protein’s transcript (wOo_08690) was upregulated (Figure 5.5). 
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Table 5.6: Transcripts most regulated by SLT at T8 and T52 
 
Wolbachia gene transcript expressions upregulated (UP) or downregulated (DOWN) at weeks 
8 (T8) or 52 (T52). NS no significant expression. → indicates direction of change. 
 
Most of the Wolbachia DE transcripts at T52 were upregulated from values at both 
T8 and T4 as Wolbachia recovered from the antibiotic stress. At T8, rimM, a ribosomal 
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maturation protein, was upregulated but severely downregulated by ADT when 
compared to SLT. The highly regulated phosphatase may be involved in energy 
metabolism or detoxification, while rimM is an efficient processor of 16S rRNA 
(Bylund et al. 1998). 
 
Figure 5.5: Volcano plot of time and group effects on Wolbachia expressed transcripts from 
bovine onchocercomata. Plots show contrast of DE transcript in the form of log-transformed 
fold changes and p values between (A) Sub lethal therapy (SLT) and Adulticidal therapy (ADT) 
at 8 weeks, (B) SLT at T4 and T8, (C) ADT at T4 and T8, and (D) untreated control and SLT 
at T52. 
 
The response of Wolbachia to antibiotic treatments was assessed by comparing 
transcript numbers of the two treatment groups (Appendix 0). At T4, the earliest 
effect of ADT was the highly upregulated transcripts from response regulators and 
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secretion systems (pleD and secY) observed between ADT and SLT (Table 5.7). At T8, 
in addition to rimM, 30S ribosomal protein S10, folA and stress induced morphogen 
(BolA) gene were significantly less expressed in the ADT, while permease and 
transketolase showed greater expression than in the SLT-treated Wolbachia (Figure 
5.5A). Although most transcripts of the SLT-treated Wolbachia were longitudinally 
upregulated at T52, they were still significantly inferior to the level of the untreated 
controls (Figure 5.5D). Hence, the Wolbachia had not fully recovered from treatment 
at T52. 
Table 5.7: Macrofilaricidal effects on Wolbachia O. ochengi transcripts 
 
↑ Also upregulated by SLT; ↓ downregulated by SLT at T52; DOWN or UP regulated: by ADT 
NS = not significant differences 
 
 Effects of ADT Treatment on Wolbachia Transcripts 
All DE transcripts after macrofilaricidal therapy observed at T4 and T8 are reported 
in Table 5.7. The most upregulated Wolbachia gene by ADT at T8, PleD (Figure 5.5, C), 
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was upregulated earlier at T4 in the ADT/CON (Table 5.7) or ADT/SLT (FC = 8, P = 0.003) 
comparisons. PleD is a cell cycle response regulator (Ontology: K02488) that initiates 
motility and cell density before cell division while under stress, could mutate to cause 
pleiotrophic polar defects during cell differentiation (Aldridge et al. 2003). The 
upregulation of pleD was accompanied by an increased regulation of ribosome 
biogenesis and protein translocation (SecY) and export across membranes (Ko03060).  
Only three Wolbachia transcripts were downregulated by ADT (Table 5.7), although 
transcripts regulating glutamine amidotransferase domain containing protein and 
ankyrin repeat containing protein domains were not significantly different from 
expression in the CON. However, VirB4 (wOo_02790), a type IV secretion system 
protein (K03199), was the only transcript that was downregulated by ADT when 
compared to the CON (log FC = 2, P < 0.01). 
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5.4 Discussion 
 
RNA-Seq of O. ochengi onchocercomata, the closest biological relative of O volvulus 
and arguably its best research system (Trees 1992), was used to evaluate changes in 
gene expression between the treated and untreated nodules for the first time. Prior 
to this study, we evaluated female worm proteomics under similar treatments 
(Chapter 4, results 4.3). Unlike with female worm proteomics, two-thirds of the 
quantified transcripts obtained from nodules were derived from the filarial parasite 
and the majority of those exhibiting significant changes were uncharacterized. As the 
nodule is characterised by an adult female worm circumscribed within collagenous 
tissues (Bwangamoi 1969; Hildebrandt et al. 2014), and Mf released in their hundreds 
every day, it was expected to express more worm transcripts than cattle-derived 
transcripts. The high expression of worm transcripts is an indication that the worm 
orchestrates control of its nodule environment. Post-genomic technology has been 
of great service to generate knowledge on the biology of filarial nematodes, leading 
to the identification of novel vaccine candidates, drug targets and biomarkers for 
diagnosis of O. volvulus in humans (Lustigman et al. 2017; Stoltzfus et al. 2017). 
However, a lot still needs to be done to characterize and identify the functions of 
these expressed worm genes and use this technology to elucidate the mechanism of 
action of drugs that are macrofilaricidal. 
The first evidence of the efficacy of ADT in killing adult worms in this study was the 
low level of RNA quantified from ADT treated nodules at T52. The bovine tissue 
collected at the site of resorbed nodules were mostly fibrous connective tissue and 
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could not have been homogenized easily by the technique employed, as it did not 
include a pre-digestion step. However, we expected some level of scavenger immune 
cells to be present if the time of worm death was close to T52. This was not the case, 
implying that the worms died shortly after 36 weeks post-treatment and 
macrophages might have had enough time to phagocytose debris, leading to only a 
remnant of acellular scar tissue at the original nodule location. Eosinophil 
degranulation onto the worm’s cuticle precedes worm death (Hansen et al. 2011), 
but the mechanism of worm killing caused by eosinophils has not been clearly 
elucidated. Population dynamic studies of immune cells that surround the worm after 
treatment did not illustrate significant increases in macrophages around the dying 
worm at any time points, in contrast to the major changes in neutrophil and 
eosinophil numbers (Nfon et al. 2006). Nevertheless, qualitative changes in 
alternatively-activated macrophage activity play a key role in the recruitment of 
helminthotoxic (CCR3-dependent) eosinophils in the B. malayi murine model (Turner 
et al. 2018). The first immune cells to be recruited at the site of infection are 
neutrophils (Delves et al. 2011). Neutrophils stimulated by WSP attract more 
neutrophils to be recruited to the site with little effect on worm viability. The 
withdrawal of WSP and the endosymbiotic bacteria may deprive worms of immune 
defence modulation and essential energy in the form of ATP, which is needed 
particularly during the reproductive phase of the worm (Darby et al. 2012). Perhaps 
to compensate for energy deficiency following depletion of Wolbachia, the filarial 
ATP synthase beta-subunit transcript was one of the most upregulated transcripts in 
the ADT group at T8. 
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Lack of reference transcriptomes of bovine eosinophils and neutrophils made the 
evaluation of the type of immune cells involved in worm death impossible without 
making assumptions. Histological studies have unequivocally shown that the 
depopulation of neutrophils around antibiotic-treated worms is preceded by 
sustained depletion of the endosymbiont Wolbachia from all tissues and that the 
presence of Wolbachia could not be detected by immunohistochemistry at T8 
(Gilbert et al. 2005; Nfon et al. 2006). However, by RNA-Seq we observed that 
Wolbachia were not completely depleted at T8, and most of the Wolbachia 
transcripts were not downregulated, contrary to what would be expected from PCR 
analysis of doxycycline-treated human samples (Hoerauf et al. 2008b). All 640 
Wolbachia transcripts were detected in the ADT treated nodules at T8, but very few 
of them had significant DE. The most upregulated transcript at T8 (PleD) is a response 
regulator (a member of two-component signal transducer system) that is known to 
regulate intracellular replication in relatives of Wolbachia such as Ehrlichia 
chaffeensis (Kumagai et al. 2011). PleD was also upregulated in the untreated control 
group at T52, perhaps due to ageing and natural death of one nodule in the cow ear-
tagged 239. Stress-induced morphogen bolA gene, upregulated by SLT and 
downregulated by ADT regulates metabolic activities associated with resistance to 
antibiotic stress as simulated on the MetaCyc data modelling for metabolism and 
enzyme activity (Caspi et al. 2016). The role of the bolA transcript after SLT therapy 
may bring to light an important role in the cattle O. ochengi filarial model during 
validation trials of new or repurposed anti-Wolbachia drugs. 
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Primary components of protein translocation channels were upregulated. They are 
important exporters of unfolded proteins across membranes (KO03060). SecY and 
SecE are upstream to SecB and complexed with SecA to improve the efficiency of 
peripheral membrane ATPase (Flower 2007). Further complexing with SecD, SecF and 
YajC improve ATP binding (Flower 2007; Lycklama et al. 2013). SecY interacts with 
SecE to form the central channel of the preprotein translocase complex (Lycklama et 
al. 2013), thereby facilitating the release of transported proteins across membranes. 
However, during previous in vitro experiments of Wolbachia under doxycycline-
induced stress, a different protein secretion system from the twin-arginine 
translocase was upregulated (Darby et al. 2014). The ribosome-binding factor A, an 
essential component for ribosome biogenesis, was probably upregulated in response 
to downregulation of the 30S ribosomal subunit. 
Tetracyclines interact with ribosomes (Tritton 1977), interfering with their ability to 
coordinate protein synthesis (Chopra and Roberts 2001). Both ribosome maturation 
protein M (RimM) and 30S ribosomal protein transcripts were downregulated by ADT 
at T8 and T4 but following withdrawal of antibiotic effects in the SLT group, 
transcription of RimM and 30S ribosomal proteins increased to a peak at T52. RimM 
facilitates the maturation of the 30S ribosomal subunit of rRNA by increasing the 
efficiency of processing 16S rRNA to bind to ribosomal protein S19 (Bylund et al. 
1998; Suzuki et al. 2007). The 30S ribosomal subunit ensures the efficiency of protein 
synthesis by coordinating the proper and accurate alignment of mRNA and tRNA for 
efficient genetic translation (Carter et al. 2000). 
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Previous analysis of Wolbachia gene expression to determine the symbiotic 
relationship with the host O. ochengi suggested that the endosymbiont supplies 
energy to and enhances immune protection of the worm (Darby et al. 2012). Both 
adulticidal and sublethal oxytetracycline therapy upregulated worm HSP60, which is 
often expressed under stressful conditions to illicit immune responses against 
diseases by acting as danger signal (Grundtman et al. 2011). Assuming that processes 
in O. ochengi and C .elegans are similar, cell death in neurons was initiated by the 
upregulation of CES-1 and CES-2 (Ellis and Horvitz 1991; Wang et al. 2006). These CES 
transcripts were downregulated in the untreated control and SLT groups from T4. 
However, the trigger for generalized cell death is controlled by the CED-3 and CED-4 
genes (Wang et al. 2006), which as at T8 in the ADT group were not expressed. Thus, 
although the precise links between the various transcripts are unclear, worm death 
seemed to be associated with targeted cell death in neurons alongside upregulation 
of the stress protein HSP 60 and the innate immune receptor MARCO. This receptor 
is a class A scavenger molecule expressed on macrophages (Kraal et al. 2000), but is 
also conserved in C. elegans. It enhances carbon nanotube uptake (Hirano et al. 2012) 
and phagocytic cell mediated immunity (Zhang et al. 2018). Its upregulation within 
worms at T8 by macrofilaricidal therapy relative to ineffective therapy was 
accompanied by uncharacterised transcripts, antigen maltose binding protein, prolyl 
4-hydroxylase, and cre-tag-297 protein. It would be exciting to find out the role of 
these immune responses within the worm and whether they are also involved in 
regulating Wolbachia density under normal conditions. 
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The highest number of regulated worm gene transcripts were from the untreated 
control worms with significant enrichments in homeobox domain and collagen helix 
protein coding genes which play important roles in tissue repair, routine maintenance 
of growth and reproductive development (Kachgal et al. 2012). This was to be 
expected during a year-long experiment, as there is seasonal variation in the 
reproductive pattern of filarial parasites (Achukwi et al. 2000) which would have led 
to significant changes in the CON transcription. However, treatment specifically 
regulated worm cuticle transcripts such as cuticle collagens, prolyl 4-hydroxylases 
and a number of others from both by the SLT and ADT groups, which serves as indirect 
evidence of eosinophil degranulation on the worm as previously suggested (Hansen 
et al. 2011). There was sustained transcription of extracellular matrix protein and 
DNA repair genes; i.e., associated with HAPLN1 involvement in cartilage repair 
(Franzén et al. 1981; Hering et al. 1995) and histone H2A type 1 gene in DNA repair10. 
The SLT accounted for the largest transcription changes from the bovine host, which 
provides fibro-collagenous tissue that encapsulates and entangles the female worm 
(Bwangamoi 1969), blood vessels and access to nutrition needed for energy, growth 
and respiration by the worm (George et al. 1985; Smith et al. 1988), and neutrophils 
that infiltrate into the capsular space and may be responsible for the worm’s 
longevity (Gilbert et al. 2005; Nfon et al. 2006; Hansen et al. 2011). These huge 
                                                             
 
10 http://www.uniprot.org/uniprot/P0C0S9 
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changes in bovine transcripts both from the SLT and ADT treatments, buttress the 
fact that the worm’s environment plays an important role in its survival. 
Changes in immune responses associated with glycoside hydrolase family 22 proteins 
were significant at T8. Downregulation of leukotriene B4 receptor 2 (LTB4R2) 
transcript variant X1 found on B-lymphocytes may depict inhibition of 
proinflammation and reduction of recruitment of monocytes, neutrophils and 
eosinophils (Crooks and Stockley 1998). Solute carrier family 5 member 7 is a 
macrophage protein (SLC5A7). Another common inhibitor of cytotoxicity by immune 
cells is the increased production of ligands that blocks cytotoxic receptor sites on 
macrophages and NK cells. Transcripts for NKG2D ligand 4 were upregulated while 
histone H2A type 1 and joining chain of multimeric IgA and IgM were downregulated 
by SLT at T8. Damaged or infected cells usually express non-self-proteins that are 
identified as danger signals (Delves et al. 2011). These antigenic proteins constitute 
ligands that are identified by scavenger immune cells and NK with NKG2D receptors. 
Natural cytotoxicity receptors (NCR) are found on NK cells, macrophages, and 
lymphocytes and when activated initiate the primary immune reaction to pathogens 
(Haik et al. 2016). The upregulation of NKG2D ligand 4 transcripts is key evidence of 
circulation of immunomodulatory molecules that block NCRs and probably promote 
immunomodulation against worms exposed to SLT. However, NKG2D ligand 4 
transcription was downregulated by ADT, thereby perhaps enabling NK and other 
mononuclear immune cells to elicit proinflammatory processes. Soluble ligands 
generated under heat stress conditions such as burns, often block NKG2D receptor 
sites, preventing cytotoxic activation by immune cells and diminishing the ability of 
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these immune cells to control new infections (Haik et al. 2016). This mechanism is 
currently being exploited and the NKG2D receptors are a therapeutic target in the 
control of cancer (Spear et al. 2013). Interestingly, NK cells have been shown to secrete 
IL-4 and IL-5, as well as upregulate expression of natural cytotoxicity receptors, when 
exposed to live B. malayi Mf. 
Transcriptional differences were observed between ADT and SLT at T4, even though 
they had received the same dose of oxytetracycline treatment by that point. Several 
groups of transcripts were upregulated from Wolbachia, the worm and the bovine 
host in the ADT group relative to the SLT group. Evaluation of worm fecundity and Mf 
load at T0 (pre-treatment) indicated that ADT treated animals were more fertile and 
produced higher Mf loads. If Wolbachia is the power house of the worm as we earlier 
hypothesized (Darby et al. 2012), then it is likely that worms treated at peak 
reproduction would respond differently to antibiotic treatment than others. With an 
additional intramuscular dose of oxytetracycline at T4, the main effect of ADT was 
visible with the upregulation of bovine VDAC1, a mitochondrial outer membrane 
channel protein through which ATP is exported out of mitochondria (Choudhary et 
al. 2014). In the eukaryotic cell outer membrane, it also regulates cell volume. VDAC1 
is involved in the apoptosis pathway and is often considered as a biomarker for 
mitochondrial dysfunction (Palmeira et al. 2014). Multidrug resistance-associated 
proteins 4 (Zimin et al. 2009), which are ATP-binding cassette transporters proteins (Dai 
et al. 2017), were significantly highly expressed in the ADT-treated nodules, alongside 
histone H2A type 1 and ATP synthase -subunit. These changes could reflect a direct 
effect of the antibiotic on worm mitochondrial translation (Moullan et al. 2015) or 
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the worm’s compensatory mechanisms for the energy gap created by Wolbachia 
depletion during antibiotic therapy (Darby et al. 2014). 
 
5.5 Conclusions 
 
Adult filarial worms were killed before week 52 after treatment. Nodule remnants at 
T52 processed for RNA extraction lacked enough mRNA for sequencing. It can be 
concluded that changes observed from samples at weeks four and eight of this study 
were early indicators of worm death. Hence, upregulation of transcripts that regulate 
apoptosis such as cell death specification protein 2 and ATP synthase beta subunit 
amongst others, reflected changes that either contributed to worm death or were 
failed attempts to mitigate the ADT regimen. Wolbachia was not killed by the ADT 
dose at T8, but upregulated genes involved in stress responses and energy 
metabolism. In the SLT group, Wolbachia and its worm host may have survived due 
to upregulation of symbiont energy metabolism during weeks four through eight, 
although by the end of the experiment, Wolbachia energy metabolism was severely 
downregulated in this group. Bovine transcripts regulated in the SLT favoured tissue 
homeostasis and angiogenesis. There is a need for further studies to be conducted 
on ADT nodules to include time-points closer to the time of worm death after the last 
treatment at T36.  
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Chapter 6 General Discussion, Conclusions, 
and Recommendations 
 
6.1 General Discussion 
The search for macrofilaricidal drugs is a major contribution in achieving the 
objectives of global eradication of onchocerciasis, given the imminent risk of 
resistance to IVM (Osei-Atweneboana et al. 2011; Nana-Djeunga et al. 2014; Doyle et 
al. 2017). This study evaluated the immunochemotherapeutic efficacy of mutated 
onchocystatin (Chapter 3, section 3.2.5), an immunogenic protein found on the adult 
worm’s cuticle and secreted by all its developmental stages except mature Mf 
(Lustigman et al. 1991). We then attempted to identify the mechanisms that lead to 
eosinophil degranulation onto the worm cuticle using the O. ochengi research model 
for the first time. We tested the possibility of shortening the duration of antibiotic 
therapy by prior vaccination of infected cattle. In natural infection, some aged 
infections tend to be self-limiting, while other exposed persons or animals resist 
infection and are considered as putative immunes, PIs (Ward et al. 1988; Boyer et al. 
1991; Elson et al. 1995). The serum of PIs contain cytophilic antibodies (IgG3) that 
targeted onchocystatin (Chapter 1, Section 1.2.1) and so we hypothesized that 
immunotherapy would strengthen Th2-mediated effector mechanisms, principally 
eosinophils, against the adult worms (Hansen et al. 2011). Unfortunately, our results 
(Chapter 3, Section 3.3.3) rejected this hypothesis. The main parameter used in 
evaluating worm death was motility of adult worms (score of zero = death) and 
resolution of nodules containing dying worms (Langworthy et al. 2000; Bronsvoort et 
al. 2005). There is a small risk that the method used might have included false 
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negatives (i.e., “terminally ill” worms that would have died shortly after the 
experiment terminated), as there is not yet a mechanism for evaluating dying adult 
worms with certainty. In the gold standard ADT protocol, worm death is confirmed 
by the resorption of nodules or the presence of degenerated, fragmented and 
calcifying worm tissues with more than a 60% reduction in worm viability (Gilbert et 
al. 2005). The calculation of worm viability factored natural changes using the 
untreated control. We assumed at the start of the experiment that no cattle recruited 
for the experiment purchased from the market within four weeks from the start of 
the study had been prior treated with oxytetracycline. However, after trypanocides 
and penicillin-based antibiotics, oxytetracycline is the third most used self-
medication by cattle farmers in the Adamawa Region of Cameroon (personal 
observation). Thus, some effects on worm viability before the experiment began are 
difficult to exclude. 
In humans treated with doxycycline for four or six weeks, significant macrofilaricidal 
effects were observed only at 20 - 27 months after treatment (Hoerauf et al. 2008b). 
However, evidence of infertility (female worm sterilisation) appeared at 6 months 
post-treatment. Previous studies might have erred in making conclusions from 
observations collected within 18 months of sampling; that is, macrofilaricidal activity 
was not initially confirmed (Hoerauf et al. 2003; Supali et al. 2008). In this 
immunochemotherapy trial, there were no obvious indicators that extending the 
period of observation would have altered the results reported.  Notwithstanding, 
both vaccinations alone or in combination (immunochemotherapy) elicited a 
significant systemic immune response against onchocystatin and local eosinophil 
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recruitment into the nodules, with the immunochemotherapeutic group displaying 
the highest median eosinophil count at T12. This finding validated the quality of the 
antigen used (Chapter 3, Section 3.2.5) in this vaccination trial and suggests that other 
immunomodulatory mechanisms exist to compensate for the targeting of one 
pathway.  
To further filarial vaccine research, it is vital to identify the best vaccine targets 
capable of preventing infection or those that can cure and prevent reinfection. The 
focus has been on worm secretary/excretory products or surface antigens, with lead 
vaccine candidates being Ov-103 and Ov-RAL-2, which are expressed in all lifecycle 
stages (Hess et al. 2014; Hotez et al. 2015; Hess et al. 2016; Lustigman et al. 2018). 
But the establishment of infection and worm survival, reproduction and viability 
depends on Wolbachia surface proteins both within, and as effectors outside 
(Melnikow et al. 2011; Armstrong et al. 2014), the worm that activate pro-
inflammatory immune responses via interactions with TLR-2/4 (Brattig et al. 2004; 
Gillette-Ferguson et al. 2007), which may protect the worm and inhibit apoptosis of 
neutrophils (Bazzocchi et al. 2007). The interaction of Wolbachia PAL with TLR 2/6 
induces Th1 immune responses against Mf and causes skin and ocular 
immunopathogenesis (Turner et al. 2009; Tamarozzi et al. 2011). 
Recently it was also shown that Wolbachia muramyl dipeptide interacts with NOD2 
receptors of keratinocytes to induce pro-inflammatory neutrophil responses that 
limits the establishment of infective larvae within the skin (Ajendra et al. 2016). 
Although Wolbachia has no organised cell wall, it can synthesises muramyl dipeptide, 
a peptidoglycan component of purported bacterial cell wall that binds intra-
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cytoplasmic NLR protein NOD2 (Grimes et al. 2012) found in keratinocytes, 
neutrophils, APC, monocytes and macrophages. The role of the NOD2 receptor 
protein in the immune regulation of filarial disease has been investigated only in the 
L. sigmondontes murine model of human lymphatic filarial using neutropenic mice 
(Pionnier et al. 2016) and NOD2-depleted mice (Ajendra et al. 2016). The activation 
of NOD2 receptors triggers NFkB-induced upregulation of pro-inflammatory genes, 
neutrophil infiltration and activation via protein kinase RIP2 (Hasegawa et al. 2008) 
and transforming growth factor-activated kinase 1 (TAK1) signalling pathways in 
epidermal cells (Kim et al. 2008). The trigger of NFkB via TAK1 signalling plays a 
homeostatic role in the regulation of apoptosis (Pionnier et al. 2016). This mechanism 
could be exploited in future research to enhance efficacy of vaccine trials in a manner 
yet to be determined. Although the efficacy of a vaccine against a Wolbachia antigen 
could be limited by the primary intracellular location of the symbionts, early removal 
of Wolbachia excretory/secretory products might inhibit the establishment of 
infective larvae and expose filariae to enhanced Th2-mediated effector mechanisms. 
Following a previous attempt to vaccinate against WSP in the L. sigmodontis model, 
which led to increased worm burdens if the vaccine was delivered in Freund’s 
adjuvant, but not alum (Lamb et al. 2008), it is clear that such an approach would 
need to carefully optimise the direction of the immune response in the early phase 
after vaccination. Since Wolbachia also has a key role in facilitating the migration of 
infective larvae via TLR2-mediated stimulation of histamine release from mast cells, 
promoting vascular permeability (Specht et al. 2011), the potential benefits of 
targeting Wolbachia in a prophylactic strategy should be a focus of future research. 
202 
 
 
Full validation of the transcriptomic and proteomic results reported herein would be 
very challenging. Even for the bovine host, relatively few antibodies that could be 
used in immunohistochemistry to identify the cellular sources of immune mediators 
and effectors are commercially available. The production of custom antibodies can 
be time-consuming and expensive, and many antibodies fail to recognise their targets 
in fixed tissue sections. In-situ hybridization to localise mRNA transcripts with specific 
nucleic acid probes might be a more practicable approach, but would leave open the 
question of how to link mRNA and protein expression throughout the nodule and 
would not be able address changes in preformed or secreted proteins, such as 
neutrophil and eosinophil granule proteins (Cowland Jack and Borregaard 1999). 
Thus, when probing the mechanisms of worm death or survival after antibiotic 
therapy from the female worm proteome and onchocercoma transcriptome, a new 
analytical tool may be needed to draw any meaningful conclusion with respect to the 
specific source of the regulated proteins and transcripts. 
 The new framework for correlating transcription and protein abundance proposed 
by Morimoto and Yahara (2018) could be used to further analyse existing datasets to 
identify stress responses from the antibiotic treatments. The vaccinated groups were 
excluded from transcriptomic and proteomic studies because of a lack of significant 
effect on worm viability. We used the female worm proteome to compares changes 
at T0, T12 and T36 and the nodule transcriptome from alternate time points (T4, T8 
and T52) due to problems with RNA quality in several nodule extracts. Nonetheless, 
we would expect transcript and protein-level changes to show similar effects, as the 
latter, while separated by a variable time-lag, should be preceded by the former. The 
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effects of transcriptional changes that will result in worm death might persist over a 
long period, so that observations of the onchocercomata transcriptome at T4 and T8 
were expected to be valuable in explaining proteomic data at T12 and T36. However, 
we would have preferred to run proteomic and transcriptomic analyses from the 
same time-points had we not lost equivalent samples during total RNA extraction 
using the RNAqueous Total RNA Isolation Kit from Ambion. The major limitation of 
this kit was the frequent blockage of the filter as nodule homogenates were forced 
through with a syringe. Secondly, RNA quality declined after DNA removal from 
extracted RNA was done before final purification and submission for sequencing. We 
resorted to using the available alternate nodule samples with QIAGEN® RNeasy MIDI 
or MAXI kits, which gave excellent results. Homogenisation, RNA extraction and 
purification were carried out the same day in Cameroon. The main advantage of the 
QIAGEN® RNeasy MIDI kits was the one-step approach, where all procedures up to 
DNA removal were performed at room temperature before eluting purified RNA for 
storage at -80°C. The procedure was more appropriate for the extraction of large 
quantities of total RNA from nodules compared with the Ambion RNAqueous kits.    
Proteomic and transcriptomic data from the ADT group supported previous findings 
that oxytetracycline has a bacteriostatic effect on Wolbachia and interferes with 
ribosomal activity and protein synthesis (Chopra et al. 1992; Connell et al. 2003). 
Although we could not correlate changes in the endobacteria with those of the worm, 
it was evident that key processes that resulted in worm death were activated. 
In this study, it is worth re-emphasizing the surprising extensive expression of 
Wolbachia genes at eight weeks (Chapter 5, Section 5.3.4.2) and a few proteins thirty-
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six weeks (Chapter 4, Section 4.3.2.2) after start of oxytetracycline treatment when 
we least expected them given previous allusions that their complete depletion led to 
worm death based on histological observation (Hoerauf et al. 2001; Hoerauf et al. 
2003; Gilbert et al. 2005; Hoerauf et al. 2008b; Frederic Landmann et al. 2011). This 
brings to light a major limitation of some of the research tool used so far especially 
when interpretation is made without proper knowledge of the biology of an 
organism. The effect of ADT on the expression of pleD transcript (Aldridge et al. 2003) 
and its contribution to positioning Wolbachia where it can be easily identified by 
immunohistochemistry techniques will need to be investigated in future studies. The 
identification of the role of Wolbachia effectors (Rice et al. 2017) and effects on 
secretory pattern could contribute in explaining whether changes observed by 
immunohistochemistry were due to relocation of WSP or not.  
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6.2 General Conclusions 
 
6.2.1 Control of Onchocerciasis by Vaccination 
This study confirms the potency and immunogenicity of mutated O. ochengi 
onchocystatin as a vaccine candidate. The enhanced immune response observed 
from the vaccinated O. ochengi infected cattle is evident by the significantly raised 
and sustained IgG levels over four weeks. The onchocystatin, as expected, did attract 
the highest number of eosinophils into the nodules of the immunochemotherapy 
group during the first 12 weeks, but eosinophil levels dropped thereafter; whereas 
those in the ADT group continued to rise, thus effecting worm killing. It can be 
concluded that the vaccination failed due to a lack of booster dose after treatment, 
which might have sustained a high eosinophil level between 12 and 36 weeks, 
considered the critical period for worm killing. 
6.2.2 Worm Proteomics and Transcriptomics 
Our female worm proteomic data confirmed previous findings that worm death is 
preceded by depletion of Wolbachia and neutrophils, while eosinophil degranulation 
is enhanced. All proteins of Wolbachia and bovine origin involved in proinflammatory 
responses were downregulated. The bovine response was dominated by neutrophil 
granule proteins. Meanwhile, the majority of those few worm proteins exhibiting 
regulation were upregulated. Eosinophil granule proteins were also upregulated, and 
their effects on the worm could be deduced from the upregulation of cuticle and 
collagen proteins. Transcriptomic data did not significantly amplify our understanding 
of the immune mechanisms leading to worm killing. Mitochondrial transcripts and 
those regulating cuticle formations of treated worms were upregulated, while 
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Wolbachia transcripts were downregulated. Granulocytes within the nodules are rich 
in preformed granules and contain relatively little RNA (~1 µg per 107 cells in humans) 
(Tamassia et al. 2014). It was not possible to determine with precision the regulatory 
effect of antibiotic therapy on this cell population. However, the worms (the 
organism from which the highest number of transcripts could be quantified in the 
onchocercoma) showed evidence of interference with ingestion and apoptotic 
changes as early as eight weeks after the start of protracted treatment. 
Transcriptomic data enabled us to observe changes during ADT therapy that 
eventually killed adult worms, leading to resorption of several nodules by week 52. 
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6.3 Recommendations 
 
6.3.1 Immunochemotherapy 
1. The vaccination trial using mutated onchocystatin for immunochemotherapy 
should be repeated, with the cattle given booster doses at 4 and 8 weeks 
after treatment in the expectation of sustaining nodule eosinophilia for a 
longer period. Ideally, sampling and evaluation of animals for worm viability 
should last for a duration of two years. 
2. In addition, the therapeutic effect of onchocystatin on IVM-attenuated 
worms should be evaluated, with monitoring of effects on both adult worm 
viability and skin Mf. 
6.3.2 Research Cattle and Sampling 
The quality and availability of O. ochengi-infected experimental cattle has always 
been a challenge. In addition, the clinical history of cattle, especially past treatments 
with oxytetracycline, is not always available. Even though we made every effort to 
obtain healthy cattle, it is recommended that the research group should own a farm 
for the production O. ochengi- infected cattle along the River Vina. In the absence of 
this farm, future purchases of infected experimental cattle should take place at least 
six months before the start of experiments. 
The mechanism of evaluating male worm viability needs to be standardized to enable 
their absence to be factored alongside that of females. We recommend a specific 
study that will not only determine the normal range of male worms per female in 
nodules, but also solve the equation on how to factor viability of dying worms 
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following treatment in forecasting eventual worm death with high degree of 
accuracy. 
The strong positive association between observed nodule diameter, Mf densities, 
fecundity, and the number of viable worms observed only in the ADT group indicates 
that the parameters measured and analysed were true estimates of viability. Future 
studies should model the contribution of each measurement of viability, although 
larger datasets will be needed, and parameters monitored for a longer time to 
validate complete worm mortality in the macrofilaricidal group. 
The “gold standard” oxytetracycline therapy has rarely attained 80% macrofilaricidal 
efficacy. In the current study, worms with high fecundity tended to respond to initial 
antibiotic therapy differently from those with low fecundity. Future studies should 
verify this hypothesis, as it might have serious implications for the application of 
antibiotic therapy for human onchocerciasis patients in future. 
6.3.3 Worm Proteomics and Transcriptomics 
There remain a considerable number of uncharacterised nematode genes. In the 
current study, many of these genes were affected by antibiotic therapy. While several 
groups worldwide continue to annotate filarial genomes and integrate data on 
WormBase ParaSite (Howe et al. 2017), functional characterisation of the thousands 
of unique genes in filarial nematodes is a massive undertaking that requires 
significant investment. 
As leukocytes and other immune-related cells often produce overlapping proteins 
and transcripts, the identification of the source of an important protein can be 
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difficult unless immunohistochemical methods are properly optimised. We 
recommend that research be intensified in characterising bovine immune cells with 
the goal of identifying unique markers for bovine neutrophils, eosinophils, and 
macrophages, as well as extending the range of available markers for lymphocyte 
subsets. 
Given the presence of Wolbachia transcript in dying worms, studies will need to be 
conducted to re-evaluate the role of Wolbachia in worm killing. The effect of ADT on 
the expression of pleD transcript (Aldridge et al. 2003) and its contribution to 
positioning Wolbachia where it can be easily identified by immunohistochemistry 
techniques will need to be investigated. The identification of the role of Wolbachia 
effectors (Rice et al. 2017) and effects on secretory pattern could contribute to 
explaining whether changes observed by immunohistochemistry were due to 
relocation of WSP or not. 
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Appendix 
Appendix 6-1: Regulated Wolbachia Transcripts. I. 
Longitudinal significant expressions 
GENE ID 
log2 
FC 
P-
value 
Annotation Comparison 
wOo_06960 6 0.002 Response regulator PleD ADT_T4vsT8 
wOo_08620 5 0.003 Hypothetical protein ADT_T4vsT8 
wOo_01580 5 0.004 Preprotein translocase subunit SecE ADT_T4vsT8 
wOo_05010 5 0.005 tRNA-Glu-TTC ADT_T4vsT8 
wOo_06350 1 0.007 WAS family protein ADT_T4vsT8 
wOo_10250 1 0.006 30S ribosomal protein S11 ADT_T4vsT8 
wOo_03610 -1 0.007 NADPH-dependent glutamate synthase beta chain ADT_T4vsT8 
wOo_09850 -2 0.005 Glutamine amidotransferase domain-containing protein ADT_T4vsT8 
wOo_05150 -3 0.000 Ankyrin repeat-containing protein ADT_T4vsT8 
wOo_00530 5 0.001 Hypothetical protein CON_T4vsT52 
wOo_03610 -2 0.009 NADPH-dependent glutamate synthase beta chain CON_T4vsT52 
wOo_03760 6 0.003 tRNA pseudouridine synthase A CON_T4vsT8 
wOo_06590 5 0.002 Preprotein translocase subunit SecD CON_T4vsT8 
wOo_07930 -2 0.009 
tRNA uridine 5-carboxymethylaminomethyl modification 
enzyme GidA CON_T4vsT8 
wOo_08690 -2 0.001 Hypothetical protein CON_T4vsT8 
wOo_00530 5 0.001 Hypothetical protein CON_T8vsT52 
wOo_03610 -2 0.009 NADPH-dependent glutamate synthase beta chain CON_T8vsT52 
wOo_05670 7 0.000 Phosphatase  SLT_T4vsT52 
wOo_08750 7 0.000 
ABC-type Mn2+Zn2+ transport system permease 
component SLT_T4vsT52 
wOo_10500 7 0.000 30S ribosomal protein S10 SLT_T4vsT52 
wOo_03860 6 0.000 Putative translation factor SUA5 SLT_T4vsT52 
wOo_00220 6 0.000 tRNA-Ser-GCT SLT_T4vsT52 
wOo_07890 6 0.003 Hypothetical protein SLT_T4vsT52 
wOo_05560 6 0.002 RimM protein required for 16S rRNA processing SLT_T4vsT52 
wOo_01370 5 0.004 N6-adenine-specific methylase SLT_T4vsT52 
wOo_06810 5 0.003 stress-induced morphogen BolA SLT_T4vsT52 
wOo_06060 5 0.005 Hypothetical protein SLT_T4vsT52 
wOo_09480 5 0.007 Lipoprotein OsmY ortholog SLT_T4vsT52 
wOo_06870 5 0.006 Dihydrofolate reductase SLT_T4vsT52 
wOo_09200 5 0.008 NADH ubiquinone oxidoreductase 18 kDa subunit SLT_T4vsT52 
wOo_03940 5 0.007 Asp-tRNAAsnGlu-tRNAGln amidotransferase C subunit SLT_T4vsT52 
wOo_03270 5 0.009 tRNA-Val-TAC SLT_T4vsT52 
wOo_06050 5 0.010 Deoxycytidine triphosphate deaminase SLT_T4vsT52 
wOo_01870 4 0.002 peptidyl-tRNA hydrolase SLT_T4vsT52 
wOo_10010 3 0.003 tRNA processing exoribonuclease BN SLT_T4vsT52 
wOo_03020 3 0.004 HesBYadRYfhF family protein SLT_T4vsT52 
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wOo_10260 2 0.007 30S ribosomal protein S13 SLT_T4vsT52 
wOo_04550 2 0.007 
bifunctional GMP synthaseglutamine amidotransferase 
protein SLT_T4vsT52 
wOo_06300 1 0.005 
membrane protease subunit stomatinprohibitin-like 
protein SLT_T4vsT52 
wOo_07060 -1 0.010 transketolase SLT_T4vsT52 
wOo_04090 -1 0.006 inorganic polyphosphateATP-NAD kinase SLT_T4vsT52 
wOo_08840 -2 0.002 major facilitator superfamily permease SLT_T4vsT52 
wOo_09420 -2 0.007 permease SLT_T4vsT52 
wOo_01620 -2 0.002 50S ribosomal protein L10 SLT_T4vsT52 
wOo_10190 -6 0.001 cytochrome C oxidase assembly protein SLT_T4vsT52 
wOo_00160 -5 0.009 DnaK suppressor protein SLT_T4vsT8 
wOo 10280 -5 0.004 preprotein translocase subunit SecY SLT_T4vsT8 
wOo_10680 -5 0.008 ferredoxin SLT_T4vsT8 
wOo_10190 -6 0.001 cytochrome C oxidase assembly protein SLT_T4vsT8 
wOo_10500 7 0.000 30S ribosomal protein S10 SLT_T8VsT52 
wOo_06810 6 0.001 stress-induced morphogen BolA SLT_T8VsT52 
wOo_08750 6 0.000 
ABC-type Mn2+Zn2+ transport system permease 
component SLT_T8VsT52 
wOo_03860 6 0.000 putative translation factor SUA5 SLT_T8VsT52 
wOo_02750 6 0.001 cytochrome B561 SLT_T8VsT52 
wOo_05670 6 0.000 phosphatase SLT_T8VsT52 
wOo_09200 6 0.002 NADH ubiquinone oxidoreductase 18 kDa subunit SLT_T8VsT52 
wOo_01370 6 0.003 N6-adenine-specific methylase SLT_T8VsT52 
wOo_05560 6 0.003 RimM protein required for 16S rRNA processing SLT_T8VsT52 
wOo_00840 6 0.006 F0F1 ATP synthase epsilon subunit SLT_T8VsT52 
wOo_06870 6 0.002 dihydrofolate reductase SLT_T8VsT52 
wOo_08030 6 0.002 cytochrome c-type biogenesis protein CcmE SLT_T8VsT52 
wOo_09930 6 0.004 hypothetical protein SLT_T8VsT52 
wOo_06060 6 0.003 hypothetical protein SLT_T8VsT52 
wOo_00220 5 0.001 tRNA-Ser-GCT SLT_T8VsT52 
wOo_03940 5 0.003 Asp-tRNAAsnGlu-tRNAGln amidotransferase C subunit SLT_T8VsT52 
wOo_06050 5 0.003 deoxycytidine triphosphate deaminase SLT_T8VsT52 
wOo_07890 5 0.008 hypothetical protein SLT_T8VsT52 
wOo_06380 5 0.003 uroporphyrinogen-III synthase SLT_T8VsT52 
wOo_09480 5 0.007 lipoprotein OsmY ortholog SLT_T8VsT52 
wOo_03690 5 0.006 tRNA-Ala-TGC SLT_T8VsT52 
wOo_01450 5 0.005 hypothetical protein SLT_T8VsT52 
wOo_00340 5 0.007 NAD-specific glutamate dehydrogenase SLT_T8VsT52 
wOo_10280 5 0.004 preprotein translocase subunit SecY SLT_T8VsT52 
wOo_03270 5 0.007 tRNA-Val-TAC SLT_T8VsT52 
wOo_05010 5 0.009 tRNA-Glu-TTC SLT_T8VsT52 
wOo_04360 5 0.008 hypothetical protein SLT_T8VsT52 
wOo_02410 5 0.008 tRNA-Pro-TGG SLT_T8VsT52 
wOo_00740 5 0.008 hypothetical protein SLT_T8VsT52 
wOo_03810 3 0.006 ribonuclease HII SLT_T8VsT52 
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wOo_03020 3 0.003 HesBYadRYfhF family protein SLT_T8VsT52 
wOo_04240 3 0.007 GTPase ObgE SLT_T8VsT52 
wOo_10010 3 0.006 tRNA processing exoribonuclease BN SLT_T8VsT52 
wOo_10300 2 0.005 preprotein translocase subunit SecY SLT_T8VsT52 
wOo_04550 2 0.002 
bifunctional GMP synthaseglutamine amidotransferase 
protein SLT_T8VsT52 
wOo_05000 2 0.008 Asp-tRNAAsnGlu-tRNAGln amidotransferase A subunit SLT_T8VsT52 
wOo_02550 1 0.004 ribonucleotide-diphosphate reductase subunit beta SLT_T8VsT52 
wOo_05050 1 0.007 fructose-bisphosphate aldolase SLT_T8VsT52 
wOo_03400 1 0.008 Kef-type K+ transport system membrane component SLT_T8VsT52 
wOo_01630 -1 0.006 50S ribosomal protein L7L12 SLT_T8VsT52 
wOo_03330 -1 0.007 DNA gyrase subunit A SLT_T8VsT52 
wOo_04090 -1 0.004 inorganic polyphosphateATP-NAD kinase SLT T8VsT52 
wOo_06150 -2 0.008 DNA_recombination protein rmuC-like protein SLT_T8VsT52 
wOo_09720 -2 0.009 tRNA nucleotidyltransferasepolyA- polymerase SLT_T8VsT52 
wOo_09850 -2 0.001 glutamine amidotransferase domain-containing protein SLT_T8VsT52 
wOo_08840 -2 0.001 major facilitator superfamily permease SLT_T8VsT52 
wOo_07060 -2 0.000 transketolase SLT_T8VsT52 
wOo_08780 -2 0.001 
ATP-dependent exoDNase exonuclease V- beta subunit 
RecB SLT_T8VsT52 
wOo_08240 -2 0.005 prenyltransferase SLT_T8VsT52 
wOo_09420 -3 0.001 permease SLT_T8VsT52 
wOo_10150 -3 0.006 hypothetical_protein SLT_T8VsT52 
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Appendix 6-2. Regulated Wolbachia Transcripts. II. Between 
treatment significant expressions 
GENE ID 
Log2 
FC 
P-
value 
Annotation Comparison 
wOo_10150 3 0.000 hypothetical protein T52_CON_SLT 
wOo_09720 2 0.008 tRNA nucleotidyltransferasepolyA- polymerase T52_CON_SLT 
wOo_02790 -2 0.008 Type_IV_secretory_pathway_VirB4_component T8_CON_ADT 
wOo_07400 2 0.004 histidyl-tRNA_synthetase T52_CON_SLT 
wOo_08690 1 0.004 hypothetical_protein T52_CON_SLT 
wOo_00040 -2 0.002 dihydrolipoamide_dehydrogenase_E3_component T52_CON_SLT 
wOo_07910 -2 0.004 HesBYadRYfhF_family_protein T52_CON_SLT 
wOo_07390 -2 0.004 NifU_family_protein T52_CON_SLT 
wOo_02160 -4 0.004 tRNA-Thr-GGT T52_CON_SLT 
wOo_06950 -5 0.003 response_regulator_PleD T52_CON_SLT 
wOo_10500 5 0.002 30S_ribosomal_protein_S10 T8_CON_SLT 
wOo_09420 2 0.002 permease T8_SLT_ADT 
wOo_06810 5 0.001 stress-induced_morphogen_BolA T8_CON_SLT 
wOo_07060 2 0.001 transketolase T8_SLT_ADT 
wOo_06870 -5 0.009 dihydrofolate_reductase T8_SLT_ADT 
wOo_08250 9 0.009 ribosome-binding_factor_A T4_CON_ADT 
wOo_06960 10 0.003 response_regulator_PleD T4_CON_ADT 
wOo_06960 8 0.008 Response regulator PleD T4_SLT_ADT 
wOo_05890 -5 0.002 Ancestral ankyrin repeat-containing protein orthologue T52_CON_SLT 
wOo_02410 -5 0.002 tRNA-Pro-TGG T52_CON_SLT 
wOo_03370 -5 0.002 tRNA-Ser-TGA T52_CON_SLT 
wOo_06870 5 0.003 dihydrofolate_reductase T8_CON_SLT 
wOo_10280 10 0.007 preprotein_translocase_subunit_SecY T4_CON_ADT 
wOo_03270 -5 0.001 tRNA-Val-TAC T52_CON_SLT 
wOo_09200 5 0.008 NADH_ubiquinone_oxidoreductase_18_kDa_subunit T8_CON_SLT 
wOo_07020 4 0.004 hypothetical_protein T8_CON_SLT 
wOo_08060 3 0.006 NADH_ubiquinone_oxidoreductase_chain_N T8_CON_SLT 
wOo_03950 2 0.002 2-methylthioadenine_synthetase T8_CON_SLT 
wOo_05000 2 0.001 Asp-tRNAAsnGlu-tRNAGln_amidotransferase_A_subunit T8_CON_SLT 
wOo_06810 -5 0.002 stress-induced_morphogen_BolA T8_SLT_ADT 
wOo_04360 -5 0.001 hypothetical_protein T52_CON_SLT 
wOo_10300 2 0.006 preprotein_translocase_subunit_SecY T8_CON_SLT 
wOo_02950 2 0.009 geranylgeranyl_pyrophosphate_synthase T8_CON_SLT 
wOo_08760 -5 0.001 hypothetical_protein T52_CON_SLT 
wOo_00590 -5 0.001 hypothetical_protein T52_CON_SLT 
wOo_08690 2 0.005 hypothetical_protein T4_CON_SLT 
wOo_01780 -5 0.001 putative_monovalent_cationH+_antiporter_subunit_G T52_CON_SLT 
wOo_06380 -5 0.001 uroporphyrinogen-III_synthase T52_CON_SLT 
wOo_09590 -5 0.001 cardiolipin_synthase T52_CON_SLT 
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wOo_09480 -5 0.001 lipoprotein_OsmY_ortholog T52_CON_SLT 
wOo_08030 -5 0.000 cytochrome_c-type_biogenesis_protein_CcmE T52_CON_SLT 
wOo_04000 -5 0.000 tRNA-Val-GAC T52_CON_SLT 
wOo_00150 -5 0.000 
ABC-type transport system involved in cytochrome c 
biogenesis permease component T52_CON_SLT 
wOo_10680 -5 0.000 ferredoxin T52_CON_SLT 
wOo_08620 -6 0.000 hypothetical_protein T52_CON_SLT 
wOo_06150 -2 0.005 DNA_recombination_protein_rmuC-like_protein T8_CON_SLT 
wOo_03780 -6 0.000 YggT_family_membrane_protein T52_CON_SLT 
wOo_10280 -6 0.000 preprotein_translocase_subunit_SecY T52_CON_SLT 
wOo_02950 2 0.003 geranylgeranyl_pyrophosphate_synthase T8_CON_ADT 
wOo_07060 -2 0.001 transketolase T8_CON_SLT 
wOo_03620 -6 0.000 3R--hydroxymyristoyl-ACP_dehydratase T52_CON_SLT 
wOo_07090 -2 0.008 cytochrome_c_biogenesis_factor T8_CON_SLT 
wOo_09420 -3 0.001 permease T8_CON_SLT 
wOo_01620 -3 0.007 50S_ribosomal_protein_L10 T8_CON_SLT 
wOo_04620 -6 0.000 lipoprotein_signal_peptidase T52_CON_SLT 
wOo_01810 -3 0.010 putative_monovalent_cationH+_antiporter_subunit_C T8_CON_SLT 
wOo_10500 -6 0.001 30S_ribosomal_protein_S10 T8_SLT_ADT 
wOo_06060 -6 0.000 hypothetical_protein T52_CON_SLT 
wOo_08240 -3 0.008 prenyltransferase T8_CON_SLT 
wOo_01020 -3 0.001 phosphatidylglycerophosphatase_A_PgpA T8_CON_SLT 
wOo_03860 -6 0.000 putative_translation_factor_SUA5 T52_CON_SLT 
wOo_03520 -4 0.008 amino_acid_transporter T8_CON_SLT 
wOo_09930 -6 0.000 hypothetical_protein T52_CON_SLT 
wOo_08680 -6 0.000 hypothetical_protein T52_CON_SLT 
wOo_03760 -7 0.000 tRNA_pseudouridine_synthase_A T52_CON_SLT 
wOo_05560 -6 0.001 RimM_protein_required_for_16S_rRNA_processing T8_SLT_ADT 
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Appendix 6-3. Onchocerca ochengi Regulated Transcripts 
from Onchocercomata. Longitudinal differential expressions 
GENE ID 
log2 
FC 
P-
value 
Annotation Comparison 
nOo.2.0.1.t12597-RA 10 0.000 antigen maltose binding protein ADT_T48 
nOo.2.0.1.t12681-RA 10 0.000 collagen alpha-1 chain-like ADT_T48 
nOo.2.0.1.t13501-RA 10 0.000 no description ADT_T48 
nOo.2.0.1.t08607-RA 9 0.000 no description ADT_T48 
nOo.2.0.1.t10492-RA 9 0.000 no description ADT_T48 
nOo.2.0.1.t10494-RA 9 0.000 #N/A ADT_T48 
nOo.2.0.1.t13462-RA 9 0.000 no description ADT_T48 
nOo.2.0.1.t11104-RA 9 0.000 no description ADT_T48 
nOo.2.0.1.t11709-RA 8 0.000 cre-tag-297 protein ADT_T48 
nOo.2.0.1.t13865-RA 8 0.000 amidophosphoribosyltransferase [Callosobruchus chinensis] ADT_T48 
nOo.2.0.1.t10208-RA 8 0.000 
nematode cuticle collagen n-terminal domain containing 
protein ADT_T48 
nOo.2.0.1.t09695-RA 8 0.000 domon domain containing protein ADT_T48 
nOo.2.0.1.t12513-RA 8 0.000 no description ADT_T48 
nOo.2.0.1.t11532-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t09373-RA 7 0.000 cbn-mltn-7 protein ADT_T48 
nOo.2.0.1.t04360-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t13188-RA 7 0.004 #N/A ADT_T48 
nOo.2.0.1.t13067-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t13520-RA 7 0.001 no description ADT_T48 
nOo.2.0.1.t11152-RA 7 0.000 gcc2 and gcc3 ADT_T48 
nOo.2.0.1.t03608-RA 7 0.000 astacin metalloprotease ADT_T48 
nOo.2.0.1.t01988-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t00277-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t11131-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t10608-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t06520-RA 7 0.000 hepatic leukemia factor ADT_T48 
nOo.2.0.1.t13449-RA 7 0.002 no description ADT_T48 
nOo.2.0.1.t09027-RA 7 0.000 heat shock protein 60 ADT_T48 
nOo.2.0.1.t09055-RA 7 0.001 butyrate response factor 2 ADT_T48 
nOo.2.0.1.t07588-RA 7 0.000 cre-tag-297 protein ADT_T48 
nOo.2.0.1.t06269-RA 7 0.001 cell death specification protein 2 ADT_T48 
nOo.2.0.1.t11206-RA 7 0.001 no description ADT_T48 
nOo.2.0.1.t11443-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t12551-RA 7 0.001 no description ADT_T48 
nOo.2.0.1.t10815-RA 7 0.000 no description ADT_T48 
nOo.2.0.1.t10871-RA 6 0.001 no description ADT_T48 
nOo.2.0.1.t12435-RA 6 0.001 no description ADT_T48 
nOo.2.0.1.t06558-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t04545-RA 6 0.001 zinc finger ADT_T48 
nOo.2.0.1.t00085-RA 6 0.002 no description ADT_T48 
nOo.2.0.1.t12665-RA 6 0.000 estrogen receptor beta ADT_T48 
nOo.2.0.1.t10019-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t05947-RA 6 0.001 g2 mitotic-specific cyclin-b3 ADT_T48 
nOo.2.0.1.t05200-RA 6 0.000 small family member (sma-9) ADT_T48 
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nOo.2.0.1.t11374-RA 6 0.000 glutamate dehydrogenase ADT_T48 
nOo.2.0.1.t04544-RA 6 0.001 nucleolar gtp-binding protein 1 ADT_T48 
nOo.2.0.1.t11335-RA 6 0.001 no description ADT_T48 
nOo.2.0.1.t05201-RA 6 0.000 
atp-dependent clp protease atp-binding subunit clpx- 
mitochondrial isoform 2 ADT_T48 
nOo.2.0.1.t08487-RA 6 0.001 no description ADT_T48 
nOo.2.0.1.t12987-RA 6 0.000 ---NA--- ADT_T48 
nOo.2.0.1.t06624-RA 6 0.000 
hypothetical protein TRIADDRAFT_62725 [Trichoplax 
adhaerens] ADT_T48 
nOo.2.0.1.t12025-RA 6 0.000 pao retrotransposon peptidase family protein ADT_T48 
nOo.2.0.1.t02242-RA 6 0.000 cre-lpr-5 protein ADT_T48 
nOo.2.0.1.t09413-RA 6 0.002 prolyl 4-hydroxylase ADT_T48 
nOo.2.0.1.t06604-RA 6 0.001 no description ADT_T48 
nOo.2.0.1.t09889-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t07897-RA 6 0.000 protein isoform a ADT_T48 
nOo.2.0.1.t05418-RA 6 0.001 cre-col-109 protein ADT_T48 
nOo.2.0.1.t09546-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t04416-RA 6 0.001 fork head domain transcription factor slp2 ADT_T48 
nOo.2.0.1.t04231-RA 6 0.000 atp synthase beta subunit ADT_T48 
nOo.2.0.1.t06625-RA 6 0.000 uvrabc system protein a- partial ADT_T48 
nOo.2.0.1.t04497-RA 6 0.002 no description ADT_T48 
nOo.2.0.1.t10267-RA 6 0.001 target of poxn ADT_T48 
nOo.2.0.1.t10476-RA 6 0.002 glutamate receptor 1 ADT_T48 
nOo.2.0.1.t05102-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t06577-RA 6 0.001 variable abnormal morphology family member (vab-3) ADT_T48 
nOo.2.0.1.t11234-RA 6 0.001 deleted in malignant brain tumors 1 protein ADT_T48 
nOo.2.0.1.t13699-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t05047-RA 6 0.002 no description ADT_T48 
nOo.2.0.1.t06603-RA 6 0.002 twik (kcnk-like) family of potassium alpha subunit 39a ADT_T48 
nOo.2.0.1.t01172-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t10525-RA 6 0.000 leucine aminopeptidase-like protein ADT_T48 
nOo.2.0.1.t08770-RA 6 0.000 succinyl- ligase ADT_T48 
nOo.2.0.1.t10703-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t02122-RA 6 0.000 cre-wrt-9 protein ADT_T48 
nOo.2.0.1.t09210-RA 6 0.002 temporarily assigned gene name family member (tag-178) ADT_T48 
nOo.2.0.1.t10989-RA 6 0.003 bardet-biedl syndrome 2 protein homolog ADT_T48 
nOo.2.0.1.t09522-RA 6 0.004 cuticlin 1 ADT_T48 
nOo.2.0.1.t11110-RA 6 0.003 cre-hhat-1 protein ADT_T48 
nOo.2.0.1.t02515-RA 6 0.003 transcription factor coe1 ADT_T48 
nOo.2.0.1.t01103-RA 6 0.003 no description ADT_T48 
nOo.2.0.1.t02661-RA 6 0.000 phosphoribosylamine-glycine ligase ADT_T48 
nOo.2.0.1.t08089-RA 6 0.003 no description ADT_T48 
nOo.2.0.1.t09336-RA 6 0.003 
hypothetical protein TRIADDRAFT_35139 [Trichoplax 
adhaerens] ADT_T48 
nOo.2.0.1.t10047-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t05255-RA 6 0.000 
hypothetical protein TRIADDRAFT_62988 [Trichoplax 
adhaerens] ADT_T48 
nOo.2.0.1.t09663-RA 6 0.000 hepatic leukemia factor ADT_T48 
nOo.2.0.1.t12762-RA 6 0.003 ankyrin repeat and socs box protein 3 ADT_T48 
nOo.2.0.1.t11546-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t04868-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t07515-RA 6 0.000 nadh dehydrogenase ADT_T48 
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nOo.2.0.1.t10960-RA 6 0.004 no description ADT_T48 
nOo.2.0.1.t08283-RA 6 0.003 no description ADT_T48 
nOo.2.0.1.t07534-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t00955-RA 6 0.003 homeobox domain containing protein ADT_T48 
nOo.2.0.1.t07589-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t12566-RA 6 0.004 integrase core domain containing protein ADT_T48 
nOo.2.0.1.t06766-RA 6 0.004 no description ADT_T48 
nOo.2.0.1.t03924-RA 6 0.000 cytochrome c oxidase subunit i ADT_T48 
nOo.2.0.1.t07923-RA 6 0.000 protein isoform a ADT_T48 
nOo.2.0.1.t02241-RA 6 0.000 lpr-4 protein ADT_T48 
nOo.2.0.1.t10314-RA 6 0.004 cbr-eff-1 protein ADT_T48 
nOo.2.0.1.t12367-RA 6 0.004 heparan sulfate glucosamine 3-o-sulfotransferase 3a1 ADT_T48 
nOo.2.0.1.t11578-RA 6 0.010 no description ADT_T48 
nOo.2.0.1.t03907-RA 6 0.004 no description ADT_T48 
nOo.2.0.1.t06897-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t07173-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t03747-RA 6 0.005 no description ADT_T48 
nOo.2.0.1.t01280-RA 6 0.005 pao retrotransposon peptidase family protein ADT_T48 
nOo.2.0.1.t11698-RA 6 0.005 metalloprotease 1 precursor ADT_T48 
nOo.2.0.1.t08002-RA 6 0.000 no description ADT_T48 
nOo.2.0.1.t10588-RA 6 0.000 sensor histidine kinase response regulator ADT_T48 
nOo.2.0.1.t13793-RA 5 0.000 dna mismatch repair protein ADT_T48 
nOo.2.0.1.t09251-RA 5 0.000 cuticlin 1 ADT_T48 
nOo.2.0.1.t08001-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t12828-RA 5 0.000 
low-density lipoprotein receptor domain class a containing 
protein ADT_T48 
nOo.2.0.1.t11749-RA 5 0.005 pan domain protein ADT_T48 
nOo.2.0.1.t08606-RA 5 0.005 no description ADT_T48 
nOo.2.0.1.t01374-RA 5 0.005 no description ADT_T48 
nOo.2.0.1.t04120-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t13136-RA 5 0.006 cre-mlt-10 protein ADT_T48 
nOo.2.0.1.t13438-RA 5 0.005 no description ADT_T48 
nOo.2.0.1.t04918-RA 5 0.007 no description ADT_T48 
nOo.2.0.1.t09827-RA 5 0.003 odr-3 ADT_T48 
nOo.2.0.1.t08130-RA 5 0.000 kallmann syndrome 1 sequence ADT_T48 
nOo.2.0.1.t04164-RA 5 0.006 eukaryotic-type carbonic anhydrase family protein ADT_T48 
nOo.2.0.1.t04411-RA 5 0.003 myosin viia ADT_T48 
nOo.2.0.1.t12523-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t02255-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t02981-RA 5 0.000 cre-lgc-21 protein ADT_T48 
nOo.2.0.1.t06461-RA 5 0.001 leucine rich repeat family protein ADT_T48 
nOo.2.0.1.t07516-RA 5 0.000 deoxyribonuclease tatd ADT_T48 
nOo.2.0.1.t13452-RA 5 0.001 no description ADT_T48 
nOo.2.0.1.t03554-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t07451-RA 5 0.006 no description ADT_T48 
nOo.2.0.1.t12404-RA 5 0.006 helix-loop-helix dna-binding domain containing protein ADT_T48 
nOo.2.0.1.t05974-RA 5 0.008 no description ADT_T48 
nOo.2.0.1.t09038-RA 5 0.000 glutathione s-transferase domain-containing protein ADT_T48 
nOo.2.0.1.t06668-RA 5 0.000 nuclear hormone receptor family member nhr-25 ADT_T48 
nOo.2.0.1.t04452-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t07379-RA 5 0.000 glutathione s- n-terminal domain containing protein ADT_T48 
nOo.2.0.1.t08642-RA 5 0.000 cre-col-182 protein ADT_T48 
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nOo.2.0.1.t09565-RA 5 0.000 lectin c-type domain containing protein ADT_T48 
nOo.2.0.1.t10630-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t12692-RA 5 0.008 hypothetical kda protein in hem2-och1 intergenic ADT_T48 
nOo.2.0.1.t10526-RA 5 0.000 transcription termination factor rho ADT_T48 
nOo.2.0.1.t10779-RA 5 0.008 heparan sulfate glucosamine 3-o-sulfotransferase 3b1 ADT_T48 
nOo.2.0.1.t02071-RA 5 0.001 no description ADT_T48 
nOo.2.0.1.t09146-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t02926-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t04498-RA 5 0.008 zinc c2h2 type family protein ADT_T48 
nOo.2.0.1.t13664-RA 5 0.008 no description ADT_T48 
nOo.2.0.1.t08342-RA 5 0.008 no description ADT_T48 
nOo.2.0.1.t13621-RA 5 0.008 no description ADT_T48 
nOo.2.0.1.t12798-RA 5 0.006 no description ADT_T48 
nOo.2.0.1.t12530-RA 5 0.005 nas-15 protein ADT_T48 
nOo.2.0.1.t07129-RA 5 0.004 acetyl-coa synthetase ADT_T48 
nOo.2.0.1.t09963-RA 5 0.001 no description ADT_T48 
nOo.2.0.1.t06078-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t08264-RA 5 0.009 no description ADT_T48 
nOo.2.0.1.t12369-RA 5 0.001 no description ADT_T48 
nOo.2.0.1.t08000-RA 5 0.000 ---NA--- ADT_T48 
nOo.2.0.1.t13363-RA 5 0.010 no description ADT_T48 
nOo.2.0.1.t03231-RA 5 0.002 fatty acid-binding protein ADT_T48 
nOo.2.0.1.t03675-RA 5 0.006 no description ADT_T48 
nOo.2.0.1.t10182-RA 5 0.002 
nematode cuticle collagen n-terminal domain containing 
protein ADT_T48 
nOo.2.0.1.t01681-RA 5 0.001 pan domain-containing protein ADT_T48 
nOo.2.0.1.t13301-RA 5 0.002 discoidin domain-containing receptor 2-like ADT_T48 
nOo.2.0.1.t04364-RA 5 0.010 
nematode cuticle collagen n-terminal domain containing 
protein ADT_T48 
nOo.2.0.1.t11269-RA 5 0.002 no description ADT_T48 
nOo.2.0.1.t13668-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t11272-RA 5 0.001 thyroid hormone receptor ADT_T48 
nOo.2.0.1.t04595-RA 5 0.000 lbp bpi cetp n-terminal domain containing protein ADT_T48 
nOo.2.0.1.t01389-RA 5 0.000 nuclear hormone receptor e75 ADT_T48 
nOo.2.0.1.t12777-RA 5 0.007 integrase core domain containing protein ADT_T48 
nOo.2.0.1.t07294-RA 5 0.000 nematode cuticle collagen domain-containing protein ADT_T48 
nOo.2.0.1.t06331-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t09444-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t07380-RA 5 0.000 glutathione s-transferase domain-containing protein ADT_T48 
nOo.2.0.1.t04394-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t07517-RA 5 0.000 tyrosyl-trna synthetase 2 ADT_T48 
nOo.2.0.1.t08769-RA 5 0.000 diaminopimelate epimerase-like ADT_T48 
nOo.2.0.1.t10589-RA 5 0.000 5 -nucleotidase sure-like ADT_T48 
nOo.2.0.1.t06262-RA 5 0.009 complexin precursor ADT_T48 
nOo.2.0.1.t00081-RA 5 0.004 vesicular glutamate transporter 3 ADT_T48 
nOo.2.0.1.t09866-RA 5 0.003 no description ADT_T48 
nOo.2.0.1.t09042-RA 5 0.000 lbp bpi cetp c-terminal domain containing protein ADT_T48 
nOo.2.0.1.t08922-RA 5 0.003 no description ADT_T48 
nOo.2.0.1.t02676-RA 5 0.000 leucine rich repeat family protein ADT_T48 
nOo.2.0.1.t12049-RA 5 0.002 #N/A ADT_T48 
nOo.2.0.1.t08771-RA 5 0.004 fibronectin type iii domain containing protein ADT_T48 
nOo.2.0.1.t10766-RA 5 0.000 no description ADT_T48 
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nOo.2.0.1.t11500-RA 5 0.002 no description ADT_T48 
nOo.2.0.1.t07744-RA 5 0.005 no description ADT_T48 
nOo.2.0.1.t08138-RA 5 0.000 hunchback transcription factor ADT_T48 
nOo.2.0.1.t08222-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t07546-RA 5 0.000 helix-loop-helix dna-binding domain-containing protein ADT_T48 
nOo.2.0.1.t09513-RA 5 0.000 no description ADT_T48 
nOo.2.0.1.t12555-RA 5 0.004 no description ADT_T48 
nOo.2.0.1.t08281-RA 5 0.000 caveolin 1 ADT_T48 
nOo.2.0.1.t10210-RA 5 0.001 cuticle collagen dpy-2 ADT_T48 
nOo.2.0.1.t12829-RA 5 0.001 cadherin domain-containing protein ADT_T48 
nOo.2.0.1.t06159-RA 5 0.000 period circadian protein ADT_T48 
nOo.2.0.1.t12915-RA 5 0.001 ---NA--- ADT_T48 
nOo.2.0.1.t08795-RA 5 0.000 cre-atf-2 protein ADT_T48 
nOo.2.0.1.t12429-RA 5 0.002 tyrosine-protein kinase src42a-like isoform 1 ADT_T48 
nOo.2.0.1.t01803-RA 5 0.005 CES-1 [Brugia malayi] ADT_T48 
nOo.2.0.1.t10544-RA 5 0.001 cuticlin 1 ADT_T48 
nOo.2.0.1.t09594-RA 5 0.003 gcc2 and gcc3 ADT_T48 
nOo.2.0.1.t03748-RA 5 0.002 no description ADT_T48 
nOo.2.0.1.t03923-RA 5 0.000 glyceraldehyde 3-phosphate dehydrogenase ADT_T48 
nOo.2.0.1.t07225-RA 5 0.001 wrt-10 protein ADT_T48 
nOo.2.0.1.t11988-RA 4 0.002 no description ADT_T48 
nOo.2.0.1.t00013-RA 4 0.000 pan domain protein ADT_T48 
nOo.2.0.1.t06387-RA 4 0.000 von willebrand factor type a domain containing protein ADT_T48 
nOo.2.0.1.t10789-RA 4 0.002 lethal family member (let-653) ADT_T48 
nOo.2.0.1.t07481-RA 4 0.000 upf0639 protein ADT_T48 
nOo.2.0.1.t07749-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t11713-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t10758-RA 4 0.005 ankyrin repeat and socs box protein 3 ADT_T48 
nOo.2.0.1.t07243-RA 4 0.000 hypothetical protein Bm1_50630 [Brugia malayi] ADT_T48 
nOo.2.0.1.t01785-RA 4 0.001 no description ADT_T48 
nOo.2.0.1.t06440-RA 4 0.008 cre-unc-10 protein ADT_T48 
nOo.2.0.1.t12383-RA 4 0.003 no description ADT_T48 
nOo.2.0.1.t07536-RA 4 0.009 cre-mex-1 protein ADT_T48 
nOo.2.0.1.t04580-RA 4 0.004 paired box protein pax-6 ADT_T48 
nOo.2.0.1.t06089-RA 4 0.004 u uitin family member (ubq-1) ADT_T48 
nOo.2.0.1.t08970-RA 4 0.009 no description ADT_T48 
nOo.2.0.1.t06773-RA 4 0.004 cuticlin 1 ADT_T48 
nOo.2.0.1.t07514-RA 4 0.002 udp-n-acetylmuramoyl-tripeptide--d-alanyl-d-alanine partial ADT_T48 
nOo.2.0.1.t02624-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t12934-RA 4 0.002 #N/A ADT_T48 
nOo.2.0.1.t12860-RA 4 0.003 no description ADT_T48 
nOo.2.0.1.t02059-RA 4 0.006 no description ADT_T48 
nOo.2.0.1.t08117-RA 4 0.001 no description ADT_T48 
nOo.2.0.1.t00992-RA 4 0.007 unc-3 ADT_T48 
nOo.2.0.1.t12823-RA 4 0.008 no description ADT_T48 
nOo.2.0.1.t02391-RA 4 0.007 low quality protein: hemicentin-1-like ADT_T48 
nOo.2.0.1.t02243-RA 4 0.001 no description ADT_T48 
nOo.2.0.1.t06469-RA 4 0.003 cadherin domain-containing protein ADT_T48 
nOo.2.0.1.t11880-RA 4 0.001 homeobox protein onecut ADT_T48 
nOo.2.0.1.t06395-RA 4 0.001 cuticlin 1 ADT_T48 
nOo.2.0.1.t07689-RA 4 0.005 osmotic avoidance abnormal family member (osm-3) ADT_T48 
nOo.2.0.1.t13116-RA 4 0.004 no description ADT_T48 
220 
 
 
nOo.2.0.1.t06378-RA 4 0.009 no description ADT_T48 
nOo.2.0.1.t03961-RA 4 0.001 leucyl-cystinyl aminopeptidase ADT_T48 
nOo.2.0.1.t08455-RA 4 0.007 no description ADT_T48 
nOo.2.0.1.t08976-RA 4 0.000 leucine-rich repeat neuronal protein 2-like ADT_T48 
nOo.2.0.1.t10339-RA 4 0.008 no description ADT_T48 
nOo.2.0.1.t11410-RA 4 0.007 no description ADT_T48 
nOo.2.0.1.t05821-RA 4 0.003 hypothetical tyrosinase-like protein in chromosome ADT_T48 
nOo.2.0.1.t04864-RA 4 0.002 no description ADT_T48 
nOo.2.0.1.t05034-RA 4 0.001 ground-like domain containing protein ADT_T48 
nOo.2.0.1.t07375-RA 4 0.004 variable abnormal morphology family member (vab-3) ADT_T48 
nOo.2.0.1.t07090-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t10979-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t08674-RA 4 0.007 cuticle collagen dpy-2 ADT_T48 
nOo.2.0.1.t06667-RA 4 0.009 nuclear hormone receptor family member nhr-25 ADT_T48 
nOo.2.0.1.t07043-RA 4 0.000 pr domain zinc finger protein 1 ADT_T48 
nOo.2.0.1.t06230-RA 4 0.007 egl-46 ADT_T48 
nOo.2.0.1.t05378-RA 4 0.009 cugbp elav family member 4 ADT_T48 
nOo.2.0.1.t01838-RA 4 0.002 long-chain-fatty-acid-- ligase partial ADT_T48 
nOo.2.0.1.t08350-RA 4 0.000 innexin family protein ADT_T48 
nOo.2.0.1.t10613-RA 4 0.006 myosin-viia ADT_T48 
nOo.2.0.1.t12332-RA 4 0.004 no description ADT_T48 
nOo.2.0.1.t10377-RA 4 0.003 cre-unc-71 protein ADT_T48 
nOo.2.0.1.t05282-RA 4 0.000 twk-7 protein ADT_T48 
nOo.2.0.1.t07924-RA 4 0.003 calcium binding egf domain containing protein ADT_T48 
nOo.2.0.1.t10187-RA 4 0.004 gcc2 and gcc3 ADT_T48 
nOo.2.0.1.t00808-RA 4 0.000 
kunitz bovine pancreatic trypsin inhibitor domain containing 
protein ADT_T48 
nOo.2.0.1.t11983-RA 4 0.007 myosin viia ADT_T48 
nOo.2.0.1.t00148-RA 4 0.005 ras-related protein rab-28-like isoform 2 ADT_T48 
nOo.2.0.1.t06704-RA 4 0.003 protein phosphatase 1h ADT_T48 
nOo.2.0.1.t04883-RA 4 0.001 hydroxysteroid dehydrogenase ADT_T48 
nOo.2.0.1.t00712-RA 4 0.001 no description ADT_T48 
nOo.2.0.1.t05354-RA 4 0.008 gcc2 and gcc3 ADT_T48 
nOo.2.0.1.t11750-RA 4 0.009 cadherin domain containing protein ADT_T48 
nOo.2.0.1.t02834-RA 4 0.001 zinc finger protein ADT_T48 
nOo.2.0.1.t12206-RA 4 0.003 no description ADT_T48 
nOo.2.0.1.t04981-RA 4 0.003 no description ADT_T48 
nOo.2.0.1.t03667-RA 4 0.000 no description ADT_T48 
nOo.2.0.1.t07982-RA 4 0.006 cuticle collagen dpy-7 ADT_T48 
nOo.2.0.1.t11220-RA 4 0.004 protein-l-isoaspartate(d-aspartate) o-methyltransferase ADT_T48 
nOo.2.0.1.t05827-RA 4 0.005 bone morphogenetic protein 3b ADT_T48 
nOo.2.0.1.t12110-RA 4 0.003 no description ADT_T48 
nOo.2.0.1.t09205-RA 4 0.006 no description ADT_T48 
nOo.2.0.1.t02857-RA 4 0.000 patched family protein ADT_T48 
nOo.2.0.1.t03726-RA 4 0.001 patched family protein ADT_T48 
nOo.2.0.1.t05713-RA 4 0.004 no description ADT_T48 
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Appendix 6-4: Published Articles Obtained from and during 
PhD studies. 
 
• Chapter 3 was published as follows: 
Immunotherapy with mutated Onchocystatin fails to enhance the efficacy of a sub-
lethal oxytetracycline regimen against Onchocerca ochengi. 
Bah G S, Tanya V N, Makepeace B L. 
Vet Parasitol. 2015 Aug 15; 212 (1-2): 25-34. doi: 10.1016/j.vetpar.2015.06.005. Epub 
2015 Jun 12. PMID: 26100152. 
 
• While working on my thesis, I contributed to the following related 
publications: 
Stage-specific Proteomes from Onchocerca ochengi, Sister Species of the Human 
River Blindness Parasite, Uncover Adaptations to a Nodular Lifestyle. 
Armstrong S D, Xia D, Bah G S, Krishna R, Ngangyung H F, LaCourse E J, McSorley H J, 
Kengne-Ouafo J A, Chounna-Ndongmo P W, Wanji S, Enyong P A, Taylor D W, Blaxter 
ML, Wastling JM, Tanya VN, Makepeace BL. 
Mol Cell Proteomics. 2016 Aug; 15(8): 2554-75. doi: 10.1074/mcp.M115.055640. 
Epub 2016 May 25. PMID:27226403 
 
Extracellular Onchocerca-derived small RNAs in host nodules and blood. 
Quintana J F, Makepeace B L, Babayan S A, Ivens A, Pfarr K M, Blaxter M, Debrah A, 
Wanji S, Ngangyung H F, Bah G S, Tanya V N, Taylor D W, Hoerauf A, Buck A H. 
Parasite Vectors. 2015 Jan 27; 8:58. doi: 10.1186/s13071-015-0656-1. 
PMID:25623184 
 
Efficacy of three-week oxytetracycline or rifampin monotherapy compared with a 
combination regimen against the filarial nematode Onchocerca ochengi. 
Bah G S, Ward E L, Srivastava A, Trees A J, Tanya V N, Makepeace B L. 
Antimicrob Agents Chemother. 2014; 58(2): 801-10. doi: 10.1128/AAC.01995-13. 
Epub 2013 Nov 18. PMID:24247133 
 
Analysis of gene expression from the Wolbachia genome of a filarial nematode 
supports both metabolic and defensive roles within the symbiosis. 
Darby A C, Armstrong S D, Bah G S, Kaur G, Hughes M A, Kay S M, Koldkjær P, Rainbow 
L, Radford A D, Blaxter ML, Tanya V N, Trees A J, Cordaux R, Wastling J M, Makepeace 
B L. 
Genome Res. 2012 Dec; 22(12): 2467-77. doi: 10.1101/gr.138420.112. Epub 2012 Aug 
23. PMID: 22919073 
 
A worm's best friend: recruitment of neutrophils by Wolbachia confounds eosinophil 
degranulation against the filarial nematode Onchocerca ochengi. 
Hansen R D, Trees A J, Bah G S, Hetzel U, Martin C, Bain O, Tanya V N, Makepeace B 
L. 
Proc Biol Sci. 2011 Aug 7; 278(1716): 2293-302. doi: 10.1098/rspb.2010.2367. Epub 
2010 Dec 22. PMID: 21177682  
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